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The high-affinity choline transporter (CHT) supplies the substrate, choline, for the synthesis of 
acetylcholine (ACh) within cholinergic neurons.  Choline uptake mediated by this protein has 
been studied for over 30 years and many of the regulatory mechanisms governing its function are 
well characterized. Early studies, as well as more recent investigations, focused on specific 
populations of cholinergic axons in the brain, namely the cholinergic innervations of cortical, 
striatal, and hippocampal regions.  Details of the expression and subcellular localization of the 
high-affinity choline transporter within the projections of the pedunculopontine (PPT) and 
laterodorsal (LDT) tegmental cholinergic neurons have not been examined.  The studies 
described herein compare the cholinergic axons within two limbic regions that are innervated by 
the ascending projections from these brainstem nuclei.  These experiments were designed to 
characterize:  1) the relative amount and pattern of subcellular localization of the high-affinity 
 v 
choline transporter protein in the axon varicosities of this projection system; 2) the co-expression 
of the high-affinity choline transporter and the vesicular acetylcholine transporter in these two 
populations of axon varicosities; and 3) the organization and possible collateralization of 
projections of the cholinergic neurons that provide cholinergic innervation to these regions.  The 
results of these studies indicate that the expression and localization of the high-affinity choline 
transporter differs only subtly across brain regions innervated by the brainstem tegmental 
cholinergic neurons, and suggest that these differences may be accounted for by a pattern of 
specific innervation arising from distinct subsets of pedunculopontine and laterodorsal tegmental 
cholinergic neurons. 
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1.0  INTRODUCTION 
This thesis examines the pattern of expression and subcellular localization of the high-
affinity choline transporter (CHT) within cholinergic axons arising from the brainstem tegmental 
cholinergic system.  The characteristics of CHT in these axons are compared across two 
important components of the limbic system, the anteroventral nucleus of the thalamus (AVN) 
and the ventral tegmental area (VTA).  The differences in CHT observed across these regions are 
further characterized in relation to the pattern of innervation of these regions by brainstem 
cholinergic neurons. 
1.1 CHOLINERGIC SYSTEMS IN THE MAMMALIAN CNS 
Acetylcholine (ACh) is a phylogenetically ancient chemical transmitter, and has been 
adapted for an impressive range of functional roles by different species and at different sites 
within the vertebrate nervous system (Cooper et al 2003).  In mammals, ACh serves as the 
excitatory transmitter at the neuromuscular junction and is also utilized extensively throughout 
the autonomic and central nervous systems.  ACh exerts its effects through a large number of 
ionotropic and metabotropic receptor subtype and so can have vastly different effects on post-
synaptic cells.  ACh is synthesized and released by many different groups of neurons in the 
brain, as illustrated in Figure 1, including interneurons that provide local innervation in the 
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striatum,  and projection neurons in the forebrain and the brainstem (Mesulam et al 1983; Woolf 
1991) that provide cholinergic innervation to most cortical and subcortical structures. 
The projections of different cholinergic groups are organized such that the brain regions 
innervated by each major group are largely non-overlapping.  For simplicity, these projections 
systems can be divided into two loose groups.  Cholinergic neurons in several forebrain nuclei 
(e.g. diagonal band nuclei, nucleus basalis of Meynert, medial septum) provide the majority of 
acetylcholine innervation to the olfactory bulb, cerebral cortex and hippocampal formation, 
(Mesulam et al 1983; Woolf 1991).   ACh release in frontal cortical regions modulates cognitive 
processing and is important for directing attention towards information that is relevant to on-
going, goal-directed behavior (Himmelheber et al 2000; 2001).     In contrast, the majority of 
ACh innervation of the thalamus and midbrain originates from a second group of neurons in the 
brainstem mesopontine tegmentum.  Cholinergic neurons located within the pedunculopontine 
tegmental (PPT) and laterodorsal tegmental (LDT) nuclei have ascending projections to 
subcortical limbic structures.  Limbic targets of PPT and LDT cholinergic axons contribute to 
cognitive and emotional processing through their anatomical interconnection with other cortical 
and subcortical limbic areas.  Ascending cholinergic innervation from the PPT/LDT is present in 
many areas that are heavily interconnected with each other (Woolf & Butcher 1986).  The 
brainstem cholinergic system can therefore influence a variety of cognitive and behavioral 
processes, and represents a powerful modulatory force in the brain (Winn 1998; 2008). 
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Figure 1  Major sources of cholinergic innervation to limbic structures in the mammalian nervous system. 
Separate groups of ACh-synthesizing cells modulate neuronal activity in different forebrain and midbrain structures.  
Cholinergic cells in the basal forebrain (BF), medial septum (MS) provide ACh innervation of the cortical mantle 
and hippocampal formation, respectively.  The brainstem PPT/LDT nuclei have ascending cholinergic projections 
that innervate a broad variety of subcortical brain regions, such as the thalamus, hypothalamus, superior colliculus, 
and ventral midbrain.  In contrast, the ACh in the striatum (stippled region) is released by a network of intrinsic 
interneurons.  Illustration is modeled after (Woolf 1991), using a base sagittal plane illustration from (Paxinos & 
Watson 1997).  
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1.2 BRAINSTEM TEGMENTAL CHOLINERGIC NEURONS 
As indicated above, the brainstem PPT and LDT cholinergic neurons provide a 
substantial proportion of the ascending cholinergic innervation to subcortical structures in the 
midbrain and forebrain.  The cellular and physiological characteristics of these neurons, and their 
anatomical connectivity with other brain regions, indicate that there are heterogenous sub-
populations of cholinergic neurons within the larger grouping of the PPT/LDT.  
 
1.2.1 Morphological Characteristics and Anatomical Organization 
Cholinergic neurons in the brainstem tegmentum are typically large, multipolar neurons 
radiating multiple primary dendrites (Hallanger et al 1987; Hallanger & Wainer 1988; Jones 
1995).  These cells are distributed in two densely packed groups within the brainstem, in the 
lateral portion of the PPT, where ACh neurons are clustered around the lateral margin of the 
brachium of the superior cerebellar peduncle (Woolf 1991; Lavoie & Parent 1994), and, more 
caudally, within the ventral portion of the periaqueductal gray matter designated as the LDT.  
This nucleus is bordered rostrally by the dorsal tegmental nucleus and both dorsally and medially 
by the dorsal raphé nucleus.  Cholinergic neurons are also found in a ventral extension of the 
LDT, scattered within the medial longitudinal fasciculus (mlf) and in the dorsolateral reticular 
field that lies immediately ventral to this fiber tract.  A third group of ACh cells are found 
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scattered within the medial PPT (or PPT pars dissipata, PPTd) a region of the dorsolateral 
tegmentum that is bounded laterally and dorsally by the superior cerebellar peduncle (scp) 
(Lavoie & Parent 1994).  Cholinergic neurons are more loosely distributed throughout the PPTd, 
and are intermingled with numerous non-cholinergic cells, some of which are glutamatergic 
(Clements & Grant 1990).  Although non-cholinergic neurons are found in the lateral PPT and 
the LDT as well, they account for a larger proportion of cells in the PPTd (Rye et al 1987).   
PPT and LDT neurons provide ACh innervation to a large number of subcortical areas, 
including many thalamic and hypothalamic nuclei, the lateral septum, and basal forebrain (Satoh 
& Fibiger 1986; Hallanger et al 1987; Hallanger & Wainer 1988; Cornwall et al 1990; Bina et al 
1993).  Through these subcortical projections, PPT/LDT neurons can have pronounced effects 
over a range of behaviors (Inglis & Winn 1995).  For example, cholinergic projections to the 
thalamus indirectly influence neural activity in cortical regions, as the thalamic relay nuclei 
targeted by PPT/LDT cholinergic projections contain the cell bodies of the major excitatory 
afferents to the neocortex (Groenewegen & Witter 2004).  ACh release in the thalamus results in 
the activation of thalamocortical neurons, thereby influencing cortical excitability indirectly (Hu 
et al 1988; Paré et al 1990; Curro Dossi et al 1991).  Cholinergic projections from the brainstem 
that target the intralaminar thalamic nuclei can alter neural processing in cortico-subcortical 
circuitry by modulating the activity of thalamostriatal projection neurons (Erro et al 1999).  
Additionally,  projections to the locus coeruleus, raphé nuclei, and midbrain substantia nigra pars 
compacta (SNc) and ventral tegmental area (VTA) modulate, respectively, the activity of 
norephinephrine (NE), serotonin (5-hydroxytryptamine; 5-HT), and dopamine (DA) projection 
neurons that innervate widespread areas in the cerebral cortex, thalamus, hippocampus, and other 
forebrain structures (Mesulam et al 1983; Woolf & Butcher 1986; Woolf 1991). 
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The projections of the PPT and LDT are organized in a loose topography, such that the 
PPT projects more heavily to sensorimotor-associated structures (e.g. relay nuclei of the 
thalamus, the SNc (Beninato & Spencer 1987; Clarke et al 1987)), while the projections of the 
LDT more commonly target limbic-related regions, such as the midline and intralaminar nuclei 
of the thalamus (Satoh & Fibiger 1986), and the VTA (Oakman et al 1995).  Similarly, the 
reciprocal projections of many regions innervated by the cholinergic brainstem neurons show a 
preferential targeting of the nucleus from which its input arises (Semba & Fibiger 1992; 
Steininger et al 1992). The functional topography of PPT and LDT projections is not strict, as 
most targets of ascending PPT/LDT axons receive projections from both brainstem tegmental 
nuclei.  Rather, some structures have afferent populations that are more heavily drawn from 
either the PPT or the LDT (Satoh & Fibiger 1986; Hallanger & Wainer 1988; Oakman et al 
1995).   
   In addition, axon collaterals of single PPT/LDT neurons have been shown to project to 
multiple targets, indicating that ACh release might be coordinated across disparate brain regions 
(Woolf & Butcher 1986).  In particular, it has been reported that almost all cholinergic neurons 
in the cholinergic mesopontine tegmentum send a projection to the thalamus, implying that the 
innervation of non-thalamic targets results from the collateralization of ascending cholinergic 
axons (Oakman et al 1999).  PPT/LDT neurons can innervate multiple thalamic nuclei (Steriade 
et al 1990a; Bolton et al 1993) and separate studies have demonstrated collateralized input to 
both a thalamic target and the basal forebrain (Losier & Semba 1993), cerebral cortex (Jourdain 
et al 1989), olfactory bulb (Cornwall & Phillipson 1989), superior colliculus (Billet et al 1999), 
or the VTA (Bolton et al 1993).  Despite these observations, the organization of collateral 
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projections from PPT/LDT neurons to specific combinations of discrete thalamic nuclei and non-
thalamic targets is far from fully understood.    
 
1.2.2 Heterogeneity of Physiological Characteristics in PPT/LDT cells 
The best-characterized PPT/LDT neurons are the large, ACh synthesizing cells with 
ascending projections throughout the forebrain.  Neurons that utilize glutamate or GABA as a 
neurotransmitter are interspersed among the cholinergic cells, and these transmitters may be co-
released by ACh neurons as well (Clements & Grant 1990; Lavoie & Parent 1994; Ford et al 
1995; Grofova & Zhou 1998; Parent et al 1999; Jia et al 2003; Hur & Zaborszky 2005).  
Cholinergic PPT/LDT neurons express NADPH-diaphorase (Lavoie & Parent 1994; Lolova et al 
1996; Nemcova et al 2000), a nitric oxide synthase, and actively generate nitric oxide as a 
signaling agent (Williams et al 1997), although ACh neurons are not unique in the tegmentum in 
expression of this enzyme (Scherer-Singler et al 1983).  Finally, some ACh neurons colocalize 
various neuropeptides, including substance P (Vincent et al 1983; Sutin & Jacobowitz 1990), 
corticotrophin releasing factor, and atriopeptin (Crawley et al 1985; Standaert et al 1986).  
Although some targets of ACh and peptide co-expressing neurons have been identified (Crawley 
et al 1985), the specific projections of the ACh/neuropeptidergic neurons have not been 
thoroughly explored.  
Electrophysiological recordings in the rat and cat indicate that the component neurons of 
the PPT and LDT have heterogeneous firing rates and responses to stimulation.  Cells with fast 
or slow spontaneous firing rates have been identified (Steriade et al 1990a), and at least three 
separate groups of neurons have been postulated on the basis of ionic currents and firing patterns 
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(Kang et al 1990; Reese et al 1995b).  Furthermore, the correlation of activity in PPT/LDT 
neurons with behavioral states (i.e. wake (W), slow-wave sleep (SWS), and rapid eye movement 
sleep (REM)) reveals at least three sub-populations of tegmental neurons within the PPT and 
LDT (Steriade et al 1990a; Datta & Siwek 2002).  Many neurons show elevated firing during W 
and REM sleep, some display progressive increases in activity across stages, with REM firing > 
SWS > W, and still others have behavioral state-independent spontaneous rates of activity.   
Unfortunately, these physiologically-defined groups do not strictly correspond to distinct 
neurochemical phenotypes (Leonard & Llinás 1990), but there are indications that most 
mesopontine tegmental cholinergic neurons display tonic firing patterns, increased activity in W 
and REM states, and an absence of low-threshold calcium currents that underlie some neuronal 
bursting behavior.  Some of these neurons may be capable of firing bursts of action potentials 
(Wilcox et al 1989), through the activation high-threshold calcium currents (Kang et al 1990; 
Leonard & Llinás 1990), and so might fire differentially based on their relative depolarization 
state, but this possibility is still contentious.  Although cholinergic PPT/LDT neurons are all 
thought to have relatively fast (>10 Hz) spontaneous firing rates, the tonic firing rates observed 
within this physiological category still displays some variability across neurons, indicating that 
some cholinergic PPT/LDT cells probably fire action potentials at higher resting rates than others 
(Steriade et al 1990a).   
Although in vitro and in vivo recordings have provided invaluable information on the 
activity of brainstem neurons, it is, as yet, practically impossible to determine the biophysical 
properties of a neuron, its behaviorally correlated responses, its innervation targets, and its 
neurochemical phenotype within the a single experiment. The variable physiological 
characteristics of PPT/LDT neurons imply that there may be significant heterogeneity along a 
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number of dimensions within this group of cells that is only beginning to be understood (Steriade 
et al 1990b).  Nevertheless, it is clear that subgroups of PPT/LDT neurons are likely to mediate 
different functional roles in their projections to the forebrain through unique activity patterns and 
distinctive receptor targets. 
1.2.3 Ascending Projections from the Cholinergic PPT/LDT:  Functional Effects in 
Distinct Innervation Targets 
The major function generally ascribed to ascending cholinergic projections from the 
tegmental brainstem is the promotion of arousal.   Stimulation of the brainstem projections to the 
thalamus generally increases the responsiveness of thalamocortical neurons to inputs from other 
regions (Steriade et al 1997) (e.g. glutamatergic corticothalamic afferents, hypothalamic inputs, 
etc.) and increases c-Fos expression in selected thalamic nuclei, confirming a general activating 
effect of PPT signaling (Ainge et al 2004).  Furthermore, the increased activity in the PPT/LDT 
that appears during W and REM states mediates a switch in the mode of thalamic firing, 
producing the characteristic changes in electroencephalographic recordings that are used to 
define sleep states (Steriade et al 1990a; Williams et al 1997; Huitron-Resendiz et al 2005).   
Overall, the excitatory effects of brainstem cholinergic input to the thalamus are thought 
to facilitate the entry of sensory information into the cortico-subcortical circuits that connect 
distinct cortical regions with topographically specific parts of the basal ganglia and thalamus, 
and that mediate complex behaviors such as cognition and goal-oriented behavioral selection 
(Inglis & Winn 1995; Ding et al 2010).  In addition, the projections to the intralaminar nuclei in 
the thalamus can potentially influence cortical activation globally, as the thalamocortical 
projections of these nuclei are diffuse throughout the cortex (Berendse & Groenewegen 1991; 
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Groenewegen & Witter 2004; Vertes et al 2006).  Similarly, in non-thalamic targets of brainstem 
tegmental ACh innervation, the net effect of cholinergic stimulation appears to be increased 
excitability of primary circuit neurons and decreases in inhibitory tone impinging on these cells 
(Kobayashi & Isa 2002). In the case of projections to the monoamine systems, increased 
excitability is noted with stimulation of the PPT/LDT, leading to greater monoaminergic tone in 
the forebrain regions innervated by these cells (Mesulam 1995a; Gronier & Rasmussen 1998; 
Mena-Segovia et al 2008).  These effects are typically blocked by systemic or local 
administration of cholinergic antagonists, indicating that the activating effects of PPT/LDT 
activity are mediated, at least in part, by the cholinergic neurons in these areas (Hu et al 1988; 
Forster & Blaha 2000; Grillner et al 2000; Forster & Blaha 2003). 
In awake animals, many PPT/LDT neurons respond in a time-locked manner to 
environmental stimuli in one or more modalities, including auditory, visual, somatosensory, 
and/or nociceptive systems (Grant & Highfield 1991; Pascoe & Kapp 1993; Reese et al 1995a; 
Kayalioglu & Balkan 2004; Pan & Hyland 2005).  The sensory responsiveness of these neurons 
appears to facilitate detection of novel or behaviorally relevant environmental stimuli by 
forebrain systems (Kobayashi & Isa 2002), and these projections may have significance for the 
direction of attentional resources toward salient events in the outside world (Florio et al 1999; 
Mena-Segovia et al 2008; Wilson et al 2009). 
1.2.4 Diversity of Cholinergic Signaling Mechanisms in Innervation Targets of PPT/LDT 
Neurons 
While PPT/LDT is thought to generate a common “arousal” signal in forebrain systems, 
the actions of acetylcholine at a cellular level are likely to differ across regions receiving 
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tegmental cholinergic inputs.  Specifically, ACh can exert its effects on a wide variety of 
receptors expressed by different cellular components of an innervated region.  Nicotinic 
acetylcholine receptors (nAChRs) on post-synaptic dendrites or neuronal cell bodies mediate 
direct depolarization of neurons in the innervated region.  In addition, activation of nAChRs on 
presynaptic axon terminals can increase neurotransmitter release by non-cholinergic afferents 
(McGehee et al 1995; Wonnacott 1997; MacDermott et al 1999; Schilström et al 2000).  
Depending on the specific subunit identity, the activation of G-protein coupled muscarinic 
acetylcholine receptors (mAChRs) can exert excitatory or inhibitory effects on neuronal firing, 
primarily through the activation or inactivation of potassium conductances (Cooper et al 2003).  
mAChRs are frequently localized to extrasynaptic sites on dendrites and cell bodies, and are 
expressed on some presynaptic terminals as well (Sikes & Vogt 1987; Sherman & Friedman 
1990; Amadeo et al 1995; Zhou et al 2003; Oda et al 2007).  
The localization of AChRs to non-synaptic sites indicates that volume transmission is a 
significant mode of communication utilized by cholinergic modulatory systems.  Axo-axonic 
synapses are infrequently observed in regions where presynaptic modulation of transmitter 
release by acetylcholine has been demonstrated (Wonnacott 1997; Jones & Wonnacott 2004).  
Similarly, mAChRs on somatodendritic profiles are not usually associated with direct synaptic 
innervation.  The expression of ACh receptors at these sites, some distance from cholinergic 
axon varicosities, implies that ACh must diffuse away from the point of its release to reach its 
receptor targets (reviewed in Descarries et al., 1997).  Further evidence that volume transmission 
is used by cholinergic systems comes from the observation that central cholinergic axon 
varicosities often fail to form synapses despite the presence of synaptic vesicles within these 
profiles.  The synaptic incidence, or proportion of axon terminals displaying the morphological 
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specializations associated with classical synapses, can be significantly lower than 100% and 
varies across brain regions, indicating that the release of ACh from non-synaptic sites may be 
more prominent in some regions than in others (Descarries et al 1997; Turrini et al 2001).  
Cholinergic axons within discrete thalamic nuclei show different rates of synapse formation 
(Hallanger et al 1990; Parent & Descarries 2008), even though the majority of thalamic 
cholinergic input comes from the brainstem PPT/LDT.  Importantly, the cholinergic innervation 
of some brain regions appears to be entirely synaptic (Parent & Descarries 2008), indicating that 
the low synaptic incidence reported in other regions is not due to experimental factors limiting 
the ability to detect synaptic structures.  The hetereogeneity of these axons and the great diversity 
in subunit composition and cellular localization of AChRs in different brain regions implies that 
ACh signaling probably differs considerably between targets of the same cholinergic group.   
The collective differences in the anatomical organization of PPT/LDT cholinergic 
projections, in co-transmitter content, and in the physiological characteristics of these cells 
support the view that within the larger PPT/LDT complex, subsets of cholinergic neurons exist 
that might influence activity in their target structures in unique ways.  Due to these differences, 
we hypothesized that the expression and regulation of the high-affinity choline transporter might 
show similar heterogeneity in the projections of the PPT/LDT as well. 
1.3 HIGH-AFFINITY CHOLINE TRANSPORTER 
ACh released from cholinergic axons must be enzymatically degraded by 
acetylcholinesterase, unlike the monoamine neurotransmitters (DA, NE, and 5-HT) that are 
primarily cleared from the extracellular space by specific reuptake transporters (Cooper et al 
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2003).  The hydrolysis of ACh produces choline and acetate ions that then diffuse through the 
extracellular space.  Extracellular choline is taken up by cholinergic neurons via the high-affinity 
choline transporter (CHT) and resynthesized into ACh. 
CHT is a Na+/Cl- dependent membrane transporter that provides the substrate, choline, 
for acetylcholine (ACh) synthesis (Apparsundaram et al 2000; Okuda et al 2000; Löffelholz & 
Klein 2006).  The expression of this protein is, with few exceptions (Lecomte et al 2005), limited 
to cholinergic neurons (Misawa et al 2001; Ferguson et al 2003; Kus et al 2003) and closely 
resembles that of the vesicular acetylcholine transporter (VAChT) and the acetylcholine 
synthetic enzyme choline acetyltransferase (ChAT).  The highly matched expression pattern of 
CHT with ChAT and VAChT is consistent with its role in supporting ACh synthesis. 
1.3.1 Cellular Expression of CHT 
Although the expression of CHT is a strong indicator of cholinergic phenotype, high-
affinity choline uptake characteristic of that mediated by CHT is detectable in some non-ACh-
synthesizing cells, such as retinal photoreceptors (Masland & Mills 1980), skin (Haberberger et 
al 2002), and vascular smooth muscle (Lips et al 2003).  Such ectopic expression of CHT 
indicates that transcription and translation of the gene is not necessarily exclusive to cholinergic 
neurons, but can be utilized by cells that have a high biological demand for choline.  
Loss of CHT by genomic deletion does not preclude some synthesis of ACh (Matthies et 
al 2006), as the precursor choline may be acquired through low-affinity uptake transporters 
(Michel et al 2006) or derived from hydrolysis of membrane phospholipids (Zhao et al 2001).  
Still, the ability of cholinergic neurons to maintain elevated and/or sustained cholinergic 
signaling depends upon functional CHT expression.  Loss of CHT at the mammalian 
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neuromuscular junction is fatal after birth (Ferguson et al 2004; Ferguson & Blakely 2004) due 
to paralysis of the diaphragm and subsequent asphyxiation.  CHT heterozygotes (+/-) appear to 
have normal baseline levels of ACh, but neurotransmitter release quickly becomes depleted 
under conditions that require sustained elevations in ACh release (Bazalakova et al 2007).  
Finally, blockade of CHT with hemicholinium-3 (HC-3), a potent inhibitor of high-affinity 
choline uptake, results in decreased quantal ACh content (Van der Kloot et al 2000; Van der 
Kloot et al 2002).  
At central cholinergic synapses, the consequences of CHT hypofunction are not as 
serious as for the NMJ.  In fact, there is apparent variability in the levels of CHT protein among 
different sets of cells with cholinergic phenotype, identified by positive immunoreactivity for the 
vesicular acetylcholine transporter (VAChT) or the ACh synthesizing enzyme, choline 
acetyltransferase (ChAT).  In the rat median eminence, CHT immunoreactivity is strikingly 
absent from fibers that contain both ChAT and VAChT (Misawa et al 2001). In the primate CNS, 
subpopulations of ChAT+/CHT- neurons have been described, and the relative size of these 
populations varies across different cholinergic neuronal groups (0-20% of all ChAT+ neurons 
within selected sets of ACh cells) (Kus et al 2003).  Although absence of immunolabeling is not 
necessarily indicative of a total lack of expression of CHT protein, the varying degrees of 
colocalization observed suggest that levels of CHT protein may be heterogenous, even among 
the neurons of a single cholinergic group. 
The proposed heterogeneity of CHT protein expression levels in relation to other 
cholinergic proteins is made possible by the specific genomic organization of genes necessary 
for the expression of cholinergic phenotype.  The expression of VAChT and ChAT is 
coordinated through the targeted location of their corresponding genes into a single, “cholinergic 
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gene locus” (Erickson et al 1994; Eiden 1998).   In contrast, CHT is transcribed from a separate 
chromosome (Eiden 1998; Ferguson & Blakely 2004), and mRNA levels are regulated 
independently from those of VAChT and ChAT (Slotkin et al 1994; Bissette et al 1996; Brock et 
al 2007).  Although many factors that upregulate the expression of VAChT and ChAT also 
increase CHT expression (Berse et al 2005), differential regulation of gene expression can occur 
(Lecomte et al 2005). Increases in functional CHT appear at later developmental time points than 
developmental increases in ChAT (Zahalka et al 1993), and during the regeneration of damaged 
nerves, CHT is transcribed in significant quantities only after a new synaptic contact has been 
established (Oshima et al 2004).  It appears that in developing axons, ChAT expression increases 
prior to upregulation of CHT, indicating that other sources of choline may suffice to meet the 
demand for acetylcholine synthesis in neurons with only low levels of ACh release (e.g. prior to 
the establishment of synapses).  Furthermore, increased expression of CHT can compensate for 
ChAT hypofunction in mature animals (Brandon et al 2004), and the increases in functional 
choline uptake that are observed in cortical tissue from Alzheimer’s patients probably represent 
compensatory mechanisms in the face of reduced cholinergic tone (Slotkin et al 1990; Slotkin et 
al 1994).   
Recent evidence indicates that expression of CHT may be reduced or absent from some 
cholinergic synapses, and that synaptic strength can influence the level of CHT protein in axon 
terminals.  CHT immunoreactivity is lost at “silent synapses” that lack post-synaptic nicotinic 
acetylcholine receptors (nAChRs) in ganglionic preparations from α3 nAChR knock-out mice 
(Krishnaswamy & Cooper 2009) suggesting that the activation of post-synaptic mechanisms 
resulting, in retrograde signaling to the presynaptic axon, are necessary to support continued 
expression and trafficking of CHT to cholinergic release sites.   
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Interestingly, ultrastructural examination of cholinergic axon varicosities in central 
cholinergic systems has revealed that many cholinergic axon varicosities fail to display synaptic 
contacts in the rat cortex (Umbriaco et al 1982; Turrini et al 2001), thalamus (Levey et al 1987; 
Hallanger et al 1990; Parent & Descarries 2008) and midbrain dopaminergic VTA (Omelchenko 
& Sesack 2006; Holmstrand et al 2010).  The non-synapsing boutons contain synaptic vesicles, 
mitochondria, and transmitter-associated protein immunoreactivity such as ChAT or VAChT, 
and so are presumed to be active sites of transmitter release.  Furthermore, non-synaptic release 
of neurotransmitters into the extracellular fluid environment (i.e. volume transmission) is 
accepted as a major mode of neurochemical signaling.  At non-synaptic release sites, transmitter 
diffuses away from its parent axon to act on extrasynaptic receptors within the vicinity of the site 
of release, or at considerable distance from its axonal source (Agnati et al 1995; Bjelke et al 
1995).  Volume transmission is thought to be a particularly important mode of signaling for 
modulatory transmitters, such as ACh and monoamines (Fuxe et al 1988; Descarries et al 1997; 
Zoli et al 1998; Fuxe et al 2010).  
 The absence of classical synapses at these sites of release raises interesting questions 
concerning the expression of CHT in these axons.  If activation of post-synaptic receptors is 
necessary for the continued axonal expression of CHT in central as well as autonomic 
cholinergic axons, then cholinergic pathways that release ACh from non-synaptic sites may not 
contain reduced amounts of CHT, and may rely on other sources to maintain adequate levels of 
ACh.  Alternatively, the intracellular mechanisms regulating the trafficking of CHT may differ 
according to the type of cholinergic neurons considered, or the region into which they release 
ACh. 
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1.3.2 Membrane Trafficking of CHT 
Newly synthesized CHT protein is modified post-translationally and trafficked 
predominantly to axons.    Within cholinergic axons, CHT is localized to small synaptic vesicles 
(Ferguson et al 2003; Nakata et al 2004) and endosomal membranes (Ribeiro et al 2007a).  
Surprisingly, relatively little CHT is found in the plasma membrane under conditions of minimal 
neuronal activity.  A predominantly vesicular localization of CHT has been observed at the 
neuromuscular junction (Nakata et al 2004), and in numerous brain regions, including the 
brainstem facial nucleus, striatum, interpeduncular nucleus, and VTA (Ferguson et al 2003; 
Holmstrand et al 2006; Holmstrand et al 2010).  Expression of CHT in cultured cells yields a 
similar subcellular distribution of the protein (Krishnaswamy & Cooper 2009). 
The localization of CHT to synaptic vesicle membranes enables the protein to be 
delivered to the plasma membrane as a consequence of ACh release (see Figure 2).  Exocytosis 
of synaptic vesicles increases the high-affinity choline uptake in synaptosomes (Roskoski 1978) 
and in vitro slice (Antonelli et al 1981) and in vivo preparations (Apparsundaram et al 2005); the 
increases in choline transport are due to concomitant increases in the number of transporters 
situated in the plasma membrane (Ferguson et al 2003; Apparsundaram et al 2005).  Increased 
ACh synthesis, required to support sustained cholinergic release through the refilling of depleted 
vesicular stores of ACh following high-frequency neuronal firing, is met by the increased 
capacity of high- affinity choline uptake that occurs as a result of the fusion of CHT containing 
synaptic vesicles during periods of high frequency neuronal activity.   
CHT is removed from the plasma membrane via clathrin-dependent endocytosis (Ribeiro 
et al 2003), the same process by which synaptic vesicles are efficiently recycled at the synapse.  
However, the rate at which CHT is endocytosed through this mechanism can be modulated by  
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Figure 2 Plasma membrane trafficking of CHT 
 
A CHT is delivered to the plasma membrane through fusion of synaptic vesicles containing both 
CHT and VAChT.  Readily releasable vesicles are docked at the plasma membrane in close 
proximity to voltage-gated calcium channels (1).  Ca2+ entry through these channels causes docked 
vesicles to fuse with the plasma membrane, releasing ACh during exocytosis and exposing the 
luminal surface of CHT to the extracellular space (2).  The fusion of vesicular membrane with the 
plasmalemma results in the transfer of CHT to a functional pool mediating high-affinity choline 
uptake (3).  B  CHT is removed from the plasma membrane through clathrin mediated endocytosis 
(1).  Recycled synaptic vesicles may be returned to the readily releasable pool (2) or trafficked 
through endosomal pathways to the reserve pool (3).  Alternatively, CHT may be retained in the 
plasma membrane even as VAChT is endocytosed, resulting in VAChT+/CHT- synaptic vesicles 
(4). 
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intracellular signaling cascades.  Phosphorylation by PKC, or inhibition of protein phosphatase 
1/2A, promotes the internalization of CHT and decreases choline uptake (Ferguson & Blakely 
2004; Gates et al 2004).  Similarly, exposure to peroxynitrite or hydrogen peroxide appears to 
decrease choline uptake by accelerating the endocytosis of CHT, while leaving the rate of 
exocytosis unaltered (Pinthong et al 2008).  Subcellular trafficking of CHT may be further 
regulated through interaction with other proteins (Ribeiro et al 2007b) such as vesicular-sorting 
proteins (SEC14-like protein, (Ribeiro et al 2007b)) and amyloid β (Aβ) (Bales et al 2006; Wang 
et al 2007) a protein implicated in the pathology of Alzheimer’s disease.  
The current view of CHT membrane trafficking is that only a small fraction of transporter 
molecules comprise a “recycling pool” of CHT that is inserted into the membrane, endocytosed, 
then redelivered to the plasma membrane within minutes (Ribeiro et al 2007a).  New transporters 
are constitutively recruited to this pool, as evidenced by the complete restoration of choline 
transport within 2 hours of exposure to an irreversible antagonist of CHT (Ivy et al 2001).  These 
pools of CHT-containing synaptic vesicles are believed to correspond to the “readily releasable” 
and “reserve” pools that have generally been described in other types of axon terminals 
(Pieribone et al 1995; Brodin et al 1997; Ferguson & Blakely 2004).  The addition of new CHT 
molecules to the recycling pool of vesicles is presumably offset by removal of transporters from 
the membrane or readily releasable pool, producing stable rates of high-affinity choline uptake.  
However, increased choline transport is predicted to result from the accelerated recruitment of 
CHT-containing reserve pool vesicles to the readily releasable pool, thereby increasing the 
number of transporters that are cycling through the plasma membrane and vesicular 
compartments (Ivy et al 2001).   The ultrastructural distribution of CHT may therefore be an 
indicator of recent synaptic activity or increases in tonic cholinergic tone (Grailhe et al 2009).  
 20 
Elevations in neuronal activity mobilize reserve-pool vesicles to the releasable pool, thereby 
transiently increasing the number of transporters in the plasma membrane and the functional 
capacity of high-affinity choline uptake in highly active terminals (Figure 3). During periods of 
relative quiescence, endocytosis of CHT may exceed the rate of its delivery to the membrane, 
reestablishing lower equilibrium levels of choline uptake as the demand for ACh synthesis 
decreases.  In terminals with higher expression of CHT, the amount of CHT in the recycling pool 
of vesicles would be elevated, leading to an increased level of CHT in the plasma membrane 
under baseline firing conditions.  Increased activity in these terminals would result in a larger 
upregulation of choline transport as well (Figure 3B). 
The utility of CHT localization as an indicator of synaptic activity is uncertain, however, 
because the rate of CHT internalization through endocytosis can be altered independently from 
the rate of its delivery to the plasma membrane.  Although a few molecular players that influence 
the trafficking of CHT have been identified, much remains to be discovered.  For instance, 
although phosphorylation of the transporter decreases choline uptake by promoting the 
endocytosis of CHT (Breer & Knipper 1990; Gates et al 2004), the cellular mechanisms that can 
alter phosphorylation of CHT at central synapses are only beginning to be identified.  Activation 
of protein kinases through receptor-mediated mechanisms could also potentially modulate the 
capacity of high-affinity choline uptake at the level of individual cholinergic boutons.  
It is difficult to say whether CHT density in the plasma membrane of different sets of 
cholinergic terminals would be relatively uniform across different brain regions or would vary 
due to differing local signaling environments or activity patterns. Still, in the cholinergic systems 
studied so far, activity dependent increases of CHT are extremely robust (Haga & Noda 1973; 
Simon & Kuhar 1975; Murrin & Kuhar 1976; Antonelli et al 1981; Krištofiková et al 1998).   
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Figure 3  Membrane levels of CHT are upregulated by elevations in neuronal activity.   
A  Increases in ACh release lead to increased numbers of transporters in the plasma membrane through activity-
dependent trafficking mechanisms.  Sustained neuronal firing results in the recruitment of reserve pool vesicles to 
the readily releasable pool, increasing the number of transporters that are actively cycling between the plasma 
membrane and vesicular compartments.  B  The total level of CHT protein contained within synaptic vesicles affects 
the functional capacity of high-affinity choline transport.  Axon terminals with more CHT-containing vesicles 
(compare B to A) have more CHT cycling through the readily releasable pool, higher levels of plasma membrane 
associated CHT, and consequently more choline uptake.  When stimulated, axons with higher expression of CHT 
recruit more transporter containing vesicles to the readily releasable pool, resulting in larger increases in choline 
uptake. 
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This evidence indicates that the level of membrane CHT is primarily driven by relative 
levels of neuronal activity, and that higher overall levels of CHT protein probably support more 
active cholinergic release sites.  The idea that CHT could serve as an indicator of activity in 
cholinergic varicosities suggests that different levels of total and membrane CHT should be 
detectable in brain regions innervated by distinct groups of cholinergic neurons.  Additionally, 
given the possible differences in neurochemical signaling impinging on cholinergic axon 
varicosities locally, it seems reasonable that the rate of endocytosis of CHT may also differ 
across brain regions due to the specific activation of intracellular signaling molecules.  In fact, 
relative differences in the regulation of membrane levels of CHT, or in high-affinity choline 
uptake, are detectable across brain regions under certain experimental (Wecker & Dettbarn 1979; 
Stanton & Johnson 1987) and pathological conditions .   However, the majority of investigations 
into CHT function have been conducted in reduced preparations from cortical, hippocampal, or 
striatal tissue.  In contrast, very little is known about the function of this protein within the 
projections of the tegmental brainstem cholinergic neurons. 
Our laboratory’s long-standing interest in the VTA initially drove our interest in the 
cholinergic afferents to this region.  In addition, the observation that LDT cholinergic neurons 
tend to preferentially innervate limbic structures in the midbrain and forebrain (in contrast to the 
PPT ACh projections) led us to focus our investigation of CHT immunoreactivity on limbic 
innervation targets.  Furthermore, we tried to maximize the possibility of detecting a difference 
in CHT localization in the axonal populations examined by comparing the cholinergic 
innervation of the VTA to that of the anteroventral nucleus of the thalamus (AVN), a region that 
is also associated with the limbic system, but is sufficiently different in its connectivity from the 
VTA to support hypothesized differences in cholinergic modulation. 
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1.3.3 Cholinergic Innervation of the Anteroventral Thalamus 
In the rat, the anteroventral nucleus of the thalamus (AVN) has a remarkably dense 
cholinergic innervation that arises exclusively from brainstem cholinergic neurons (Sofroniew et 
al 1985; Gonzalo-Ruiz et al 1995).  This stands in contrast to other limbic nuclei in the thalamus 
(Heckers et al 1992), which can receive substantial cholinergic input from the basal forebrain 
cholinergic groups ((Cornwall & Phillipson 1989); but see Parent et al., 1988 for species 
differences in basal forebrain cholinergic innervation of the limbic thalamus).  As in most 
thalamic nuclei, stimulation of the PPT or LDT results in transient depolarization of 
thalamocortical neurons in the AVN that is mediated through primarily dendritic nicotinic ACh 
receptors.  Evidence from in situ hybridization and radioligand binding studies indicate that these 
are likely to be α4β2 nAChRs (Wada et al 1989; Tribollet et al 2004; Rasmussen & Perry 2006).  
A longer-lasting increase in the excitability of thalamocortical cells, mediated by muscarinic 
ACh receptors, follows the brief nicotinic depolarization (Paré et al 1990; Steriade et al 1997; 
Groenewegen & Witter 2004).  Muscarinic receptors are also present on the axons of selected 
glutamatergic afferents to the AVN, but mAChR inhibitory autoreceptors are unlikely to be 
expressed on cholinergic axons innervating this region (Sikes & Vogt 1987).  Furthermore, a 
complex pattern of M2 and M3 subtypes of mAChR expression within the AVN suggests that 
ACh may have different effects in distinct subregions of this nucleus (Sikes & Vogt 1987; Oda et 
al 2007).  Cholinergic projections from the brainstem can also inhibit GABA neurons in the 
reticular nucleus of the thalamus that provide the only source of inhibitory synaptic input to the 
rat AVN (Wang et al 1999; Oda et al 2007) and appear to modulate selected inhibitory inputs to 
the AVN at the terminal level as well (Curro Dossi et al 1992).  The sum of these effects is 
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increased firing of thalamocortical neurons in these nuclei, and the subsequent excitation of 
cortical circuitry.   
    Functionally, the AVN plays an important role in hippocampal-dependent memory, 
particularly with respect to spatial memory and learning processes.  It is heavily interconnected 
with the posterior cingulate cortex and the hippocampal region (including projections to the post- 
and parahippocampal cortices, and from the presubiculum and subiculum) (Woolf & Butcher 
1986; Bentivoglio et al 1993; Oda 1997; Oda et al 2003), and it receives a prominent input from 
the mammillary nuclei in the hypothalamus (Dekker & Kuypers 1976; Paré et al 1990; Shibata 
1992).  The specific cortical projections of the AVN fit within a topographically organized 
thalamocortical projection from the dorsal thalamus, in which more lateral structures such as the 
AVN project to posterior associative cortical areas, while the medial thalamic nuclei 
communicate with more anterior regions of cortex (Reep 1984; Vertes 2006). Natural or 
experimental lesions of the AVN result in amnesiac symptoms while leaving many other aspects 
of cognition unaltered (Mitchell & Dalrymple-Alford 2006; Wolff et al 2008).  Damage to the 
AVN results in impairment of spatial-memory dependent tasks, such as the Morris Water maze, 
and suggests a specific inability to use allocentric cues to navigate the environment (Aggleton et 
al 1996; Warburton & Aggleton 1999; Aggleton et al 2009).  These effects are distinct from the 
deficits encountered following midline thalamic lesions (Gibb et al 2006; Mitchell & Dalrymple-
Alford 2006), reflecting the specific mediation of limbic functions by segregated circuits with 
distinct thalamic components (Vogt et al 1992; Morgane et al 2005). 
 25 
1.3.4 Cholinergic Innervation of the Ventral Tegmental Area 
Dopamine released in the limbic forebrain exerts a powerful influence over behavior, and 
pathophysiological changes in the midbrain DA system are thought to underlie many core 
features of both substance abuse disorders and schizophrenia (Yeomans 1995; Weiss & Koob 
2001).  DA projections to the ventral striatum, prefrontal and anterior cingulate cortices, and the 
amygdala originate in the midbrain VTA (Sesack et al 2003; Lammel et al 2008).  Interestingly, 
the specific limbic regions that are directly connected to the AVN receive little DA input.  DA 
innervation of the thalamus is generally poor in the rat, with the exception of medial structures 
such as the mediodorsal and parafascicular nuclei (Sanchez-Gonzalez et al 2005; Garcia-Cabezas 
et al 2009).  These medial thalamic nuclei innervate the same cortical and striatal regions that are 
most heavily targeted by VTA DA axons (Hökfelt et al 1974; Lindvall et al 1974; Berger et al 
1985; Berger et al 1991), suggesting complex but specific functional organization in differing 
limbic circuits.  It is unknown whether the segregation of these limbic circuits extends as well to 
their cholinergic afferent innervation, a question that is specifically explored in this thesis. 
The limbic circuitry that is targeted by VTA DA neurons mediates such well-known 
functions as motivation and the selection of appropriate goal-oriented behavior (Reep 1984; 
Gabbott et al 2005; Morgane et al 2005; Vertes 2006)   Perhaps the most appreciated actions of 
this transmitter are its contributions to cognitive processes like working memory and action 
selection within the context of reward-reinforced learning (Cooper 2002; Schultz 2007).  DA 
neurons fire characteristic “bursts” of action potentials in response to unexpected rewards; this 
mode of firing results in dramatically increased levels of extracellular DA in the ventral striatum 
(Grace & Bunney 1984; Ljungberg et al 1992; Suaud-Chagny et al 1992; Overton & Clark 
1997).  These reward-related responses can be conditioned to external stimuli that predict an 
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imminent or response-contingent reward (Ljungberg et al 1992; Yun et al 2004; Pan & Hyland 
2005).  This process of associative learning enables the animal to choose behavioral strategies 
that have proved effective in procuring natural rewards such as food in the past, and to base the 
selection of current behavior on salient aspects of the external environment (Schultz 2002).  
Furthermore, when such behavior fails to produce an expected reward, the DA system responds 
with a decrease in activity below baseline, which may attenuate repetition of the ineffective 
action (Schultz et al 1993).  This pattern of physiological activity has lead researchers to consider 
DA as a signal of reward prediction error (Schultz 2002; Okada et al 2009). 
Through ascending projections to the VTA, the characteristic sensory-evoked excitation 
of PPT/LDT neurons is translated into increased excitability of DA neurons (Mena-Segovia et al 
2008).  Furthermore, evoked activity in the PPT/LDT is necessary for an animal to acquire 
associations between external cues and reward-reinforced behavioral responses (Lepore & 
Franklin 1996; Florio et al 1999; Pan & Hyland 2005), just as the reward-evoked and cue-
conditioned responses of VTA DA neurons are required for such learning (Yun et al 2004).  
Accordingly, disruption of the brainstem cholinergic input to the VTA can significantly inhibit 
motivated behavior (Wilson et al 2009) and has often been noted to lead to increased omission of 
appropriate responses on cue-driven operant tasks (Florio et al 1999; Chilton et al 2004). 
  ACh axons in the VTA are of moderate density, and form synapses with both 
dopaminergic and GABAergic dendrites and neurons (Omelchenko & Sesack 2006).   
Cholinergic projections from the LDT to the VTA facilitate the release of DA in the ventral 
striatum (Forster & Blaha 2000) by specifically enhancing the behaviorally relevant burst-firing 
of DA neurons that drives dramatic increases in DA release in response to reward-predictive cues 
(Floresco et al 2003; Lodge & Grace 2006).  Direct application of cholinergic agonists to the 
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midbrain DA cell-containing regions also results in net excitation of DA neurons that is mediated 
through multiple cellular processes (Mansvelder et al 2003). 
Briefly, activation of nAChRs expressed on cell bodies and dendrites directly depolarizes 
DA neurons.  Secondly, nAChRs on presynaptic axon terminals can potentiate glutamate release 
onto DA neurons as well (Schilström et al 1998; Schilström et al 2000; Jones & Wonnacott 
2004), and enhance synaptic plasticity at these excitatory synapses (Mansvelder & McGehee 
2000).    These choline-sensitive receptors are present in the VTA and can alter the processing of 
salient environmental stimuli to guide behavior (Schilström et al 1998; Chilton et al 2004; Jones 
& Wonnacott 2004; Keller et al 2005).  Activation of α7 nAChRs can induce long-term 
potentiation (Mansvelder et al 2003), a form of synaptic plasticity, at excitatory synapses 
impinging on DA neurons, thereby contributing to the acquisition of learned stimulus-response 
associations. Interestingly, the nAChRs mediating this enhancement of presynaptic glutamate 
release (α7 nAChRs) show sensitivity to both ACh and choline as agonists, a property that is not 
shared by other AChR subtypes (Alkondon et al 1997; Mike et al 2000; Alkondon & 
Albuquerque 2006), presenting the possibility that the rate of high-affinity choline uptake may 
have secondary effects on cholinergic modulatory processes in this region.  Finally, mAChRs on 
VTA DA neurons (probably the M5 subtype) mediate a slower and prolonged excitation that 
significantly increases DA release in the ventral striatum (Yeomans 1995; Gronier & Rasmussen 
1998; Forster & Blaha 2000; Gronier et al 2000; Miller & Blaha 2004), and the cholinergic 
afferents to the VTA may also express cholinergic autoreceptors that depress ACh release when 
activated.   
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1.4 EXPERIMENTAL HYPOTHESES AND DESIGN 
PPT/LDT neurons display heterogeneity in their projection targets and co-transmitter 
content, and may vary in their firing rates, afferent input, and activity patterns as well; therefore, 
we hypothesized that neurons in this central cholinergic system might display differential 
expression or localization of CHT.  We tested this hypothesis by comparing the level and pattern 
of immunoreactivity for CHT between distinct regions that receive cholinergic innervation from 
these brainstem nuclei.   
 
1.4.1 Choice of Regions for Comparison 
As discussed in the preceding section, acetylcholine released from the ascending 
projections of PPT/LDT neurons alters the sensitivity of cholinoceptive neurons to afferent input, 
both by directly exciting these neurons at somatodendritic receptors, and by modulating 
transmitter release from non-cholinergic axon terminals.  However, the functional roles of the 
AVN and the VTA appear to be different, and the cellular heterogeneity observed in the 
brainstem tegmental cholinergic nuclei suggests that ACh modulation might differ considerably 
between these innervation targets.  As the expression and localization of CHT have not been 
characterized in this cholinergic projection system, we undertook immunohistochemical studies 
to determine if the distribution of this transporter is similar in PPT/LDT projections to that 
observed in other cholinergic axons.  We also tested the hypothesis that the subcellular 
distribution of CHT can differ between unique targets of the same cholinergic system by 
comparing CHT-immunoreactivity in axons innervating the AVN to those in the VTA.  We 
 29 
chose to compare these specific regions in order to maximize the chances of detecting such 
hypothesized differences. 
  There are many prominent ways in which the AVN and VTA differ.  Obviously, the 
AVN is a thalamic nucleus containing glutamate neurons that convey information to certain 
limbic cortical regions through direct point-to-point connections (Groenewegen & Witter 2004).  
In contrast, VTA DA neurons modulate the neural processing of convergent excitatory and 
inhibitory inputs in limbic structures distinct from those that communicate with the AVN 
(Bamford et al 2004a; Bamford et al 2004b; Wolf et al 2004; Kroener et al 2009; Kehagia et al 
2010).  While the AVN has a clear role in supporting spatial learning and memory (Warburton & 
Aggleton 1999; Jenkins et al 2002; Gibb et al 2006; Sziklas & Petrides 2007; Yasoshima et al 
2007; Wolff et al 2008; Aggleton et al 2009), the output of the VTA impacts appetitively 
motivated behavior and associative learning (Cooper 2002; Yun et al 2004; Geisler & Zahm 
2005).  Furthermore, differences in the density of ACh innervation and the spatial distribution of 
AVN versus VTA afferents within the PPT/LDT, combined with the cellular heterogeneity 
observed within the brainstem tegmental cholinergic nuclei, suggests that the cholinergic 
modulation of the AVN and VTA could arise from neurons with different intrinsic properties.  
Finally, the differences in AChR subunit expression between the AVN and the VTA lends 
further support to the hypothesis that these regions may differ along other dimensions of 
cholinergic signaling as well.  Interestingly, the presynaptic α7 nAChRs in the VTA can be 
desensitized by exposure to micromolar concentrations of choline present in the extracellular 
fluid (Uteshev et al 2003; Alkondon & Albuquerque 2006), presenting the possibility that the 
regulation of high-affinity choline uptake may have secondary effects on cholinergic 
transmission in the midbrain.  In contrast, cholinergic transmission in the AVN does not appear 
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to contain choline-sensitive nAChRs (Morley et al 1977; Morley & Garner 1986; 1990; Tribollet 
et al 2004; Guseva et al 2006).  We aimed to detect gross differences in CHT immunoreactivity 
that might arise from the collective differences in these two by comparing the axon terminals in 
the AVN to those in the VTA. 
Unlike other “limbic” thalamic nuclei such as the mediodorsal nucleus or parafascicular 
nucleus (Cornwall & Phillipson 1989), the AVN receives cholinergic innervation exclusively 
from the tegmental brainstem neurons (Gonzalo-Ruiz et al 1995); cholinergic cells in the basal 
forebrain group do not contribute to its innervation, at least in the rat (Parent et al 1988).  
Similarly, midbrain DA regions (SNc and VTA) are innervated by only the PPT/LDT cholinergic 
neurons (Woolf 1991).  By selecting these regions for examination, we ensured that any 
differences observed reflected true heterogeneity in the projections of the brainstem ACh 
neurons.   
 
1.4.2 Experimental Framework 
As previously stated, the PPT/LDT cholinergic system is perhaps the least well-studied 
group of cholinergic neurons within the CNS, and the characteristics of CHT expression and 
subcellular trafficking have not been described for this system.  The lack of data for this system 
stems in part from the small size of its terminal fields and the resulting difficulty of extracting 
sufficient tissue for use in synaptosomal preparations or traditional protein analytical methods.   
In order to overcome these experimental issues, we used immunohistochemical methods 
to characterize CHT expression in the axons of PPT and LDT neurons.  By utilizing fixed brain 
tissue and both fluorescence and electron microscopy, these experiments had the additional 
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advantage of preserving the native spatial distribution of CHT within cholinergic axons in 
innervated regions.   
 
1.4.3 Experimental Questions 
Our experiments aimed to characterize CHT in the axons of PPT and LDT neurons.  To 
this end, we examined: 1) the level of expression and the subcellular localization of CHT within 
these axonal populations; 2) the occurrence of colocalization of CHT and VAChT within axons 
in the AVN and VTA, and the relative levels of expression of these two proteins; and 3) the 
source population(s) of cholinergic axons to the AVN and VTA. 
 
1.4.4 Ultrastructural localization of CHT 
Immunohistochemistry has been used to examine the ultrastructural distribution of CHT 
immunoreactivity in presumed cholinergic axon varicosities from a number of CNS regions, 
including the neuromuscular junction (Lips et al 2002; Nakata et al 2004), striatum, and facial 
nucleus (Ferguson et al 2003).  All of these studies utilized silver-enhanced immunogold 
histochemistry, a reaction that produces discrete electron-dense particles at the site of antibody 
binding.  In contrast to diffusible reaction products such as immunoperoxidase, the immunogold 
method allows a high degree of spatial resolution (accurate to ~20 nm) (Umeda et al 1997; 
Mathiisen et al 2005; Miner et al 2006), making it the preferred method for studies of the precise 
subcellular localization of proteins.  In all prior reports, the majority of CHT-ir appeared to be 
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confined to an intracellular compartment and associated with small clear synaptic vesicles (Lips 
et al 2002; Ferguson et al 2003; Ferguson & Blakely 2004; Nakata et al 2004).  A minority (5-
20%) of CHT immunogold-silver particles could be found in association with the plasma 
membrane of immunoreactive axonal structures, indicating that the functioning pool of 
transporters at any given time represents a small fraction of the total CHT protein.   
Given the similar distribution of CHT-ir across the different cholinergic neurons 
examined thus far, we hypothesized that this pattern of a predominantly cytoplasmic subcellular 
localization of CHT would also be true in the axon varicosities of brainstem cholinergic neurons.  
However, we also wished to know if axonal populations arising from a common cholinergic 
group would display similar characteristics despite innervating different anatomical structures.  
We therefore used immunogold-silver histochemistry to compare the total immunoreactivity for 
CHT and the amount of CHT associated with the plasma membrane between axons examined in 
the AVN and VTA from the same group of animals. 
 
1.4.5 Expression and Localization of CHT Relative to VAChT  
Although CHT is robustly expressed in most cholinergic neurons and axons in the rat 
CNS, this protein may not be strictly necessary for proper cholinergic function at brain synapses 
(Matthies et al 2006).  CHT-immunoreactivity is absent from some choline acetyltransferase 
(ChAT) and vesicular acetylcholine transporter (VAChT) immunoreactive (VAChT-ir) neurons 
(Misawa et al 2001), and its constituitive expression can be extinguished in some cells by 
genomic deletion of post-synaptic nicotinic receptors (Krishnaswamy & Cooper 2009).  In other 
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regions of the brain, qualitative observations indicate that CHT immunoreactivity appears to vary 
among otherwise homogenous populations of axon terminals (Ferguson et al 2003).   
Although cholinergic cell bodies in the primate PPT/LDT show 100% colocalization of 
ChAT and CHT (Kus et al 2003), the colocalization of CHT with other cholinergic markers has 
not been examined in the axonal compartments of these cells in any species.  Consequently, dual 
fluorescence immunohistochemistry combined with spinning disk confocal microscopy was used 
to examine and compare the rate of colocalization of CHT and VAChT in the AVN and the 
VTA.  Given the central role of choline uptake in the maintenance of a synaptic pool of 
releasable ACh (Ferguson & Blakely 2004), we hypothesized that a majority of the 
immunofluorescent puncta in both regions would demonstrate co-localized VAChT and CHT 
immunoreactivities.  However, we also expected that the rate of colocalization observed in 
VAChT-ir puncta would be lower in the VTA, based on preliminary observations that levels of 
CHT immunoreactivity were qualitatively lower in this region, and thus might fall below our 
detection level.  We examined the colocalization of VAChT immunoreactivity within CHT-ir 
puncta, to determine if there might be sites of high-affinity choline uptake that may not primarily 
subserve ACh synthesis (e.g. sites that remove choline from the extracellular space in order to 
facilitate the excitation of presynaptic nAChRs), as evidenced by low or absent VAChT 
immunofluorescence.  Although the occurrence of such CHT-ir puncta was entirely speculative, 
the experimental design would allow us to detect such sites if they exist. 
In addition, we examined the relationship between VAChT immunoreactivity and CHT 
immunoreactivity within these regions in order to determine if CHT expression is primarily 
driven by the relative levels of vesicular ACh.  We expected that VAChT levels would 
significantly predict levels of CHT immunoreactivity within these axons, as larger reserves of 
 34 
vesicular ACh (as indirectly evidenced by VAChT immunoreactivity levels) are expected to 
require higher levels of choline uptake to maintain adequate ACh synthesis.  Finally, we 
compared this relationship between the AVN and the VTA to determine if CHT expression 
might vary in relation to VAChT expression across different innervation targets of the PPT and 
LDT ascending cholinergic system, possibly due to differences in the local extracellular 
environment of these cholinergic terminals.  
 
1.4.6 Determination of the Source of Cholinergic Axons Projecting to the AVN and VTA 
The hypothesized differences in CHT expression within axon varicosities in the AVN and 
VTA could result from separate populations of afferents from the PPT/LDT.  The overall 
distribution of afferents to the AVN and VTA, as demonstrated in single retrograde tracing 
studies, appears to differ, as the VTA is innervated by both the PPT and LDT (Satoh & Fibiger 
1986; Woolf & Butcher 1986; Hallanger & Wainer 1988; Oakman et al 1995; Holmstrand & 
Sesack 2004; Omelchenko & Sesack 2005), but the AVN innervation originates predominantly 
from the LDT (Woolf & Butcher 1986; Gonzalo-Ruiz et al 1995).  However, cholinergic neurons 
from the brainstem tegmentum are known to send collaterals to thalamic nuclei and other 
subcortical structures (Woolf & Butcher 1986; Cornwall & Phillipson 1988b; Parent et al 1988; 
Jourdain et al 1989; Bolton et al 1993; Losier & Semba 1993; Billet et al 1999), and some 
studies assert that all cholinergic neurons in this region innervate the thalamus, in addition to any 
other projections that they might have (Oakman et al 1999).  To determine if axons in the VTA 
arise from collaterals of PPT/LDT neurons projecting to the AVN, we combined dual retrograde 
tract-tracing with immunohistochemistry for VAChT, and examined the PPT and LDT for 
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evidence of colocalization of both tracers in cholinergic and non-cholinergic neurons within 
these nuclei. 
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2.0  ULTRASTRUCTURAL LOCALIZATION OF HIGH-AFFINITY CHOLINE 
TRANSPORTER IN THE RAT ANTEROVENTRAL THALAMUS AND VENTRAL 
TEGMENTAL AREA: DIFFERENCES IN AXON MORPHOLOGY AND 
TRANSPORTER DISTRIBUTION. 
This chapter contains the published manuscript detailing the results of Aim 1.  This report has 
been previously published in the following peer-reviewed publication: 
 
Holmstrand, EC, Asafu-Adjei, J, Sampson, AR, Blakely, RD, and Sesack, SR.  
2010.  Journal of Comparative Neurology 518(11): 1908-1924.  
 
 
With the exception of minor changes, such as matching the formatting of the dissertation and 
updating figure numbering and titles, it is unchanged in form from that article. 
2.1 INTRODUCTION 
The Na+/Cl- dependent high-affinity choline transporter (CHT) supplies substrate for the 
synthesis of acetylcholine (ACh) in central and peripheral cholinergic neurons (Yamamura & 
Snyder 1972; Haga & Noda 1973; Yamamura & Snyder 1973; Wecker & Dettbarn 1979; 
Löffelholz & Klein 2006; Takashina et al 2008).  Due to its high affinity for choline, this protein 
can meet the demand for local ACh synthesis during prolonged activation of cholinergic neurons 
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(Simon & Kuhar 1975; Simon et al 1976).  Blockade of choline transport leads to subsequent 
depletion of ACh in brain synaptosomes, and at the neuromuscular junction (Guyenet et al 1973; 
Zapata et al 2000; Bazalakova et al 2007).  Expression of the transporter is therefore necessary to 
successful cholinergic transmission and ultimately to survival in mammals (Ferguson et al 2004). 
The regional and cellular expression of CHT mRNA and the localization of CHT protein 
closely match that of other selective markers of cholinergic phenotype in the rodent and primate 
nervous system (Misawa et al 2001; Ferguson et al 2003; Kus et al 2003).  Nevertheless, the 
transcription and translation of CHT are dissociable from those of the synthetic enzyme, choline 
acetyltransferase (ChAT) and the vesicular acetylcholine transporter (VAChT) (Erickson et al 
1994; Eiden 1998; Lecomte et al 2005).  Furthermore, CHT shows a different expression profile 
from these other markers during development (Lecomte et al 2005), following injury (Oshima et 
al 2004), and in some pathological conditions (Slotkin et al 1990; Slotkin et al 1994).  
At the ultrastructural level, CHT is localized mainly to synaptic vesicles in the 
cytoplasmic compartment of axon terminals, with only a small proportion associated with the 
plasma membrane (Ferguson et al 2003; Nakata et al 2004).  This subcellular localization 
suggests the existence of a recruitable pool of cytoplasmic transporters, consistent with decades 
of biochemical research showing that high-affinity choline uptake can be dramatically increased 
through the rapid insertion of new transporters into the plasma membrane, a process mediated by 
the fusion of CHT-containing synaptic vesicles with the plasmalemma (Haga & Noda 1973; 
Simon & Kuhar 1975; Murrin & Kuhar 1976; Roskoski 1978; Antonelli et al 1981; Ferguson et 
al 2003; Ferguson & Blakely 2004).  Membrane-bound CHT is also internalized through 
clathrin-dependent endocytosis (Ribeiro et al 2003).  The number of membrane bound 
transporters is therefore determined by the rates of exo- and endocytosis.  Furthermore, the rate 
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of endocytosis can be influenced by the activity of protein kinases and phosphatases in the axon 
terminal (Breer & Knipper 1990; Vogelsberg et al 1997; Gates et al 2004).  It therefore seems 
likely that external signaling events in the vicinity of cholinergic terminals could potentially 
influence the number of active transporters in the plasma membrane, independent of any action 
on the rate of acetylcholine release (Breer & Knipper 1990).     
Functional investigations of high-affinity choline uptake in synaptosomes have focused 
largely on striatal, hippocampal, and cortical tissues. Both the basal rate of choline uptake and 
modulation of high-affinity choline uptake have been shown to differ between striatal and 
cortical tissue (Wecker & Dettbarn 1979; Stanton & Johnson 1987).  This is not surprising given 
that the cholinergic innervation of the striatum and cortex arise from separate systems.  The 
characteristics of high-affinity choline uptake have not been described for the projections of the 
brainstem pedunculopontine (PPT) and laterodorsal tegmental (LDT) cholinergic neurons; 
therefore, it is not known whether the low level of membrane incorporation of CHT is a property 
of this system as well.  
PPT and LDT cholinergic cells provide ascending modulation to a variety of subcortical 
structures.  These neurons are the predominant source of ACh to the thalamus (Sofroniew et al 
1985; Hallanger & Wainer 1988), and the midbrain ventral tegmental area (VTA) (Gould et al 
1989; Gonzalo-Ruiz et al 1995).  They also project to the basal forebrain cholinergic system 
(Losier & Semba 1993), and thus can theoretically influence signaling in a diverse and large 
group of forebrain structures. It has been suggested that PPT/LDT cholinergic neurons modulate 
forebrain processing of environmental stimuli, thus facilitating externally directed behavioral 
responses (Kobayashi & Isa 2002). 
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We wished to examine the ultrastructural distribution of CHT protein in the projections 
of cholinergic PPT/LDT neurons in intact animals.  We chose to examine the terminal fields of 
these neurons in the VTA because of their demonstrated role in general motivational processes 
(Ikemoto & Panskepp 1996; Pan & Hyland 2005) and their relevance to nicotine addiction in 
particular (Lança et al 2000; Corrigall et al 2002; Laviolette & van der Kooy 2003; Pidoplichko 
et al 2004).  For comparison, we examined cholinergic terminals in the anteroventral nuclei of 
the thalamus (AVN) for two reasons.  First, the cholinergic innervation of this particular thalamic 
nucleus is relatively dense (Sofroniew et al 1985; Heckers et al 1992; Holmstrand et al 2006) and 
probably arises exclusively from the brainstem cholinergic system (Shibata 1992; Gonzalo-Ruiz 
et al 1995), at least in the rat (see (Parent et al 1988)).  Secondly, the AVN is an important 
component of the limbic system and so is linked functionally with the VTA, even though there 
are no direct connections between the two regions (Shibata 1992; Geisler & Zahm 2005).  We 
examined CHT-containing axonal profiles in these nuclei at the ultrastructural level and 
compared the morphology, synaptology, and both the overall density of CHT immunogold 
reactivity and the specific membrane density of CHT in cholinergic axons innervating these 
regions.  Preliminary accounts of this investigation were previously reported in abstract form 
(Holmstrand et al 2006; Holmstrand et al 2008). 
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2.2 MATERIALS AND METHODS 
2.2.1 Subjects 
All animal procedures were carried out with approval from the Institutional Animal Care 
and Use Committee at the University of Pittsburgh. Male Sprague-Dawley rats (Hilltop Lab 
Animals, Inc., Scottdale, PA) weighing 300-400 g were deeply anesthetized with sodium 
pentobarbital (60 mg/kg i.p.) and pretreated for 15 minutes with sodium diethyldithiocarbamate 
(DEDTC, Spectrum Chemical Corp., Gardena, CA; 1 mg/kg i.p.) to prevent silver enhancement 
of endogenous zinc ions in axon terminals (Veznedaroglu & Milner 1992).  A cohort of paired 
animals were then perfused using a transcardial approach with 50 mL of heparinized saline (1000 
U/mL), followed by 500 mL of 3% paraformaldehyde and 0.15% glutaraldehyde in 0.1 M 
phosphate buffer, pH 7.4 (PB).  The brains were removed and cut in the coronal plane to yield 3-
4 mm thick blocks.  Tissue was then post-fixed overnight in the same fixative at 4°C. Brains 
were sectioned through the anterior thalamus and the midbrain to a thickness of 50 μm and 
collected in PB.  Sections were treated with 1% sodium borohydride in PB for 30 minutes and 
rinsed extensively.   
 
2.2.2 Immunohistochemistry 
Sections were labeled by immunoperoxidase or immunogold-silver using a polyclonal 
antibody raised in rabbit against the C-terminus 15 amino acid sequence that is conserved in the 
human, mouse and rat CHT protein.  Several lines of evidence support the specificity of this 
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antibody (Ferguson et al 2003). The antiserum labels a band of the predicted molecular weight 
for CHT by Western blot analysis of mouse whole tissue or brain synaptosomes and from PC12 
cells transfected with human CHT. This immunoreactive band is absent from kidney and from 
PC12 cells transfected with empty vector.  Immunohistochemical labeling with the polyclonal 
rabbit antibody conforms to the expected distribution of cholinergic neurons and fibers 
throughout the mouse and rat brain and at the neuromuscular junction, and is co-localized with 
other markers of cholinergic phenotype but not other transmitters.  Pre-adsorption with the 
immunizing peptide abolishes this labeling (Ferguson et al 2003).  Finally, immunolabeling is 
absent from CHT -/- mice (Ferguson & Blakely 2004).  
Sections for immunoperoxidase visualization of CHT were rinsed in 0.1 M Tris-buffered 
saline, pH 7.6 (TBS) and incubated for 30 minutes in a blocking solution containing 1% bovine 
serum albumin (BSA), 5% normal donkey serum (NDS, Jackson Immunoresearch Laboratories, 
Inc., West Grove, PA), and Triton X-100 (Sigma, St. Louis, MO) at 0.2% or 0.04% for light or 
electron microscopy, respectively.  Sections were then transferred to blocking solution 
containing the polyclonal rabbit anti-CHT at 1:1000 and incubated overnight at 4°C. After 
rinsing, sections were incubated for 30 minutes in biotinylated donkey anti-rabbit IgG (Jackson 
Immunoresearch) diluted at 1:400 in blocking solution.  Excess secondary antibody was removed 
with several rinses in TBS, and sections were incubated in ABC solution (Vectastain kit, Vector 
Laboratories, Burlingame, CA) for 30 minutes.  Peroxidase product was developed by incubation 
in 0.022% diaminobenzidine (Sigma) and 0.003% hydrogen peroxide for 3 minutes.  Sections for 
light microscopy were rinsed extensively in TBS and 0.01 M phosphate buffered saline prior to 
mounting on Superfrost microscope slides (Fisher Scientific, Pittsburgh, PA).  After drying, 
slides were dehydrated through a series of increasing ethanol concentrations, defatted in xylene, 
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and coverslipped with Cytoseal-60 mounting medium (Richard Allen Scientific, Kalamazoo, 
MI).  Immunoperoxidase labeled sections for electron microscopy were prepared as detailed 
below.  
Sections for pre-embedding gold-silver immunostaining were treated according to the 
recommended protocol included with the Aurion RGent SEM kit (Electron Microscopy Sciences, 
Hatfield, PA).  Sections were rinsed in 0.02 M phosphate buffered saline, pH 7.4 (PBS) and 
permeabilized in 0.05% Triton X-100 for 10 minutes.  Non-specific antigenic sites were blocked 
by a 30 minute incubation in PBS containing 5% BSA, 5% NDS, and 0.1% fish gelatin (GE 
Healthcare Life Sciences, Waukesha, WI).  Sections were then rinsed in an incubation buffer 
containing 0.2% acetylated BSA (Aurion BSAc, Electron Microscopy Sciences) and incubated 
overnight at 4°C in incubation buffer containing primary antibody (rabbit anti-CHT, 1:1000). 
Sections were rinsed extensively in incubation buffer and placed in vials containing secondary 
antibody (Aurion donkey anti-rabbit 0.8 nm gold conjugate, 1:50, Electron Microscopy Sciences) 
and 5% NDS in the same buffer.  Secondary antibody binding occurred overnight at 4°C. After 
rinsing in incubation buffer and PBS, antibody complexes were fixed by incubation for 10 
minutes in 2% glutaraldehyde in PBS.  Following several rinses in PBS, gold particles were 
silver-enhanced using the Aurion RGENT SEM kit, according to the manufacturer’s instructions 
and using the optional enhancement conditioning solution (Aurion ECS, Electron Microscopy 
Sciences).  Silver enhancement proceeded from 45-75 minutes and was terminated by several 
rinses in ECS, followed by 0.1 M PB. 
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2.2.3 Tissue Preparation for Light and Electron Microscopy 
Brightfield micrographs were captured on an Olympus BX-51 microscope (Olympus 
America Inc., Center Valley, PA) equipped with a CCD camera (Hamamatsu, Bridgewater, NJ).  
Acquired images were imported into Adobe Photoshop (Adobe Systems Incorporated, San Jose, 
CA) and modified to match brightness and contrast.  
Immunoperoxidase and immunogold-silver reacted tissue was processed for electron 
microscopy by incubation in 2% osmium tetroxide in 0.1 M PB for 1 hour, dehydrated through a 
series of increasing ethanol concentrations, treated with propylene oxide, and infiltrated with an 
epoxy resin (EMBed-812, Electron Microscopy Sciences).  Sections were then flat-embedded 
between sheets of commercial plastic (Aclar, Electron Microscopy Sciences).  Ultrathin (60-70 
nm) sections were cut through the regions of interest on a Leica Ultracut ultramicrotome (Leica 
Microsystems, Bannockburn, IL) and mounted on either copper mesh grids or carbon coated 
copper slot grids (Electron Microscopy Sciences). Sections were then counterstained with 5% 
uranyl acetate and lead citrate and examined on a transmission electron microscope (Morgagni, 
FEI Company, Hillsboro, Oregon) equipped with a CCD camera (Advanced Microscopy 
Techniques, Danvers, MA).  Digital micrographs of labeled axonal profiles were captured at 
14,000 – 28,000x magnification and adjusted for exposure and contrast in Adobe Photoshop.  
 
2.2.4 Image Analysis 
 In cholinergic projections to the cortex, it has been shown that the synaptic incidence 
extrapolated from single section observations is equal to the rate of synapse formation obtained 
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from the analysis of serial ultrathin sections (Umbriaco et al 1982).  However, this relationship 
has not yet been established for the projections of the PPT/LDT cholinergic cells.  We therefore 
evaluated the rate of synapse formation observed in serial section data and compared this to an 
extrapolated synaptic incidence calculated from data obtained only from single sections. 
For each rat, two Vibratome sections were examined through each region.  For most CHT 
immunolabeled profiles, we were able to obtain a series of micrographs from adjacent ultrathin 
sections, and we used these profiles to determine if each displayed a synaptic specialization (n = 
637, Data set #1, Table 1). We also used this first data set to determine whether each CHT 
labeled profile contained at least one dense-cored vesicle or none. 
To further analyze the extent of synapse formation, we utilized a second data set of single 
sections through CHT immunoreactive profiles from 3 of the 6 animals (n = 410, Data set #2, 
Table 1) and applied a well-accepted method for post hoc size correction to generate an 
extrapolated synaptic incidence (Beaudet & Sotelo 1981).  By comparing the values obtained 
from the serial sections with that extrapolated from single section analysis, we could determine if 
this extrapolation method can accurately estimate synaptic incidence in these brain regions.  
More specifically, we recorded the minimum diameter (D), and length of the synaptic junction 
(d) for each of these profiles.  We also measured the thickness of our sections (w) using the 
minimal fold method (Small 1968).  We computed the means of these measurements for each 
region, and applied the following equation:   
     P = (d/D)*(2/π) + (w/D);   
where P is the probability of observing a synapse in a single section through an axonal profile if 
all profiles form one synapse (Beaudet & Sotelo 1981).  In other words, P*(true synaptic 
incidence) = single-section synaptic incidence.  We therefore divided the rate of synapse 
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formation we observed in our single section sample by this probability (P) to generate the 
extrapolated synaptic incidence.  
For the analysis of CHT immunogold localization, we used a third data set consisting of 
single sections through each profile from both Data sets #1 and #2 (n = 1047, Data set #3, Table 
1). To avoid bias in the selection of a single image through the serial micrographs from Data set 
#1, we chose the image that was photographed first, regardless of its position within the series. In 
this case, we assumed that the first encounter with a profile constituted a random event.   
Using a commercial image analysis software program (SimplePCi, Hamamatsu), we 
measured immunoreactive profiles and recorded the number of gold particles in the cytoplasm 
and associated with the plasma membrane.  From these data, we derived the following 
measurements:  (1) profile area, 2) profile perimeter, 3) total gold density of CHT immunogold 
particles, defined as the total number of gold particles per unit profile area, and 4) membrane 
density of CHT immunogold particles, defined as the number of membrane associated gold 
particles per unit profile perimeter. Membrane gold particles were defined as those immediately 
in contact with the plasmalemma or separated by no more than 20 nm, based on estimates of gold 
particle and immunoglobulin size (Umeda et al 1997; Mathiisen et al 2005). 
Silver-enhanced gold particles were observed at high density in axonal profiles that 
clearly contained synaptic vesicles. The presence of a lower density of gold-silver particles in 
some dendrites suggested a certain degree of background staining, which varied between 
animals.  Therefore, when there was any concern regarding specific gold labeling in axons, these 
profiles were followed in a short series of adjacent sections. Profiles that contained fewer than 10 
gold particles per square micron were excluded from our sample unless consistent   
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Table 1  Sampling scheme for ultrastructural analysis 
 
 
  
Animal Region
1 AVN
VTA
2 AVN
VTA
3 AVN
VTA
4 AVN
VTA
5 AVN
VTA
6 AVN
VTA
Total
56
79
107
92
76
Number of profiles analyzed
637 410 1047
86
80
Data set 3      
all profiles
98
91
100
93
89
7
0
79
76 0
0
0
89
107
48
39
56
0
0
44
80
Data set 1 
serial sections
Data set 2 
single sections
47
0
68
65
93
93
30
26
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immunolabeling was observed in at least 3 serial micrographs. 
  Non-specific background labeling was similar in the two regions, averaging 1.6 ± 1.3 
gold particles per µm2 in the AVN versus 1.7 ± 1.4 gold particles per µm2 in the VTA. Specific 
gold-silver labeling in the final data set was determined to be at least 2.5 times above 
background levels, with the majority of profiles well beyond this minimum level.   
2.2.5 Statistical Analysis 
Serial micrographs from the first data set (Table 1) were examined for the presence of 
synaptic specializations and dense-cored vesicles.  The probabilities of synapse presence and 
dense-cored vesicle presence were modeled using generalized linear mixed models based on the 
Bernoulli distribution, with the logit as the link function.  Brain region was treated as a fixed 
effect.  Animal pair was also treated as a fixed effect to account for the fact that animal tissue 
was processed in pairs.  To account for the correlation among observations within an animal and 
among observations within each Vibratome section, animal and section nested in animal were 
treated as independent normally distributed random effects.  
The remaining dependent measures were analyzed from the third data set of all labeled 
profiles (Table 1). A linear mixed model was used to model the profile area of CHT-
immunoreactive structures, with brain region and animal pair treated as fixed effects.  To 
account for the correlation among observations within an animal and among observations within 
each Vibratome section, animal and section nested in animal were treated as independent 
normally distributed random effects.  
A generalized linear mixed model, based on a Poisson distribution, was used to model 
total gold density of CHT immunogold positive profiles, with the log as the link function and the 
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natural logarithm of profile area as an offset variable.  Brain region and animal pair were treated 
as fixed effects.  To account for the correlation among observations within an animal and among 
observations within each Vibratome section, animal and section nested in animal were treated as 
independent normally distributed random effects. 
Membrane density of CHT immunogold positive profiles was modeled in a manner 
similar to that of total gold density of CHT immunogold positive profiles.  The only difference 
arose from the fact that the model for membrane density used the natural logarithm of profile 
perimeter as an offset variable and included total gold density and the interaction between brain 
region and total gold density as fixed effects, in addition to brain region and animal pair. 
 The analysis of profile area was implemented in SAS PROC MIXED (Version 9.2, SAS 
Institute Inc., Cary, NC), while all other analyses were implemented in SAS PROC GLIMMIX.  
The Kenward-Roger degrees of freedom method was used in each analysis.  When testing for the 
significance of fixed effects in a mixed model, the Kenward-Roger method is generally 
recommended to approximate the denominator degrees of freedom in subsequent F tests (Littell 
et al 2006).  This method corrects for the fact that the estimated variability of the fixed effects 
parameter estimates tends, on average, to be lower than the actual variability of these estimates.  
All statistical tests were conducted at the 0.05 significance level. 
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2.3 RESULTS 
2.3.1 Light Microscopic Detection of CHT 
Immunoperoxidase staining was used to examine the distribution of CHT in the AVN and 
VTA (Figure 4). The AVN division of the thalamus contained dense puncta immunoreactive for 
CHT that were suggestive of axon varicosities. Such profiles were notably absent from the 
adjacent anterodorsal thalamic nucleus (Figure 4A). In the VTA, similar axon-like 
immunoreactive puncta were observed, although the innervation appeared to be less dense 
(Figure 4B).  
2.3.2 Ultrastructural Detection of CHT 
Immunoperoxidase labeling for CHT was observed mainly in unmyelinated axonal 
profiles in the AVN and VTA (Figure 5).  By qualitative estimation of both light and electron 
micrographs, it appeared that the AVN contained a higher density of CHT-labeled profiles 
(Figure 4, inserts; Figure 5); however, this was not quantified further. In the VTA, occasional 
myelinated axons were also found to contain CHT.  The efferent fibers of the oculomotor nerve 
pass through the VTA without synapsing, and given that these are cholinergic premotor axons, 
we restricted our examination to only the unmyelinated profiles likely to represent brainstem 
cholinergic axons. Immunogold-silver labeling for CHT was also localized primarily to 
unmyelinated axonal profiles in the AVN and VTA (Figure 6). With either staining method, 
CHT-labeled axon varicosities in both regions formed axodendritic synapses with either 
symmetric or asymmetric morphology and contained mainly small-clear and occasional dense- 
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Figure 4  Light micrographic images illustrating immunoperoxidase labeling for CHT in the AVN and VTA.  
 
In A, immunoreactivity for CHT appears to be denser in the AVN than in the anterodorsal thalamic nucleus (ADN). 
The boxed region shown at higher magnification in the insert straddles the two divisions and illustrates 
immunolabeled puncta (arrows) representing probable axon varicosities. Note the absence of these puncta in the 
adjacent ADN. B shows relatively uniform CHT staining in the VTA. The boxed region shown at higher 
magnification in the insert illustrates immunoreactive puncta (arrow) that appear at lower density than in the AVN. 
Abbreviations: fr, fasciculus retroflexus; ml, medial lemniscus; mp, mammillary peduncle; sm, stria medullaris. 
Scale bar represents 500 µm in A and B, 100 µm in inserts.    
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Figure 5  Electron micrographs showing representative immunoperoxidase labeling for CHT in axonal 
profiles. 
 
In CHT immunoreactive profiles (large white arrows), the reaction product typically appears to be denser in labeled 
AVN (A) profiles than those observed in the VTA (B), although a range of immunoreactive densities is evident.  
CHT positive profiles also appear to be more numerous in the AVN than in the VTA, consistent with the 
observations made at the light microscopic level.  The lightly labeled CHT varicosities in the VTA form symmetric 
(small white arrow) or asymmetric (black arrow) synapses onto unlabeled dendrites (ud). One of these also contains 
a dense-cored vesicle (arrowhead).  The heavy peroxidase reaction product in AVN profiles makes it difficult to 
identify dense-core vesicles in this region.  Scale bar represents 0.5 µm. 
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Figure 6  Morphology of CHT-immunoreactive profiles in the AVN and VTA.   
 
Electron micrographs showing the morphological features of CHT-positive profiles in the AVN (A-C) and VTA (D-
F).  CHT labeled profiles form both asymmetric (black arrows, A & D) and symmetric (white arrows; B & E) types 
of synaptic contacts with unlabeled dendrites in the regions examined.  Occasionally, dense-cored vesicles are 
observed in labeled profiles (arrowheads in C & F). Scale bar represents 0.5 µm. 
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cored vesicles (Figures 5, 6). These morphological features were more easily visualized with the 
immunogold-silver method, and this approach was therefore used to investigate regional 
differences in the frequency of observation of synaptic specializations and dense-cored vesicles 
(see below). By either immunoperoxidase or immunogold labeling methods, CHT-containing 
axons in the AVN appeared to be smaller and more densely labeled than profiles in the VTA. 
These apparent differences were also compared quantitatively using immunogold-silver labeling 
for CHT.  
2.3.3 Morphological Features of CHT-labeled Axon Varicosities in the AVN and VTA 
For the more exhaustive approach of counting synapses in serial sections, we included 
only profiles for which 3 or more serial micrographs were available to examine. This subset of 
CHT-labeled profiles was also used for statistical comparison between the AVN and VTA. The 
majority of this data came from 5 of the 6 rats (Data set #1, Table 1); sections from animal 2 
were collected only on mesh grids and yielded few sets of serial micrographs. In the AVN, 333 
CHT-immunoreactive axon varicosities were examined in serial ultrathin sections, and of these, 
120 (36%) formed synaptic specializations of the symmetric or asymmetric type. In the VTA, 
304 CHT-labeled profiles were analyzed in serial, and 144 of these (47%) were synaptic. There 
was a significant effect of region on the synaptic incidence of the profiles examined (t(633)= -2.69, 
p = 0.0074), indicating that CHT axons in the VTA were more commonly observed to form 
synapses than those in the AVN. There was no significant effect of animal pair. Furthermore, 
there were no apparent differences across region in the extent to which CHT-labeled profiles 
formed symmetric (33% in the AVN versus 34% in the VTA) or asymmetric (60% in the AVN 
versus 54% in the VTA) synapse types; the remaining synapses had indeterminate morphology. 
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From single sections (Data set #2, Table 1), we observed 51 synapses from a total of 205 
CHT-labeled varicosities (25%) in the AVN.  In the VTA, we observed 60 synapses from a total 
of 205 CHT-labeled profiles examined (29%).  These profiles had a mean diameter of 0.38 µm 
(AVN) and 0.58 µm (VTA), with a mean synapse length of 0.32 µm (AVN) and 0.47 µm (VTA).  
The mean section thickness in these micrographs was 65 nm (AVN) and 69 nm (VTA).  Using 
the equation described in the methods, we obtained an extrapolated synaptic incidence of 35% in 
the AVN, compared to 36% observed in our serial sections. For the VTA, the extrapolated 
synaptic incidence was 47%, identical to the rate observed in our serial sections.  The close 
agreement of the extrapolated synaptic incidence with results obtained from serial ultrathin 
section analysis suggests that extrapolation from single sections is an appropriate method for 
application to the brainstem cholinergic projection system, and may be used in place of the more 
labor-intensive serial examination. 
CHT-positive varicosities were also analyzed in serial sections to determine whether 
dense-cored vesicles were present. In the AVN, 13% (44/333) of CHT-labeled profiles contained 
at least one dense-cored vesicle, compared to 29% (87/304) in the VTA. This regional difference 
was also statistically significant (t(17.5)= -2.58, p = 0.0191), confirming that dense-cored vesicles 
were more commonly observed in the VTA CHT-positive population. There was no significant 
effect of animal pair. 
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2.3.4 Size of CHT-labeled Axon Terminals in the AVN and VTA 
To quantify possible regional differences in the size and immunolabeling density of 
CHT-positive profiles, a larger data set was utilized in which profiles were collected from both 
serial and single section analyses (Data set #3, Table 1). For the AVN, 538 CHT-positive axon 
varicosities were measured, and their mean size was 0.41 µm2 (± 0.13 SD). In the VTA, 509 
profiles had a mean size of 0.63 µm2 (± 0.12 SD).  Figure 7 shows the distribution of observed 
profile areas and illustrates that similar ranges of areas were observed for both regions and that 
the distributions were overlapping. However, a large proportion of AVN profiles had small areas 
(> 90% in the first three bins), whereas VTA profiles were more likely to be of moderate area, as 
evidenced by the rightward shift of the VTA distribution compared to that of the AVN (Figure 
7A). Statistically, there was a significant regional difference in profile area (t(20.6) = -4.18; p = 
0.0004), indicating that the population of CHT-positive varicosities in the AVN is on average 
smaller than that in the VTA. There was also a significant effect of animal pair (F(2, 20.6) = 6.49; p 
= 0.007).  The reason for this is not clear, but it might reflect the fact that animals within pairs 
were more likely to be the same age and weight and might even have been litter mates.  
Alternatively, the significant effect of animal pair might be due to differences in tissue shrinkage 
during the fixation, dehydration, and/or plastic embedding processes that would be expected to 
occur, as animal pairs were processed at different times. 
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Figure 7  Cross-sectional area of CHT-ir profiles in the rat AVN and VTA. 
 
Frequency distribution (A) and quartile plots (B) of CHT-labeled axon profile areas observed in the AVN and VTA.  
A: Histogram illustrating the frequency of areas measured for profiles immunoreactive for CHT in the rat AVN 
(black bars) or VTA (white bars). Each bar represents the percentage of the total sample of immunoreactive profiles 
having a particular area. B: Box plots illustrating the range of mean profile areas (between whiskers) as well as the 
median values (central line) and the middle 50% of values observed in each region (shaded boxes).  Mean profile 
areas were computed by averaging profile areas within each region for each rat. 
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2.3.5 Total Gold and Membrane Gold Densities of CHT-labeled Axon Terminals in the 
AVN and VTA  
CHT-labeled varicosities in the AVN appeared to contain more total gold-silver particles 
than those in the VTA, although a considerable range was also evident (Figures 6, 8). In the 
AVN, CHT-positive axon varicosities had a mean total gold density of 43.5 (± 17.0 SD) gold 
particles per unit area versus a density of 22.8 (± 4.4 SD) in the VTA. As shown in Figure 9, 
A&B, this difference reflects a larger proportion of profiles with low total gold in the VTA as 
compared to the AVN. The total gold density of CHT-labeled axonal profiles was significantly 
different between the AVN and VTA populations (F(1, 20) = 18.89, p = 0.0003).  There was also a 
significant effect of animal pair (F(2, 20) = 4.45, p = 0.0252), indicating that total gold density was 
more similar within than across pairs.  This is not surprising given that tissue from paired cohorts 
were processed at separate times using different batches of immunoreagents.   
The greater density of total gold labeling might be expected to raise the probability of 
gold-silver particles contacting the plasma membrane (compare for example, Figure 8A and 8D).  
Therefore the set of all CHT-labeled profiles was also analyzed for membrane gold density, 
which had mean values of 1.05 (± 0.42 SD) and 0.55 (± 0.09 SD) gold particles per unit 
perimeter in the AVN and VTA, respectively.  As shown in Figure 9 C,D, this apparent 
difference reflects a larger proportion of profiles with high membrane gold densities in the AVN 
versus the VTA. The difference in membrane gold density was significant between regions 
(F(1,25.14) = 24.32, p < 0.0001); the effect of animal pair was not significant.  As expected, total 
gold density also had a significant effect on membrane gold density (F(1, 1041) = 684.00, p < 
0.0001).  However, there was also a significant interaction effect of region and total gold density 
on the membrane gold density (F(1, 1041) = 21.94, p < 0.0001), indicating that although membrane 
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gold density was dependent on total gold density in both regions, the relationship between these 
variables differed significantly between regions.  In other words, total gold density drove 
membrane gold density in a region-specific manner. 
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Figure 8  CHT immunogold labeling in axon varicosities from the rat AVN and VTA.  
 
Electron micrographs illustrating CHT positive-profiles labeled by immunogold-silver in the AVN (A-C) and VTA 
(D-F) and displaying a range of sizes and also total gold and membrane gold densities. Arrowheads indicate gold-
silver particles counted as being in association with the plasma membrane. Occasional symmetric (white arrow in D) 
or asymmetric (black arrow in E) synapses onto dendrites are exhibited by CHT-immunoreactive axons. Scale bars 
represent 0.5 µm. Scale bar in A represents 0.5 µm in A and B; scale bar in C represents 0.5 µm in C-F. 
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Figure 9  Total Gold Density and Membrane Gold Density of CHT-ir profiles in the rat AVN and VTA.   
 
 
Frequency distributions (A&C) and quartile plots (B&D) of values observed for the total gold density ( # gold 
particles/profile area; A&B) and membrane gold density (# membrane associate gold particles/profile perimeter; 
C&D) in the sample of CHT-labeled axonal profiles in the AVN and VTA. A&C: Histograms illustrating the 
frequency of total gold density (A) or membrane gold density (C) measured for profiles immunoreactive for CHT in 
the rat AVN (black bars) or VTA (white bars). Each bar represents the percentage of the total sample of 
immunoreactive profiles having a particular density. B&D: Box plots illustrating the range of mean total gold 
density and mean membrane gold density (between whiskers in B and D, respectively) as well as the median values 
(central lines) and the middle 50% of values observed in each region (shaded boxes).  Mean total gold density and 
mean membrane gold density were computed by averaging total gold density and membrane gold density, 
respectively, within each region for each rat. 
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2.4 DISCUSSION 
This study represents the first ultrastructural investigation of the distribution of CHT in 
the rat thalamus and midbrain as representative target areas of the brainstem mesopontine 
cholinergic system. The morphology and synaptology of the axons displaying CHT 
immunoreactivity in both regions were relatively well matched to profiles identified by other 
markers of cholinergic projections in the published literature. Nevertheless, direct comparison of 
CHT immunolabeled boutons in the rat AVN versus the VTA revealed some important 
differences, both in the morphological characteristics of these axon varicosities, and in the 
density and localization of the transporter.  Labeled axons in the AVN were smaller and less 
frequently formed synaptic specializations with neuronal elements than those in the VTA.  AVN 
profiles were also less frequently observed to contain dense-cored vesicles.  Finally, AVN 
varicosities contained more total CHT immunogold particles than their VTA counterparts and 
showed a higher density of transporters associated with the plasma membrane.  
 
2.4.1 Limitations of the Methods 
The principal limitation of immunoelectron microscopy is the potential for false negative 
results based on restricted penetration of immunoreagents. The efficiency of the preembedding 
immunogold-silver method in particular is limited by incomplete penetration of gold-conjugated 
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secondary antibodies, and the need to minimize exposure to detergents that degrade phospholipid 
membranes.  To reduce false negatives, we therefore examined tissue from only the first few 
microns of each section. We also used a stringent but consistent inclusion criterion to avoid false 
positives (see Materials and Methods).  Therefore, we acknowledge that our sampling may have 
excluded some cholinergic axons that express low levels of CHT.  As profiles in the VTA 
generally displayed a lower level of staining overall, this may have resulted in a more restricted 
sample population in this region.  Nevertheless, the analysis involved thalamic and midbrain 
sections from the same animals exposed to the same batches of immunoreagents and subjected to 
the same sampling scheme. Moreover, the range of observed values overlapped considerably for 
both regions. Hence, the reported findings are likely to reflect true regional differences.  
An additional limitation of the preembedding immunogold-silver method of antigen 
detection is the relative inefficiency of labeling membrane proteins in the synapse (Baude et al 
1995; Bernard et al 1997).  While this method localizes extrasynaptic membrane proteins well, 
the density of the synaptic space and associated structures reduces the ability of antibodies to 
gain full access to all available epitopes, hence increasing the likelihood of false negative 
staining specifically at this site.  To determine with certainty the presence of transporters within 
synaptic membranes, post-embedding methods must be employed.  However, we found that the 
antigenicity of CHT was not preserved following plastic embedding, thus preventing application 
of this more sensitive method.  Therefore, our results concerning differences in the membrane 
density of CHT are applicable only to the extrasynaptic portions of the axonal membrane. 
Finally, we must acknowledge that the low level of immunogold-reactivity associated 
with the plasma membrane may reflect a preferential association of the primary antibody with 
cytoplasmic transporters and reduced epitope recognition of membrane-bound transporters.  This 
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could occur if association with the phospholipid membrane induced allostearic changes in the 
structure of the intracellular tail of CHT, or if the tail structure is otherwise different between the 
two states (e.g. through phosphorylation or interaction with scaffolding proteins).  It should be 
noted that our sample included axonal profiles from each region that showed greater numbers of 
membrane transporters than cytoplasmic transporters, demonstrating that the heavily cytoplasmic 
staining is not artifactual.  Nonetheless, we cannot exclude the possibility of a physical bias in 
immunoreactivity. 
   
2.4.2 Population Characteristics of AVN and VTA CHT-Positive Varicosities 
Our sample of CHT-positive boutons most likely represents cholinergic axons arising 
from the ascending projections of the tegmental cholinergic cell groups.  To date, CHT 
expression in the brain has only been reported in cholinergic neurons (Okuda & Haga 2003), and 
the pattern of immunoreactivity closely matches that of VAChT and ChAT (Misawa et al 2001; 
Kus et al 2003).  Hence, immunoreactivity for CHT serves as an exclusive marker of cholinergic 
axons. Furthermore, the AVN and VTA appear to receive cholinergic innervation predominantly 
from neurons in the brainstem mesopontine tegmentum (Sofroniew et al 1985; Jones & Beaudet 
1987; Gonzalo-Ruiz et al 1995; Yeomans 1995). Although a minor projection from basal 
forebrain cholinergic cells to the AVN has been proposed (Hallanger et al 1987; Parent et al 
1988), the majority of the cholinergic innervation to this region is believed to arise from the 
brainstem (Heckers et al 1992).  Furthermore, the AVN is not immunoreactive for the nerve 
growth factor (NGF) receptor (Yan & Johnson Jr. 1989), a selective marker of basal forebrain 
cholinergic  axons (Woolf et al 1989).  The VTA is innervated by some neurons in the basal 
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forebrain (Tomimoto et al 1987; Grove 1988; Geisler & Zahm 2005), but these have never been 
demonstrated to be cholinergic.  Moreover, the VTA regions that receive these projections are 
also devoid of NGF immunoreactivity (Yan & Johnson Jr. 1989), and other authors have asserted 
that the PPT and LDT represent the sole source of cholinergic afferents to the VTA (Yeomans et 
al 1993). 
The morphology and synaptology of CHT-labeled axons in the thalamus and midbrain 
closely match previous descriptions of cholinergic boutons within these regions, including the 
relatively small size, content of small clear vesicles, and predominant formation of axodendritic 
synapses (Hallanger et al 1990; Garzon et al 1999; Oda et al 2003; Omelchenko & Sesack 2006). 
The presence of numerous dense-cored vesicles in these varicosities appears not to have been 
reported previously, most likely due to the masking effect of heavy immunoperoxidase product 
in prior studies.  
Our sample of CHT-labeled varicosities did display some distinct differences in 
synaptology as compared to cholinergic populations described in the published literature. For 
example, Oda et al. reported a higher incidence of VAChT-labeled axons forming synapses in 
the AVN (~60% versus 35-36% in the present study). Moreover, both VAChT and ChAT-
labeled axons have been reported to synapse onto cell bodies in this region (Hallanger et al 1990; 
Oda et al 2003), which we did not observe.  In the VTA, the frequency of synapses reported here 
is better matched to previous estimates (~ 50% versus the present 47%) (Garzon et al 1999; 
Omelchenko & Sesack 2006). Nevertheless, we again did not observe any CHT-containing 
axosomatic synapses in the VTA, despite prior reports of these synapses using other markers of 
cholinergic axons (Garzon et al 1999; Omelchenko & Sesack 2006). 
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The reasons for these discrepancies are not immediately clear, although differences in the 
sampling strategies used across studies are likely to contribute. For example, studies focused on 
identifying the post-synaptic targets of cholinergic axons may have been biased towards 
varicosities that were in direct apposition to other neuronal elements and therefore more likely to 
be observed making synapses (Oda et al 2003).  Our sample included all axonal profiles that 
contained synaptic vesicles and CHT immunoreactivity in excess of our inclusion threshold, 
leading us to examine both synapsing and non-synapsing varicosities.  Alternatively, both the 
lower synaptic frequency of CHT-positive profiles in the AVN observed in our study and our 
failure to detect axosomatic synapses in both regions could indicate that CHT-labeled boutons 
constitute a subset of all cholinergic varicosities in the AVN and VTA. Additional studies using 
dual immunolabeling methods for CHT and VAChT are required to address this possibility.  
Interestingly, the extrapolated synaptic incidence of cholinergic boutons in the AVN in 
this study (35%) is similar to that that observed in other thalamic nuclei receiving PPT/LDT 
cholinergic projections, including the reticular nucleus of the thalamus (33%) and the 
dorsolateral geniculate nucleus (39%), but stands in contrast to the cholinergic innervation of the 
parafascicular nucleus of the thalamus, where the incidence is reportedly 100% (Parent & 
Descarries 2008).  As noted by those authors, this contrast suggests that the formation of 
synapses may be determined by the functional role(s) played by acetylcholine in each distinct 
region. 
2.4.3 Differences between AVN and VTA CHT-labeled profiles 
Variable rates of ACh turnover have been reported between the striatum and cerebral 
cortex (Wecker & Dettbarn 1979), indicating a lack of uniformity in functional measures across 
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different cholinergic cell groups in the CNS. Whether this functional variability in ACh 
transmission reflects structural differences in these axons or their content of CHT remains to be 
addressed. Still, it is tempting to speculate that the differences we observed in morphology, 
synaptology, and CHT distribution between cholinergic axons in the AVN and VTA have 
functional correlates. According to a general scaling principle (Pierce & Lewin 1994), axon 
terminal size is positively correlated with activity. It is important to note that this principle has 
been demonstrated only for amino acid transmitter-containing axons (Lisman & Harris 1993; 
Pierce & Lewin 1994) and has not yet been investigated for cholinergic systems.  Still, CHT-
positive varicosities in the VTA might be more active and release greater amounts of ACh based 
on their larger size and higher apparent rate of synapse formation.  Alternatively, the higher total 
content and greater membrane distribution of CHT in AVN profiles suggests an overall higher 
demand for ACh synthesis that necessitates steady replenishment of choline.  It is difficult to 
reconcile these seemingly paradoxical observations, and neurochemical studies are needed to 
specifically test for differences in ACh transmission between the thalamus and midbrain.  
In addition to possible differences in overall activity level, it could be that the pattern of 
ACh release also differs between these areas and that this results in distinct demands for choline 
uptake. Different activity patterns have been recorded for presumed cholinergic neurons in the 
mesopontine tegmentum, including cells whose firing varies across sleep-wake states, as well as 
neurons with state-independent activity (Koyama et al 1994; Datta & Siwek 2002). If cells with 
phasic patterns of ACh release innervate the VTA, then their axonal stores of transmitter could 
be replenished during quiescent periods using a relatively small number of membrane-associated 
transporters. Conversely, AVN cholinergic axons might be subjected to tonic activity patterns 
that require greater continuous reuptake of choline and therefore a higher level of membrane 
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CHT. In this regard, it is interesting to note that increased membrane CHT has been reported in 
the cerebral cortex during sustained attention tasks that require tonically accelerated ACh 
transmission (Apparsundaram et al 2005).  
The fact that many CHT-labeled boutons in both the thalamus and midbrain failed to 
display evident synaptic specializations suggests that ACh released from brainstem cholinergic 
cells may be acting on extrasynaptic targets through volume transmission, as already suggested 
for forebrain cholinergic systems (Descarries et al 1997).  The lower apparent rate of synapse 
formation in the AVN as compared to the VTA further suggests that volume transmission may 
play a more important role in the former structure. Nevertheless, there is evidence consistent 
with extrasynaptic ACh transmission in both regions. For example, the AVN is likely to be the 
source of ACh for the adjacent anterodorsal thalamic nucleus that expresses cholinergic receptors 
(Sikes & Vogt 1987; Vogt et al 1992) but lacks direct cholinergic input (Levey et al 1987; Oda et 
al 2003). For the VTA, diffuse ACh transmission has been suggested based on the localization of 
α7 nicotinic receptors on glutamate axon terminals (Jones & Wonnacott 2004) and the absence 
of axo-axonic synapses in this region.   
Finally, the higher dense-cored vesicle content observed for VTA versus AVN 
cholinergic boutons suggests that peptide co-transmission may play a larger role in the 
modulation of VTA neurons.  Cholinergic cells in the mesopontine tegmentum have been 
demonstrated to synthesize and release substance P (Vincent et al 1983; Sutin & Jacobowitz 
1990) and these neurons may utilize other peptide co-transmitters as well (Crawley et al 1985; 
Standaert et al 1986). 
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2.4.4 Functional significance 
It is interesting to note that, while the AVN and VTA have no direct connections between 
them (Beckstead et al 1979; Simon et al 1979), and even project to distinctly separate cortical 
and subcortical regions (Bentivoglio et al 1993), both nuclei have been implicated in cue-driven 
behavior (Gabriel et al 1980; Pan & Hyland 2005).  The AVN is best recognized for its 
contribution to spatial memory (Warburton & Aggleton 1999) but also partially mediates 
conditioned avoidance responses (Gabriel et al 1980; Sparenborg & Gabriel 1992).  In contrast, 
the VTA plays a crucial role in conveying reward prediction to forebrain circuits that determine 
behavioral output (Schultz 2007; Redgrave et al 2008).  The cholinergic input to the VTA is 
especially necessary for both novel and conditioned cue-driven responses of VTA dopamine 
neurons (Ikemoto & Panskepp 1996; Pan & Hyland 2005).  Hence, it seems likely that both the 
AVN and VTA must receive information about external cues that can guide behavior.  This 
information might be transmitted by cholinergic neurons in the PPT and LDT, as these neurons 
are responsive to sensory input (Grant & Highfield 1991; Pan & Hyland 2005).  It is therefore 
tempting to speculate that environmental stimuli could influence divergent parts of the limbic 
system through collateral projections from the cholinergic brainstem. Collateralized projections 
of cholinergic neurons to thalamic nuclei and other regions have been documented (Jourdain et al 
1989; Semba et al 1990; Bolton et al 1993; Oakman et al 1999), although to date the possible 
existence of such projections to the VTA and AVN has not been explored.  Alternatively, such 
information may be relayed by the non-cholinergic neurons in these regions, or through separate 
populations of cells.   
If the projections to the AVN and VTA are ultimately shown to arise from a common 
brainstem cell population, then the regional differences observed here in CHT-labeled axons 
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would argue for local factors being the main determinants of bouton morphology and CHT 
distribution. This supposition is supported by recent evidence that the cholinergic innervation of 
several thalamic nuclei displays striking differences in synaptic incidence, even when this 
innervation arises from similar sources (Parent & Descarries 2008).  In regard to differences in 
CHT distribution, CHT localization and function can be influenced by intracellular signaling 
events triggered by the activity of neurotransmitter receptors on the surface of cholinergic axons 
(Breer & Knipper 1990).  Increases in high-affinity choline transport can be achieved through 
activation of protein kinase A or C, and corresponding decreases can be effected by phosphatase 
1/2A (Breer & Knipper 1990; Gates et al 2004).  It is therefore plausible that the heterogeneity of 
CHT labeling observed in this study reflects differences in the extracellular milieu in the AVN 
versus the VTA. Our finding of a significant interaction effect of region and total gold density on 
the membrane gold density of CHT-labeled axonal profiles is consistent with some as yet 
unidentified factor that is differentially active in these regions.  One possibility is that the 
presence of extracellular dopamine released from somatodendritic compartments in the VTA 
might decrease the membrane density of CHT in this region. This possibility is supported by in 
vivo data showing that elevated extracellular dopamine levels in the striatum are associated with 
reductions in high-affinity choline transport, consistent with decreased membrane levels of CHT 
(Parikh et al 2006).   
Alternatively, the differential expression of the choline-sensitive α7 nicotinic 
acetylcholine receptor (nAChR) may contribute to the differences in membrane CHT content 
reported here.  In the VTA, activation of presynaptic α7 nAChRs results in the potentiation of 
glutamate release from excitatory afferents (Schilström et al 2000; Jones & Wonnacott 2004), 
but all forms of cholinergic transmission in the AVN are mediated through non-α7 nAChRs 
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(Guseva et al 2006; Rasmussen & Perry 2006) or through muscarinic receptors.  The α7 nAChR 
is desensitized by extracellular choline (Alkondon et al 1997; Mike et al 2000; Uteshev et al 
2003; Alkondon & Albuquerque 2006). Hence, the membrane content of CHT might be 
inversely correlated with the availability of α7-mediated modes of cholinergic transmission. In 
this case, the lower membrane content of CHT in the VTA might be driven by a need to keep 
extracellular choline levels high, thereby restricting the activation of α7 nAChRs and preventing 
excessive glutamate excitation. 
Although differential regulation of choline transport could be accomplished at a local 
level, the collective morphological differences observed between the CHT-immunolabeled axons 
in the AVN and VTA are most easily explained by cholinergic innervations arising from separate 
populations of neurons in the mesopontine tegmentum.  Alternatively, the parent populations of 
AVN and VTA cholinergic inputs could be partially overlapping subsets of PPT/LDT 
cholinergic cells.  This mixed afferent population could produce a range of axon characteristics 
that favor smaller varicosities with more dense CHT content in the AVN and the converse 
characteristics in the VTA. This idea is supported by tract-tracing studies showing input from 
both PPT and LDT populations to the VTA (Satoh & Fibiger 1986; Oakman et al 1995; 
Omelchenko & Sesack 2005), but a heavier input from the LDT to the AVN (Shibata 1992).  
Tract-tracing studies will be essential for clarifying the nature of these circuits and facilitating a 
systems-level interpretation of the present findings.  
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3.0  DUAL IMMUNOFLUORESCENCE FOR VAChT AND CHT: COMPARISON OF 
COLOCALIZATION OF CHOLINERGIC PROTEINS IN THE AVN AND VTA 
3.1 INTRODUCTION 
The neurotransmitter acetylcholine (ACh) is synthesized through the reaction of acetyl 
coenzyme A, a molecule produced in mitochondria during cellular respiration, and choline, an 
essential nutrient that must be obtained from dietary sources (Cooper et al 2003; Löffelholz & 
Klein 2006).  This reaction is catalyzed in cholinergic neurons by the enzyme choline 
acetyltransferase (ChAT), and newly synthesized ACh is packaged into synaptic vesicle for 
future release by the vesicular acetylcholine transporter (VAChT) (Erickson et al 1994).  The 
choline used as a substrate for ACh synthesis is transported into these neurons through the action 
of the high-affinity choline transporter (CHT) (Yamamura & Snyder 1972; 1973; Simon et al 
1976).  Availability of choline is rate-limiting for ACh synthesis, making the functional high-
affinity choline uptake crucial to maintaining normal cholinergic signaling (Mulder et al 1974).  
Accordingly, CHT expression levels are typically increased by the same regulatory factors that 
increase levels of VAChT and ChAT (Lips et al 2003; Lecomte et al 2005), the two other 
proteins whose expression defines the cholinergic phenotype (Erickson et al 1994; Ichikawa et al 
1997).   
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In the central nervous system, CHT is expressed exclusively in cholinergic neurons 
(Misawa et al 2001; Ferguson et al 2003; Kus et al 2003).  However, CHT-ir is notably absent 
from at least one subset of cholinergic terminals within the brain (Misawa et al 2001), reflecting 
the fact that CHT expression can be regulated independently from that of the vesicular 
acetylcholine transporter (VAChT) or choline acetyltransferase (ChAT) under some conditions 
(Lecomte et al 2005).  Further evidence that transcription and translation of CHT protein can be 
dissociated from that of the other cholinergic proteins comes from reports of CHT expression by 
non-cholinergic cells (Masland & Mills 1980; Haberberger et al 2002).  Within axons, CHT is 
predominantly localized to small synaptic vesicles that provide a mechanism for its trafficking to 
the plasma membrane.  Although not all cholinergic synaptic vesicles contain CHT, virtually all 
CHT-containing vesicles contain VAChT (Ferguson et al 2003), indicating that the localization 
of the two proteins are closely linked.  Still, the trafficking of CHT and VAChT protein from the 
cell body appears to occur through separate pathways (Misawa et al 2008), allowing the 
possibility that CHT may be concentrated at some sites of ACh release, yet absent from others.  
Within the brain, there is robust colocalization of CHT with VAChT or ChAT in 
cholinergic cell bodies (Ferguson et al 2003; Kus et al 2003), but quantitative analysis of CHT 
and VAChT colocalization in axonal profiles has not been reported for any region within the 
CNS.  Furthermore, differences in high-affinity choline uptake and subsequent rates of 
acetylcholine synthesis have been reported for different cholinergic systems in the rat brain 
(Wecker & Dettbarn 1979; Stanton & Johnson 1987).  Finally, CHT and VAChT dual labeling in 
the ventral horn of the spinal cord suggest a population of VAChT-ir puncta without detectable 
levels of CHT-ir (Ferguson et al 2003), indicating that the degree of colocalization of VAChT 
and CHT may vary between different cholinergic systems, and even between cells of the same 
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cholinergic group. Thus, even if VAChT and CHT are highly colocalized in some cholinergic 
axon terminals, this is not necessarily generalizable to the brainstem tegmental cholinergic 
projections, a system in which the expression and regulation of CHT is less well-characterized 
than in the basal forebrain cholinergic system or in striatal cholinergic cells.  
Our recent investigation of CHT subcellular localization in the axon terminals of the 
anteroventral thalamus (AVN) and the ventral tegmental area (VTA) revealed that CHT-
immunoreactive varicosities in the VTA were larger and less heavily labeled for CHT than their 
counterparts in the AVN (Holmstrand et al 2010).  VTA CHT-ir axons also more frequently 
contained dense-cored vesicles, indicating a larger role for peptide co-transmission in these 
projections.  Finally, CHT-ir profiles in the VTA were more frequently observed to form 
synaptic contacts than those in the AVN, suggesting that the projections to the VTA may operate 
via point-to-point synaptic transmission to a greater degree than in the AVN (Agnati et al 1995).  
Although these brain regions are both innervated by cholinergic neurons in the brainstem 
pedunculopontine and laterodorsal tegmental nuclei (PPT and LDT, respectively), the collective 
differences we observed in these axonal populations indicate that cholinergic transmission may 
have distinctive characteristics specific to each brain region.      
In Chapter 2, we also noted that none of the synapses we observed were formed with 
somal postsynaptic targets.  This contradicted previous reports, in which a small percentage of 
cholinergic terminals, identified by immunohistochemistry for VAChT or ChAT, formed 
synapses on cell bodies in the AVN and VTA (Hallanger et al 1990; Oda et al 2003; 
Omelchenko & Sesack 2006).  While we cannot wholly exclude a possible unconscious bias in 
our sampling, the large number of terminals that we examined in serial ultrathin sections made it 
unlikely that we simply overlooked this subset of CHT-immunoreactive terminals.  
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Alternatively, some cholinergic boutons may express such low levels of CHT that they were 
excluded from our sample. It is also possible that CHT may be localized to some axonal 
compartments distinct from those containing the majority of colocalized VAChT and CHT.   If 
either of these latter scenarios is true, this should be reflected by incomplete colocalization of the 
two markers in these regions.  Furthermore, axons in the VTA express lower levels of CHT than 
those in the AVN (Holmstrand et al 2010), so we expect that the frequency of detectable 
colocalization of VAChT and CHT to be lower in the VTA than in the AVN. 
Due to the rate-limiting effect of high-affinity choline uptake on ACh synthesis, the 
ability to sustain high neuronal firing rates appears to depend on adequate expression of CHT.  
During periods of elevated ACh release, a reserve of transporters can be accessed and delivered 
to the plasma membrane through the exocytosis of CHT-containing synaptic vesicles, resulting 
in increased high-affinity choline uptake that supports rapid refilling of the vesicular pool of 
ACh.  The refilling of vesicles is also dependent on the actions of VAChT (Van der Kloot et al 
2000; Van der Kloot et al 2002).  Therefore, it is expected that the levels of VAChT protein 
within a cholinergic terminal may reflect the size of the vesicular pool of ACh, with higher levels 
of VAChT being expressed in terminals that can release greater amounts of ACh upon 
stimulation (de Castro et al 2009; Lima et al 2010).  While it seems likely that CHT and VAChT 
expression would be linked to the relative activity of a given neurons, experimental 
manipulations can increase CHT expression without affecting VAChT levels (Erb et al 2001; de 
Castro et al 2009).  Whether CHT expression is related to the level of VAChT expression under 
baseline conditions is unknown. 
We chose to examine the colocalization of CHT and VAChT in AVN and VTA axons 
using state-of-the-art spinning disk confocal immunofluorescence microscopy, to determine if 1) 
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CHT and VAChT are always colocalized within the axon varicosities of the brainstem tegmental 
cholinergic neurons; and 2) if the rate of observed colocalization in the AVN is higher than that 
observed in the VTA.  Additionally, we compared quantitative immunofluorescence levels for 
CHT and VAChT across regions to determine if variation in the levels of CHT or VAChT exists 
between two populations of axon terminals that arise from the same tegmental cholinergic 
system.  We further assessed whether CHT expression is related to VAChT protein levels, and 
therefore would be likely to reflect the relative activity of afferents to the AVN and the VTA, by 
examining the relative levels of CHT to VAChT within individual colocalized boutons in these 
regions.   
 
3.2 MATERIALS & METHODS 
3.2.1 Antibodies and Reagents 
All chemicals were purchased from Sigma unless otherwise noted.  The monoclonal 
antibody against CHT (MAB5514, Millipore, Billerica, MA) was raised in mouse against a GST-
fusion protein containing an 80 amino acid portion of the C-terminal tail of human CHT 
(Ferguson et al 2003).  Evidence for the specificity this antibody includes Western blot staining 
of the predicted size of CHT (65 kDa) from PC-12 cells transfected with hCHT but not from 
untransfected controls (Ferguson et al 2003), and absence of staining in CHT knockout mice 
(Ferguson et al 2004).  The polyclonal antibody against VAChT was raised in rabbit against an 
11 amino acid sequence from the carboxyl tail of the transporter, and was a generous gift from 
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Dr. Yongjian Liu at the University of Pittsburgh.  This antibody labels VAChT but not the 
vesicular monoamine transporter (VMAT) in transfected PC-12 cells (Liu & Edwards 1997).   In 
addition, the pattern of immunostaining that we observed with either of these antibodies matched 
the known distribution of cholinergic cells and axon terminals in the rat brain. 
3.2.2 Tissue Preparation 
Five adult male Sprague-Dawley rats were anesthetized with sodium pentobarbital 
(Nembutal, 100 mg/kg i.p.) and perfused transcardially with 50 mL heparin saline (1000 U/mL) 
followed by 500 mL PLP fixative (4% paraformaldehyde, 1.4% lysine acetate, 0.1 % sodium 
meta-periodate in 0.1 M phosphate buffer (PB); (Mclean & Nakane 1974)).  The brain was 
removed from the skull, cut into blocks containing the AVN or VTA, and post-fixed in the same 
fixative overnight at 4⁰C.  Tissue was sectioned to 30 µms using a Vibratome, treated for 30 
minutes with 1% sodium borohydride in PB, then rinsed extensively in PB.   
 
3.2.3 Immunohistochemistry 
From each rat, a one in six series of sections through each region was used for dual 
fluorescence immunohistochemistry.  Briefly, sections were rinsed several times in 0.01 M 
phosphate buffered saline (PBS), and then incubated for 3 hours at room temperature in a 
blocking solution containing 0.1% L-lysine, 0.1% glycine, 0.3% Triton X-100 and 5% nonfat dry 
milk in PBS.  Sections were then transferred to vials containing the primary antibodies diluted in 
blocking solution: polyclonal rabbit anti-VAChT (1:20,000) and monoclonal mouse anti-CHT 
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(1:100,000).  Incubation in primary antibodies proceeded for 48 hours at 4⁰C with agitation.  
Sections were then rinsed several times in PBS and incubated in fluorophore-conjugated 
secondary antibodies, diluted in blocking solution:  Alexa 488 donkey anti-mouse and Alexa 568 
donkey anti –rabbit (1:500, Invitrogen, Carlsbad, CA).  Sections were incubated in secondary 
antibodies for 24 hours at 4⁰C with agitation, and protected from light during this time.  
All sections were rinsed extensively in PBS, mounted on glass slides and allowed to air 
dry while protected from ambient light.  Slides were coverslipped the same day with 
Fluoromount G (Southern Biotech, Birmingham, AL). 
3.2.4 Microscopy 
All sections were photographed at low magnification (4X) in the 488 channel on an 
Olympus BX51 microscope (Olympus, Center Valley, PA) equipped with Xenon/Argon 
illumination source with very brief exposure times, so as to limit photobleaching of this 
fluorophore.  These low power images were used to delineate the borders of the AVN and the 
VTA and to select regions for high-magnification (60X) imaging by confocal microscopy.  A 
numbered sampling grid was overlaid on these low-magnification images, and the sections and 
grid squares to be sampled were selected using a random number generator in Microsoft Excel.   
High magnification images were collected on an Olympus BX51W1 microscope 
equipped with a spinning disc confocal unit (Olympus), and a motorized stage (Bioprecision 
stage with MAC 6000 controller, Ludl Electronics Products, Ltd., Hawthorne, NY) with XYZ-
axis encoding (Heidenhain, Schaumburg, IL).  Sections were illuminated with a metal arc lamp 
(Prior Lumen 200, Prior Scientific, Rockland, MA) and excitation and emission fluorescence 
were filtered to appropriate wavelengths with matched filter sets (89000 Sedat Quad Filter Set, 
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Chroma Technology Corp, Bellows Falls, VT).  Images were captured at 60X magnification 
(PlanApo Objective, 1.42 N.A., Olympus) with a CCD camera (Orca R2, Hamamatsu, 
Bridgewater, NJ) and SlideBook software (version 5.0, Intelligent Imaging Innovations, Inc., 
Denver, CO).  Paired images were obtained from the 488 and 568 channels at 0.25 µm intervals 
along the Z-axis, starting 1-2 µm from the surface of the bottom of the section and continuing 
through to a plane 1-2 µm below the surface of the top of the section.  
Due to the large difference in the number of immunofluorescent puncta between the 
AVN and the VTA, overall fluorescence intensity was much higher in image stacks obtained 
from the AVN.  It was therefore necessary to use different capture parameters in order to 
optimize detection of immunofluorescent objects without saturating the camera.  For AVN 
stacks, the 488 channel was collected with a gain of 0 and exposure time of 1700 ms, and the 568 
channel was collected with a gain of 0 and exposure time of 1500 ms.  In the VTA, images from 
the 488 channel were collected with a gain of 50 and exposure time of 2500 ms, and 568 channel 
images were collected with a gain of 0 and exposure of time 2300 ms.  In order to compare the 
fluorescence intensity values (FI) of our sample puncta, we applied a correction to the AVN data 
that was determined empirically from calibration with reference fluorescent polystyrene beads 
(Inspeck Green beads and Inspeck Orange beads, 6 µm, 0.3% intensity, Invitrogen, Carlsbad, 
CA).  This correction, detailed below in Section 3.2.6.2 Exposure and Gain Corrections, scaled 
the AVN data to the same quantitative range as our VTA data points, making quantitative 
comparison of the two regions possible. 
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3.2.5  Image Analysis 
Image stacks were corrected for photobleaching and deconvolved using a constrained 
iterative approach and a calculated point spread function.  The deconvolved images were 
background subtracted using the mode FI value in each channel as “background.”   A masking 
procedure (Figure 10) identified immunofluorescent objects using a simple threshold 
segmentation of the 488 (CHT) or 568 (VAChT) channels.  The fluorescence channel used to 
define an object (e.g. 488-CHT for CHT-ir objects) was designated the primary channel for that 
object.  The threshold value applied to each stack was equal to 2x the background intensity (i.e. 
mode value) of the original deconvolved image stack.  This value was then applied to the 
background subtracted image, making the effective intensity criterion for each voxel 3x the 
background fluorescence.    A size criterion of 3 voxels was applied to the resulting objects, to 
reduce the number of false positive objects included in the sample.  After defining objects in 
each mask (CHT-ir and VAChT-ir objects, respectively), colocalization of the two markers 
within the same objects was assessed using the overlap of the primary VAChT or CHT masks.  
Each VAChT-ir or CHT-ir object was thus assigned to a colocalized or non-colocalized group. 
The mean 488 and 568 fluorescence intensities of both VAChT-ir and CHT-ir objects 
were recorded.  These means were calculated over the set of voxels defined for each object 
within a selection mask, including those voxels that had subthreshold intensity values in the 
secondary (i.e. non-selection) channel (see Figure 11). Paired mean fluorescence intensities were 
exported to Microsoft Excel, along with the volume, x-, y-, and z-axis center co-ordinates, and 
colocalization status of each VAChT-ir and CHT-ir object.   
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 Figure 10  Segmentation masking of fluorescent objects. 
 
The procedure for masking objects began with single channel 
deconvolved image data.  Original images (A) were 
background subtracted using the mode intensity value of the 
corresponding channel (B).  A simple threshold of 2x the mode 
value of the original image was applied to the background 
subtracted image.  The automated analysis identified the edges 
of objects as voxels that met or exceeded the threshold, and 
treated all voxels contained within this border as a single 
immunofluorescent object.  The resulting mask is shown in C.  
Scale bar in C represents 10 µm and applies to all panels.  
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Figure 11  Component voxels used to calculate mean fluorescence intensities in VAChT-ir 
and CHT-ir objects.   
 
VAChT-ir (A) and CHT-ir (B) objects were defined by the set of voxels that had fluorescence intensities 
(FI) greater than the stack-specific threshold value in the corresponding channel (e.g. 568-VAChT channel 
for VAChT-ir objects).  A colocalized object (left panels, A and B), identified by overlapping VAChT-
masked and CHT-masked objects, has both VAChT-ir and CHT-ir component objects.  The mean VAChT 
and CHT FI values could be calculated for each VAChT-ir or CHT-ir object, by averaging over the set of 
voxels that comprised the VAChT-ir or the CHT-ir objects.  This approach resulted in the inclusion of 
voxels that had above threshold values in the selection channel but that could have subthreshold values in 
the secondary channel (darkened pixels in the CHT FI panel in A; in the VAChT FI panel in B).  The 
horizontal line is shown to indicate which puncta from the merged panel is used for calculating mean FI.  
For non-colocalized puncta, the mean FI of each channel was still calculated, even though the voxels in the 
secondary channel were below threshold.  
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A guard zone was applied to these data, removing any objects that lay within the first or 
last 20 pixels in the x and y dimensions, or if objects were located outside of the central 6 µm of 
the Z-stack.  Microsoft Excel was used to filter data in preparation for statistical analysis and to 
prepare summary tables and graphs.   
3.2.6 Statistical Analysis 
3.2.6.1 Odds Ratios 
To compare the rate of colocalization observed in the AVN versus the VTA, we 
calculated the odds ratio (OR) of colocalization for the AVN in reference to the VTA.  The odds 
ratio (OR), defined as 𝑂𝑅 =  𝑝�𝐴𝑉𝑁
𝑝�𝑉𝑇𝐴
 , where ?̂?𝐴𝑉𝑁 is the odds of colocalization for VAChT-ir or 
for CHT-ir puncta in the AVN,  ?̂?𝑉𝑇𝐴 is the odds of colocalization for VAChT-ir or CHT-ir 
puncta in the VTA.  These parameter estimates were obtained using the following definitions: 
?̂? =  𝑝𝑐𝑜𝑙𝑜𝑐(1−𝑝𝑐𝑜𝑙𝑜𝑐)  , 𝑝𝑐𝑜𝑙𝑜𝑐 =  # 𝑐𝑜𝑙𝑜𝑐𝑎𝑙𝑖𝑧𝑒𝑑 𝑝𝑢𝑛𝑐𝑡𝑎# 𝑡𝑜𝑡𝑎𝑙 𝑝𝑢𝑛𝑐𝑡𝑎  . 
 
Point estimates and 95% confidence intervals of the odds ratio of colocalization with the 
secondary immunofluorescent marker were calculated for both the VAChT-ir  and  CHT-ir 
populations using Microsoft Excel. 
3.2.6.2 Exposure and Gain Corrections 
To compare mean FI values across regions, we first applied a correction to the AVN data 
to compensate for the lower exposure time and lower gain setting used to collect data in this 
region.  We determined that the effects of varying exposure time (ms) or gain on mean 488 FI 
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were linear by imaging reference fluorescent beads with varying exposure and gain settings (see 
Appendix B, Figure 25).  For the 488-corrections, Green beads of 0.3% intensity were imaged to 
create calibration curves over the range of exposure times and gain settings used to collect 
images from immunolabeled tissue.  For the 568-corrections, Orange beads of 0.3% intensity 
were imaged to calibrate FI over the range of exposure times only.  These image stacks were 
deconvolved and background subtracted in the same manner as the data obtained from tissue 
sections.  Linear regression of the mean FI values obtained from these calibration stacks revealed 
a significant dependence of FI on both the exposure and gain used for capture in the 488 channel, 
and a significant effect of exposure on the mean FI of 568 labeled beads (see Appendix B, Figure 
26).  For mean 488 FI, the calibration data were fit to the following regression line:  y = 
0.237(exposure (ms)) + 11.570 (gain), R2 = 0.991.   For mean 568 FI the regression line was 
defined as:  y = 1.243(exposure), R2 = 0.980 (Appendix B, Figure B-3).   Therefore, we 
transformed our AVN CHT mean FI values by the addition of ((0.237*800 ms) + (11.570*50)) = 
768.1.  Similarly, we scaled the AVN VAChT mean FI values by adding ((1.243)(800 ms)) = 
994.4 to all AVN 568 FI mean intensities. 
 
3.2.6.3 Mixed Model Analysis of Mean CHT and Mean VAChT FI 
 
To test for differences in the mean FI of CHT immunoreactivity and VAChT 
immunoreactivity between the AVN and VTA populations, a linear mixed model was used.  The 
model tested for a fixed effect of brain region (AVN versus VTA) and included the random 
effects of animal and section within animal to control for variability in the data due to repeated 
sampling from the same rats and the same tissue sections.  For these analyses, we compared the 
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mean FI of immunofluorescence for the primary channel used to define the object (e.g. mean 
CHT FI in CHT-ir objects).   
In colocalized objects, we examined the relationship between CHT immunofluorescence 
intensity and VAChT immunofluorescence intensity within individual boutons by calculating the  
Pearson’s correlation coefficients for the log(mean FI) for CHT and VAChT within colocalized 
objects. 
Finally, we compared the ratio of mean FI in the secondary channel to mean FI in the 
primary channel to determine if the relative levels of CHT and VAChT within colocalized 
objects (i.e. likely cholinergic boutons) differed systematically between the AVN and VTA 
populations.  A linear mixed model with the same fixed and random effect structure described 
above was used to test for regional differences in the ratio of  log(𝑚𝑒𝑎𝑛 𝐶𝐻𝑇 𝐹𝐼)
log(𝑚𝑒𝑎𝑛 𝑉𝐴𝐶ℎ𝑇 𝐹𝐼)   in objects 
defined by VAChT immunofluorescence (VAChT-ir objects) that also displayed above threshold 
CHT fluorescence, thus meeting criterion for colocalization.  For the CHT-ir objects, the ratio 
compared across regions was  log(𝑚𝑒𝑎𝑛 𝑉𝐴𝐶ℎ𝑇 𝐹𝐼)
log(𝑚𝑒𝑎𝑛 𝐶𝐻𝑇 𝐹𝐼) .    All statistical tests were performed with 
PASW 18 (SPSS Inc, Chicago, IL) with a significance level set at p = 0.05. 
3.3 RESULTS 
3.3.1 Extent of Colocalization of VAChT and CHT 
Representative 60x dual fluorescence images from the AVN and the VTA are shown in 
Figure 12.  Qualitatively, it appeared that most puncta in both regions displayed colocalized  
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Figure 12 Dual immunofluorescence for VAChT and CHT in the AVN and the VTA.   
 
Paired Z-stack projection images depicting Alexa-568-VAChT immunoreactivity (A,D,G) and Alexa 488-CHT 
immunoreactivity (B,E,H) were merged to display colocalization of the two proteins (C,F,I).  In both the AVN (A-
C) and the VTA (D-F), prominent colocalization was observed in structures resembling axon terminals.  Closer 
examination of the region indicated in panel F (G-I) revealed puncta singly labeled for VAChT (arrowheads) or 
CHT (arrows) in these regions.  Scale bar in F represents 10 µm and applies to A-F, scale bar in I applies to G-I and 
represents 5 µm.  
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immunofluorescence for VAChT and CHT, but singly labeled puncta could also be identified.  
Hence, both regions contained a mix of colocalized and non-colocalized immunofluorescent 
puncta. 
The total number of VAChT-ir and CHT-ir objects sampled from each animal, and the 
number and percentage of these that were colocalized is shown in Table 2.  Overall, it appeared 
that immunofluorescent objects in the VTA were less likely to display both CHT and VAChT 
immunoreactivity compared to similar objects in the AVN (63% versus 75% for VAChT-ir 
objects and 55% versus 75% for CHT-ir objects in the VTA versus the AVN, respectively).  
Nevertheless, in both regions the majority of objects showed labeling above threshold for both 
proteins.  In order to determine if the rate of colocalization differed on a regional basis, we 
calculated the odds ratio of colocalization in the AVN versus the VTA from the VAChT-ir and 
the CHT-ir samples.  For VAChT-ir objects, the odds ratio for colocalization in the AVN 
population with reference to the VTA population was 1.4, with a 95% confidence interval of 1.2 
– 1.7.  As the lower bound of this confidence interval was >1, colocalization was more likely to 
be observed in the AVN population than in puncta imaged from the VTA.  For objects identified 
on the basis of CHT-ir, the odds ratio for colocalization of VAChT in the AVN versus the VTA 
populations was 2.8, with a 95% confidence interval of 2.2 – 3.4, again suggesting a regional 
difference in the extent of colocalization of the two proteins. 
Puncta immunoreactive for VAChT and/or CHT displayed a similar distribution of 
volumes, shown in Figure  13A.  The frequency distributions of both VAChT immunoreactive 
objects and CHT immunoreactive objects were heavily skewed toward small volumes, with 70-
80% of each dataset having calculated volumes below 0.3 µm3.  Furthermore, there were clear 
size-dependent differences in the rate of colocalization of VAChT and CHT immunoreactivity  
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Table 2  Colocalization of VAChT and CHT immunoreactivity in the AVN and VTA 
 
 
  
CHT-ir objects
Animal
Colocalized 
VAChT 
objects
Total 
VAChT 
objects
% 
colocalized Animal
Colocalized 
CHT objects
Total CHT 
objects
% 
colocalized
1 1261 2009 63% 1 1320 1564 84%
2 809 1165 69% 2 749 1085 69%
3 1627 1998 81% 3 1127 1632 69%
4 1425 1965 73% 4 1599 2025 79%
5 1905 2196 87% 5 1938 2588 75%
Average 75% Average 75%
Animal
Colocalized 
VAChT 
objects
Total 
VAChT 
objects
% 
colocalized Animal
Colocalized 
CHT objects
Total CHT 
objects
% 
colocalized
1 206 298 69% 1 203 274 74%
2 223 377 59% 2 215 527 41%
3 210 303 69% 3 204 444 46%
4 381 709 54% 4 374 722 52%
5 309 497 62% 5 323 530 61%
Average 63% Average 55%
VAChT-ir objects
A. AVN
B. VTA
CHT-ir objectsVAChT-ir objects
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Figure 13 Frequency distribution of object volumes and colocalization rates of object volumes in the AVN 
and VTA.   
 
A The volumes of CHT-immunoreactive and VAChT-immunoreactive puncta in both brain regions were strikingly 
similar, with most of the sample population having a volume < 0.3 µm3.    B  The rate of colocalization observed in 
the smaller profiles (< 0.3 µm3) was lower than in larger immunofluorescent objects.  Above this volume, 
colocalization with the second marker was observed in over 90% of profiles. 
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across the range of volumes, such that only the smallest objects showed a substantial tendency 
toward non-colocalization (Figure 13B).  In puncta with a volume greater than 0.3 µm3, 
colocalization was detected in >90% of both VAChT- and CHT-immunoreactive objects from 
either brain region.  
An obvious technical concern for colocalization studies is whether the antibodies used to 
detect the two proteins penetrated the tissue sections equally.  However, we observed roughly 
equal numbers of CHT- and VAChT-ir objects throughout the Z-axis of the stack (Figure 14), 
indicating that single labeled puncta were not contained within a zone of suboptimal labeling in 
the secondary immunofluorescence channel.  The visual inspection of image stacks similarly led 
to the qualitative impression on our part that non-colocalized objects were distributed throughout 
the same three-dimensional space as colocalized ones. 
 
3.3.2 Quantitative Immunofluorescence Assessment of VAChT and CHT Levels Within 
Individual Puncta 
Object colocalization was formally determined on the basis of immunofluorescence 
intensity above a stack-specific threshold in each channel (see Methods).  Therefore, the lower 
incidence of colocalization in VAChT-ir objects and CHT-ir objects from the VTA compared to 
the AVN could result from lower overall expression of these proteins within the VTA.  The 
simple threshold used (effectively >3x background fluorescence, see Methods) would 
presumably exclude more immunoreactive puncta in the VTA if, overall, CHT expression is 
lower in axon terminals innervating this region.  To ascertain if VAChT or CHT FI differed 
systematically by region, a linear mixed model analysis was used to evaluate mean FI of the  
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Figure 14 Detection of CHT-ir and VAChT-ir objects throughout the sample tissue sections.   
 
anti-CHT and anti-VAChT antibodies appeared to penetrate the tissue sections equally well, as similar numbers of 
immunofluorescent objects for each marker throughout the tissue thickness.  Although there was an increase in 
objects towards the top of the section in the AVN (top lines, squares), this was equivalent for both CHT and 
VAChT-ir puncta.  The equal penetration of antibodies against both proteins argues against artifactual explanations 
for the lack of complete colocalization of CHT and VAChT. 
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primary mask marker used to define objects, without regard to colocalization status (e.g. mean 
CHT FI of all CHT-ir objects; see Figure 11).  Analysis of the exposure- and gain-corrected 
mean CHT fluorescence intensities observed within CHT-ir objects (shown in Appendix B, 
Figure 27, top panel) revealed a significant effect of region (F(1, 47.94) = 42.52, p < 0.001).  The 
estimated means of CHT FI indicated that AVN puncta contained greater immunoreactivity for 
CHT than VTA puncta (AVN = 1493, VTA = 1029, diff = 464).  Similar differences in VAChT 
FI within VAChT-masked objects were detected between the two regions (F(1, 45.38) = 45.267, p < 
0.001; estimated means: AVN = 2088, VTA = 1318, diff = 770; distribution of sample values is 
shown in Figure 27, bottom panel).   
To assess whether the level of CHT expression might be correlated with the level of 
VAChT expression in individual cholinergic boutons, we examined the relationship between 
VAChT and CHT immunofluorescence intensities within individual puncta in the AVN and 
VTA.  We restricted this analysis to those CHT-ir and VAChT-ir objects that met criteria for 
colocalization in order to focus on likely sites of ACh release.  We plotted the log-transformed 
mean CHT and VAChT FI for each these object in both the AVN and VTA populations (Figure 
15).  Pearson’s correlation coefficients indicated a significant but surprisingly weak positive 
association of CHT and VAChT FI in both VAChT-ir and CHT-ir populations sampled from the 
VTA and the AVN.  Although there was a general trend for objects with more intense 
fluorescence in the primary channel (x-axis) to also show higher mean FI in the secondary 
channel, there was substantial dispersion in the data that most likely contributed to the low 
Pearson’s r values obtained for both regional populations.  
  
 92 
 
 
Figure 15 Relative mean fluorescence intensities of CHT and VAChT in colocalized puncta in the AVN and 
VTA.   
 
The relationship between the mean CHT and VAChT intensity within CHT-ir puncta (A) and VAChT-ir puncta (B) 
that met colocalization criteria is plotted to demonstrate the correlation of intensity values.  In both graphs, the 
intensity of the protein used to define objects (e.g. CHT for CHT-ir puncta in A) is plotted on the x-axis, while the 
intensity of the 2nd marker is on the y-axis.   
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Finally, we evaluated the ratio of CHT immunofluorescence intensity relative to VAChT 
intensity in individual colocalized VAChT-masked puncta across brain regions, using a linear 
mixed model analysis.  For VAChT-masked objects, there was no significant difference in the  
ratio of log(mean CHT FI) / log(mean VAChT FI) (F(1, 45.12) = 0.436, p = 0.512) .  The estimated 
mean ratios for each region indicated that CHT immunoreactivity, relative to VAChT 
immunoreactivity, is remarkably similar between the two regions (AVN mean ratio: 0.950, VTA 
mean ratio: 0.964).   
Similarly, in colocalized objects defined in the CHT mask, mixed model analysis of the 
ratio of log(mean VAChT FI) / log(mean CHT FI) revealed no significant difference across brain 
region (F(1, 44.71) = 1.370, p = 0.248; AVN mean ratio: 1.055, VTA mean ratio: 1.027).   
3.4 DISCUSSION 
This study represents the first examination of CHT and VAChT colocalization, and the 
first quantitative analysis of CHT and VAChT immunofluorescence, within individual terminals 
of tegmental brainstem cholinergic axons.  Our results indicate that CHT and VAChT 
colocalization is prevalent but not complete in cholinergic axon boutons.  The rate of 
colocalization also varied between varicosities innervating the AVN and those innervating the 
VTA.  In addition, we were able to evaluate immunofluorescence intensities for these two 
cholinergic proteins within individual puncta.  The intensities of CHT and VAChT 
immunofluorescence were positively correlated within varicosities that contained detectable 
levels of both proteins.  However, despite regional differences in the mean intensities of CHT 
and VAChT immunofluorescence within CHT-ir and VAChT-ir puncta, respectively, the relative 
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levels of CHT and VAChT within dually-labeled boutons did not differ across brain regions.  
The methodological caveats and functional interpretations of these findings are discussed below. 
 
3.4.1 Methodological Considerations 
The primary antibodies used in this study have been previously characterized and shown 
to label their target proteins with a high degree of specificity (see Materials & Methods), and 
both VAChT and CHT are localized primarily at sites of vesicular ACh release (i.e. axon 
terminals) (Arvidsson et al 1997; Misawa et al 2001; Ferguson et al 2003).  Immunofluorescent 
labeling for VAChT and CHT was punctate in appearance, consistent with the localization of 
both proteins in axon varicosities.  Furthermore, the range of object volumes observed is 
consistent with the volumes estimated from ultrastructural studies of cholinergic terminals in 
these regions.  The minimum value of 0.01 µm3 observed in the present sample populations 
corresponds to a sphere with a diameter of approximately 0.26 µm.  Objects of this approximate 
size were observed in our previous sample of immunogold-silver labeled CHT-ir axon 
varicosities, although they comprised less than 20% of those profiles (unpublished observations 
from that dataset).  Of course, cholinergic boutons are not necessarily spherical in shape, and the 
immunofluorescent labeling used for volume calculations in the present study probably does not 
accurately depict the full morphological dimensions of these boutons.  Therefore, comparison 
between these two studies is useful only for confirming that immunofluorescent objects detected 
here are roughly consistent in size with the dimensions of cholinergic axon terminals in the AVN 
and the VTA, and that our size exclusion criterion was not inappropriate.   
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The detection of non-colocalized puncta raised concerns that a failure of one or the other 
primary antibody to adequately penetrate the brain tissue resulted in false-negatives.  Limited 
antibody penetration prevents dual-labeling of these proteins in material for electron microscopic 
examination (Sesack et al 2006), particularly because the use of detergents to improve antibody 
penetration is detrimental to the preservation of tissue morphology needed for ultrastructural 
analysis.  By using a light-microscopic approach, we were able to gain better antibody 
penetration through the generous use of Triton X-100 and long (48 hours) antibody incubation 
steps, facilitating access to the subcellular compartments containing the target proteins.  We did 
not observe any differences in the distribution of CHT versus VAChT immunofluorescent 
objects detected throughout the depth of the tissue section, suggesting that the antibodies 
penetrated the sections equally well.  Qualitatively, puncta singly labeled for CHT or VAChT 
were interspersed with other profiles that showed strong colocalization.  Finally, it seems 
unlikely that experimental factors contributing to false negative staining would have differential 
effects on tissue sections from the AVN versus the VTA. The difference in the rate of 
colocalization between brain regions is most easily explained by the assertion that the singly 
labeled objects in our study are true examples of non-colocalization, and not false negative data.   
However, we must stress that lack of colocalization in objects from our sample does not 
necessarily indicate that these puncta do not express any of the second protein, only that the 
levels of protein were low in comparison to objects that met criteria for colocalization.  
Nevertheless, such variability in the levels of CHT and VAChT immunoreactivity within 
probable cholinergic terminals are still expected to have functional significance for ACh levels in 
the brain. 
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3.4.2 Functional Significance of Incomplete Colocalization of VAChT and CHT in Axons 
Consistent with the view that CHT is an integral component of cholinergic function, a 
majority of cholinergic axon varicosities displayed significant immunoreactivity for both 
VAChT and CHT protein.  The co-expression of CHT and VAChT in the AVN and VTA verify 
the colocalization of these proteins for the brainstem tegmental cholinergic neurons, just as 
shown for most other cholinergic systems examined to date (Misawa et al 2001; Lips et al 2002; 
Ferguson et al 2003; Kus et al 2003; Nakata et al 2004).  Colocalized puncta probably represent 
ACh release sites, where CHT and VAChT reside on the same synaptic vesicles and these 
vesicles are densely packed within the axon terminal.  This supposition, however, require explicit 
testing by ultrastructural analysis that is not technically feasible at this time. 
We also detected some VAChT-ir terminals that did not contain significant levels of 
CHT immunoreactivity in both the AVN and the VTA.  Furthermore, VAChT-ir objects from the 
AVN were more likely to colocalize suprathreshold levels of CHT immunoreactivity than their 
counterparts in the VTA, as shown by the odds ratio estimate.  This probably reflects the higher 
overall levels of CHT contained within cholinergic axons in the AVN, a finding previously 
reported from immunogold-silver ultrastructural analysis of AVN and VTA axon varicosities 
(Holmstrand et al 2010).   
Surprisingly, we also found evidence of CHT-ir puncta that were not colocalized with 
VAChT immunoreactivity.  Similar to singly labeled VAChT-ir puncta, this population of non-
colocalized CHT-ir puncta accounted for a larger percentage of the total CHT-ir population in 
the VTA than in the AVN.  It is not clear what these sites of single CHT labeling represent.  If 
they are cholinergic terminals with subthreshold levels of VAChT, then high levels of CHT 
should not be necessary, given that the vesicular pool of ACh would be expected to be small 
 97 
(Oosawa et al 1999). It is possible for choline transported through CHT to be utilized for other 
choline-dependent cellular processes, such as membrane lipid synthesis (Farber et al 1996; 
Cooper et al 2003), even though cholinergic cells also express low-affinity choline transporters 
that usually suffice to provide choline for this purpose.  The larger axon profiles we observed in 
Chapter 2 might require higher levels of choline for phospholipid generation, simply in order to 
maintain their larger surface area.  CHT could be used to help meet this demand if it exceeded 
the capacity of low-affinity uptake mechanisms.  However, the predominantly vesicular (versus 
plasmalemmal) localization of CHT immunoreactivity reported in all prior studies makes this 
proposed secondary function of CHT unlikely, as the transporter must be situated in the plasma 
membrane in order to transport choline.   
Alternatively, these small, singly labeled puncta might result from the clustering of non-
vesicular CHT within varicosities or intervaricose segments. Indeed, the restriction of most non-
colocalized puncta to the smallest object volumes observed in this study suggests that the lack of 
colocalization could result from the concentration of the two proteins within different subcellular 
compartments.  For example, the non-colocalized CHT-ir puncta could result from antibody 
binding to clusters of transporters within the plasma membrane of axons, perhaps in the 
intervaricose segments, or a pool of CHT that has been recently retrieved from the plasmalemma 
via endocytosis, and is located on early endosomes that do not contain VAChT.  A third 
alternative is that these small non-colocalized puncta represent CHT or VAChT that is in transit 
from the cell body to axonal varicosities.  While the resolution limits of fluorescence microscopy 
(in this study, the minimum displacement for two-point resolution in the xy dimensions is 
estimated at 220 nm for the 488-channel and 255 nm for the 568-channel; in the z plane, these 
distances are 777 nm and 903 nm, respectively) would most likely prevent the detection of 
 98 
separate CHT containing and VAChT containing vesicular pools within a single terminal, 
concentration of CHT within intervaricose segments of the axonal plasma membrane might be 
discriminable.   
In experiments using CHT-transfected cultured cells, the transporter is rapidly 
endocytosed through vesicle recycling pathways, making clustering of transporters at the plasma 
membrane unlikely (Ivy et al 2001; Ribeiro et al 2003; Ribeiro et al 2005; Ribeiro et al 2006).  
However, the promotion of internalization of CHT by phosphorylation of the transporter (Gates 
et al 2004) suggests that the retention of CHT in the plasma membrane can be varied by the 
relative activation of protein kinases and phosphatases, as well as by a number of interacting 
proteins (Ribeiro et al 2007b; Wang et al 2007; Misawa et al 2008). To date, protein kinase C has 
been shown to increase CHT internalization, and PKC-dependent modulation of choline 
transport can be induced through the activation of certain G-protein coupled receptors (Breer & 
Knipper 1990; Gates et al 2004).  The activation of heteroreceptors on cholinergic axons could 
therefore potentially alter the phosphorylation of CHT, leading to greater retention of functional 
transporters in the plasma membrane of the VTA.  Finally, recent evidence that reactive oxygen 
species can alter CHT membrane trafficking (Pinthong et al 2008) may have special relevance 
for the regulation of choline uptake in these brainstem cholinergic pathways, as PPT/LDT ACh 
neurons also release nitric oxide as a co-transmitter (Williams et al 1997). 
Future work aimed at identifying intracellular pathways that influence high-affinity 
choline uptake by altering the levels of membrane CHT might provide insight into how the 
specific extracellular milieu impacts cholinergic function.  Such work could also reveal unique 
expression patterns of heteroreceptors on cholinergic axons that would differentially impact 
high-affinity choline uptake in the AVN versus the VTA. 
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We previously reported that CHT immunogold particles were more concentrated in the 
plasma membrane of AVN axon terminals, contradicting the aforementioned speculation.  
However, we excluded labeled profiles that did not contain synaptic vesicles in that study; 
therefore, we may have overlooked evidence of CHT clustered in intervaricose segments of 
axons.  Further examination of CHT ultrastructural localization will be necessary to determine if 
the singly labeled CHT-ir puncta in the present study might result from this hypothesized sub-
cellular distribution of CHT.    
Of course, we cannot summarily dismiss the possibility that some of these small, non-
colocalized objects are artifactual, resulting from the selection masking process.  For example, if 
CHT- or VAChT-immunofluorescence does not follow a spherical gradient within puncta (i.e. 
highly concentrated in the center of the object, uniformly decreasing as distance from the center 
increases), then the threshold segmentation mask used here could incorrectly split a single CHT-
ir or VAChT-ir puncta into multiple fluorescent objects, with the central object displaying 
colocalization, but peripheral artifactual objects being more likely to fail to colocalize the second 
immunofluorescent marker.  While our qualitative impression of the masking threshold used to 
define objects in each channel was that the masks accurately captured all voxels within single 
puncta, further experimentation is needed to determine if the non-colocalized objects described 
here are truly examples of differential localization of CHT and VAChT.   
Additionally, the larger size of VTA axon terminals observed by electron microscopy 
might allow greater separation of CHT and VAChT proteins within a single profile.  This 
confound could have affected our estimates of colocalization across the two regions.  However, 
the majority of CHT and VAChT protein is contained within the same synaptic vesicles; the 
small size of these structures would prevent optical resolution of such a small physical 
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separation.  CHT or VAChT contained within other cellular compartments (e.g. trafficking or 
recycling endosomes) might be physically separated by greater distances in the larger VTA 
varicosities, leading to greater numbers of non-colocalized puncta in the present study.  Although 
the estimated size of VTA cholinergic axon terminals is still likely to prevent discrimination of 
separate vesicle populations, any results concerning these singly labeled puncta should be 
interpreted with these caveats in mind.   
3.4.3 Relative Levels of CHT and VAChT Immunoreactivity in Colocalized Puncta  
CHT and VAChT immunofluorescence intensities were significantly correlated in 
colocalized puncta from either primary mask, indicating that CHT expression is likely to be 
higher in more active cholinergic axons.  VAChT packages newly synthesized ACh into synaptic 
vesicles; therefore, it is expected that all mature, ACh-containing synaptic vesicles would be 
immunoreactive for this transporter, and that protein levels of VAChT reflect the relative size of 
the vesicular ACh supply (Erickson et al 1994; Oosawa et al 1999).  It is plausible that 
cholinergic neurons that release ACh at higher rates, or that have distinctive firing patterns such 
as bursting behavior, would require a larger functional pool of vesicles that could be recruited 
during periods of elevated neuronal activity, and therefore would contain more VAChT protein.  
In parallel, higher rates of ACh synthesis would also be expected to require greater uptake of 
choline to supply the enzymatic reaction. A linear relationship between CHT and VAChT 
immunoreactivity is indicated by the significant correlations of immunofluorescence intensity for 
these two proteins that we reported here.  This finding supports the view that CHT expression is 
primarily driven by the requirements of ACh synthesis in all cholinergic neurons.   However, the 
associations between CHT and VAChT intensities were remarkably weak, suggesting significant 
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variability in the relative levels of these proteins, even across cholinergic boutons innervating a 
single brain region. 
However, formal testing of the ratio of CHT to VAChT immunofluorescence intensities 
in VAChT-ir objects revealed that there is no significant regional difference in the relative levels 
of these proteins within individual puncta.  Similarly, the ratio of VAChT to CHT 
immunofluorescence intensity in CHT-ir objects did not differ between the two regions.  The 
strikingly stable relationship of VAChT and CHT immunoreactivity within AVN and VTA 
boutons provides further support for the view that the expression of these two proteins is 
similarly influenced by cellular mechanisms of transcriptional regulation, and probably reflects 
the importance of CHT expression for the maintenance of adequate vesicular pools of ACh. 
 
3.4.4 Functional Implications  
The stable relationship of VAChT and CHT immunoreactivity levels, combined with the 
higher overall levels of both VAChT and CHT immunofluorescence in the AVN population 
suggests that these axons have a greater overall demand for ACh synthesis.  While the higher 
synthetic load in these terminals might reflect higher rates of release, an alternative explanation 
is that the morphological characteristics of AVN cholinergic boutons contribute to the need for 
high levels of ACh synthesis.  Cholinergic terminals in this region are smaller than their 
counterparts in the VTA (Hallanger et al 1990; Omelchenko & Sesack 2006; Holmstrand et al 
2010), and presumably contain fewer synaptic vesicles packed into this smaller space.  If the 
total number of vesicles in AVN terminals is lower than in similar terminals in the VTA, the rate 
of recycling for synaptic vesicles would have to be quicker in this region to support similar levels 
 102 
of ACh release.  Consequently, these vesicles might contain multiple copies of VAChT and be 
more likely to contain CHT as well, a hypothesis that is consistent with the present finding that 
both VAChT and CHT-immunofluorescence levels are higher in AVN boutons.  Quantification 
and comparison of the number of synaptic vesicles within AVN versus VTA cholinergic axon 
terminals could help distinguish between these possibilities.  
Alternatively, differential demand for choline may be driven by unique features of the 
extracellular microenvironment in this thalamic nucleus.  The dense cholinergic innervation of 
the AVN is thought to supply ACh to cholinergic receptors in the adjacent anterodorsal nucleus 
of the thalamus, as there are no cholinergic projections to this region (Sofroniew et al 1985; 
Levey et al 1987; Gonzalo-Ruiz et al 1995; Arvidsson et al 1997).  Furthermore, there is high 
cholinesterase activity in the ADN, while in the adjacent AVN such activity displays a gradient 
distribution (Paxinos & Watson 1986; Darvesh & Hopkins 2003; Alelú-Paz & Gimenéz-Amaya 
2007).  High levels of cholinesterases are found in the ventrolateral portion of the AVN, but 
enzymatic staining methods reveal diminished activity of these enzymes in the dorsomedial 
division that lies between the ventrolateral AVN and the dorsally situated ADN (Figure 16).  The 
more medially situated anteromedial nucleus (AM) also displays only moderate cholinesterase 
activity and has a relatively light cholinergic innervation.  Light or absent cholinergic innervation 
would result in lower concentrations of ACh in these regions, and the high cholinesterase levels 
in the AD would further reduce extracellular levels of ACh, creating a steep concentration 
gradient through which ACh, released from axons in the AVN, could diffuse.  Diffusion to 
neighboring regions would lower the extracellular levels of ACh in the dorsomedial AVN 
(AVDM), blunting the elevations of choline that would be expected to result from local 
hydrolysis of ACh in the immediate vicinity of the axon terminal.   
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Figure 16  Cholinergic microenvironment in the anterior nuclei of the thalamus. 
A  Illustration of cholinesterase activity in the anterior nuclei of the thalamus.  The anterodorsal 
nucleus (AD) displays high levels of cholinesterase activity, despite having no innervation by 
cholinergic fibers.  In the anteroventral nucleus, a gradient of cholinesterase is seen, higher levels 
of enzyme activity in the ventrolateral division (AVVL) and lower activity in the dorsomedial 
division (AVDM).  The anteromedial nucleus (AM) displays a low level of cholinesterase activity 
and a low cholinergic innervation (Paxinos & Watson 1986; Groenewegen & Witter 2004).  ACh 
released in the AVDM could theoretically diffuse toward the other nuclei (arrows) and would 
preferentially diffuse to the AD and AVVL where ACh concentrations would be lower due to 
hydrolysis by cholinesterases.  B  Summary characteristic ACh innervation and cholinesterase 
activity in the anterior thalamic nuclei, with predicted relative extracellular levels of ACh and 
choline.  In the AVDM, choline would be scarce due to the diffusion of ACh out of this nucleus, 
combined with low cholinesterase activity. In the AD, diffusion of ACh from the AVDM would 
result in higher ACh concentrations than would otherwise result (as ACh is not released here), but 
still limited by diffusion and the amount of ACh released in AVDM.  High cholinesterase activity 
would efficiently hydrolyze any ACh in this brain region.  
ACh innervation
Cholinesterase 
Activity
Predicted ACh 
levels
Predicted Choline 
levels
AD none high low moderate
AVDM high moderate to low low low                    
AVVL high high low high
AM low low low low to moderate
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Extracellular choline levels might therefore also be lower, and cholinergic axons in the AVN 
might show a high level of choline uptake in order to compensate for the reduced availability of 
substrate.   
Additionally, the high density of cholinergic terminals packed into the AVN probably 
contributes to an environment of intense competition by many transporters for limited substrate 
molecules, placing further demands on the high-affinity choline uptake system in this region.  In 
this case, the increased VAChT immunoreactivity observed within AVN terminals might not 
have a functional relevance, but might be the result of increased activity of transcriptional 
regulatory mechanisms, prompted by the need to increase CHT protein levels, that coincidentally 
increases the expression of VAChT.  Additional experimentation is needed to directly measure 
the levels of extracellular ACh and choline, and to assess functional high-affinity choline uptake 
in this region in order to further our understanding of the dynamics of cholinergic signaling in 
different brain microenvironments. 
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4.0  PROJECTIONS FROM THE RAT PEDUNCULOPONTINE AND 
LATERODORSAL TEGMENTAL NUCLEI TO THE ANTEROVENTRAL THALAMUS 
AND VENTRAL TEGMENTAL AREA ARISE FROM LARGELY SEPARATE 
POPULATIONS OF NEURONS 
Having found differences in the expression and localization of CHT between cholinergic 
axons innervating the AVN and the VTA, we hypothesized that these differences might reflect 
the innervation of these regions by separate sub-populations of PPT/LDT afferents.  However, 
brainstem cholinergic neurons frequently send axon collaterals to thalamic and non-thalamic 
targets, allowing for the possibility that differential regulation of CHT trafficking in axons could 
produce the regional differences in CHT immunoreactivity that we observed.  Dual tract-tracing 
from the AVN and the VTA was combined with VAChT immunohistochemistry in order to 
elucidate the nature of PPT/LDT afferents to the AVN and the VTA. 
4.1 INTRODUCTION 
The brainstem pedunculopontine (PPT) and laterodorsal tegmental (LDT) nuclei contain 
cholinergic neurons noted for their wide-reaching projections to diverse brain structures.  
Cholinergic neurons in these regions provide ascending input to virtually the entire thalamus 
(Hallanger et al 1987; Jones & Webster 1988; Heckers et al 1992), the midbrain dopaminergic 
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cell groups in the substantia nigra pars compacta (SNc) and ventral tegmental area (VTA) 
(Beninato & Spencer 1987; Oakman et al 1995), the basal forebrain (Woolf & Butcher 1986; 
Hallanger & Wainer 1988), the hypothalamus (Satoh & Fibiger 1986; Woolf & Butcher 1986; 
Cornwall et al 1990), and, in a more limited manner, the cerebral cortex (Crawley et al 1985; 
Satoh & Fibiger 1986).  Furthermore, several studies indicate that these brainstem cholinergic 
neurons can innervate both thalamic and extrathalamic target structures through divergent axonal 
branches (Woolf & Butcher 1986; Cornwall & Phillipson 1989; Jourdain et al 1989; Bolton et al 
1993; Losier & Semba 1993).   
The ascending cholinergic projections play an important role in the regulation of 
behavioral state and the detection of salient environmental stimuli (Inglis & Winn 1995; Reese et 
al 1995b; Yeomans 1995; Kobayashi & Isa 2002; Pan & Hyland 2005). Interestingly, these 
cholinergic groups innervate many brain structures associated with limbic circuitry (Mesulam et 
al 1983; Mesulam 1995a).  This is particularly true of the LDT, whose cholinergic neurons send 
projections to the anterior, parafascicular, mediodorsal and intralaminar thalamic nuclei, and 
even provide a minor input to the medial prefrontal cortex (Satoh & Fibiger 1986; Woolf & 
Butcher 1986; Cornwall et al 1990).  Additionally, cholinergic LDT neurons innervate other 
ascending neuromodulatory systems important for limbic functions, such as serotonin neurons in 
the raphé nuclei and dopamine neurons in the VTA (Satoh & Fibiger 1986; Cornwall et al 1990; 
Omelchenko & Sesack 2006; Mena-Segovia et al 2008). 
Although collateral projections from single LDT neurons have been described for the 
VTA and the intralaminar/midline thalamic groups (Bolton et al 1993), the possibility of 
collateralized projections to the VTA and anterior thalamus (AVN) has yet to be examined.  We 
previously examined the expression of the high-affinity choline transporter (CHT) in two limbic 
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areas that receive afferent cholinergic innervation exclusively from the brainstem tegmental 
nuclei: the VTA and the AVN (Holmstrand et al 2010).  We found that axons in the AVN 
displayed higher total levels of CHT immunoreactivity and greater plasma membrane density of 
CHT immunogold particles.  Cholinergic terminals in the VTA were larger, more frequently 
formed synaptic junctions, and were more likely to contain dense-cored vesicles, an indication of 
neuropeptide co-transmission.  Given these differences, we hypothesized that the cholinergic 
afferents to the AVN and the VTA would originate from separate populations of PPT/LDT cells.   
The existence of separate projections to the AVN and VTA is supported by the known 
distribution of related afferents to these regions.  The AVN innervation arises predominantly 
from the LDT (Shibata 1992), while afferents to the VTA appear to more equally derive from the 
PPT and LDT (Oakman et al 1995; Holmstrand & Sesack 2004; Mena-Segovia et al 2008).  With 
regard to forebrain connections of the AVN and VTA, these nuclei are interconnected with 
cortical and subcortical limbic regions that are largely exclusive of each other.  For example, the 
mesocortical dopamine innervation heavily targets medial prefrontal cortex and the anterior 
cingulate cortex (Beckstead et al 1979; Loughlin & Fallon 1984), whereas AVN neurons project 
only to the posterior cingulate cortex (Shibata 1993), at least in the rat (Barbas et al 1991).  
Another significant target of VTA dopamine neurons is the nucleus accumbens, yet the AVN 
does not send a substantial projection to this region (Giménez-Amaya et al 1995; Erro et al 1999; 
Smith et al 2009).  Such segregated circuitry suggests that these systems may receive specific 
cholinergic modulation from distinct subpopulations of PPT/LDT neurons.   
We tested this hypothesis by performing dual retrograde tract-tracing using the beta 
subunit of cholera toxin (CTxβ) and fluorescent latex microspheres (Retrobeads™) as 
discriminable tracing agents from the AVN and VTA, respectively. We combined tracing with 
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immunofluorescence histochemistry for VAChT to determine whether the ascending input to 
these target regions arises from separate groups of brainstem cholinergic and non-cholinergic 
neurons or results from the collateralization of ascending axons.   
4.2 MATERIALS AND METHODS 
All procedures were conducted in accordance with protocols approved by the 
Institutional Animal Care and Use Committee (IACUC) at the University of Pittsburgh. All 
chemicals were purchased from Sigma (St. Louis, MO) unless otherwise noted. 
4.2.1 Surgical Procedures 
Male Sprague-Dawley rats (Hilltop, 250-300g) were anesthetized with a mixture of 
ketamine, xylazine and acepromazine (35 mg/kg, 6 mg/kg, 1.2 mg/kg respectively, i.m.), and 
placed in a stereotaxic apparatus.  Throughout the surgical procedure, body temperature was 
maintained at 37˚C with a heating pad.  Supplement al anesthetic was administered when 
necessary to maintain suppression of the limb withdrawal reflex throughout the surgical 
procedure.  Unilateral injections of CTxβ (1% solution, List Laboratories, Campbell, CA) were 
made in the AVN by pressure or iontophoresis at the following co-ordinates, referenced to 
Bregma:  AP: -1.8 mm, ML: 1.8 mm, DV: 5.0 – 5.2 mm ventral to the surface of the brain.  
Iontophoretic injections were made using a Midgard constant current source (Stoelting, Wood 
Dale, IL) set to deliver a pulsed 5 µA current (8 sec ON, 8 sec OFF).  These injections proceeded 
for 5-8 minutes.  Unilateral injections of green fluorescent latex microspheres (Retrobeads™, 
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Lumafluor Inc., Naples, FL, referred to hereafter as Rbeads) were made by pressure into the 
ipsilateral VTA at the following co-ordinates, with reference to Bregma, and at an angle of 5˚
from vertical in the mediolateral plane:  AP:  -5.3 - -5.8 mm, ML: 1.6 – 1.8 mm, DV: 7.6 – 7.8 
mm from the surface of the brain.  A total of ~100 nL of the Rbeads was injected into the VTA.  
The scalp wound was treated with a topical antibiotic ointment and local anesthetic (Xylocaine 
2% jelly) and subsequently closed with surgical staples.  Rats were administered additional 
analgesic (ketoprofen, 2 mg/kg, i.m.) and had access to oral acetaminophen solution (3.25 
mg/mL) in their food and water during the post-operative recovery period (5-7 days).   
4.2.2 Tissue Preparation 
Rats were deeply anesthetized with sodium pentobarbital (Nembutal, 100 mg/kg, i.p.), 
and perfused transcardially with ~ 50 mL of heparin saline (1000 U/mL), followed by 500 mL of 
4% paraformaldehyde containing L-lysine acetate and sodium meta-periodate (PLP fixative, 
(Mclean & Nakane 1974)).  The brain was removed, cut in the coronal plane into blocks 4-5 mm 
thick, and post-fixed for 24 hours at 4°C.   
Blocks through the thalamus, midbrain, and mesopontine tegmentum were rinsed in 0.1 
M phosphate buffer (PB) and sectioned to 50 μm.  All sections were then treated for 30 minutes 
with sodium borohydride (1% in PB) and rinsed extensively in PB. 
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4.2.3 Visualization of Injection Sites 
CTxß injections were examined with immunoperoxidase staining for proper placement in 
the AVN and adequate deposit of tracer.  Briefly, sections were rinsed in 0.1 M Trizma buffered 
saline (TBS) and then treated for 30 minutes in a blocking solution containing 1% bovine serum 
albumin (BSA; Spectrum Chemical Corp.) and 0.2% Triton X-100.  Sections were then 
incubated overnight in blocking solution containing primary antibody (goat anti-CTxß, 1:20,000, 
List Laboratories).  After rinsing several times in TBS, sections were incubated for 30 minutes in 
secondary antibody (biotinylated rabbit anti-goat IgG, 1:500, Jackson ImmunoResearch, West 
Grove, PA).  Sections were rinsed again in TBS, and processed for peroxidase staining using the 
ABC Elite kit (Vector, Burlingame, CA).  Peroxidase staining was developed for 3-5 minutes in 
0.022% diaminobenzidine and 0.003% hydrogen peroxide.  Finished sections were rinsed several 
times in TBS and 0.01 M phosphate buffered saline (PBS) before mounting on glass slides 
(Superfrost, Fisher, Pittsburgh, PA).  Slides were dried, dehydrated through a series of increasing 
ethanol concentrations, soaked in three changes of xylene, and coverslipped with Cytoseal-60 
(Richard-Allan Scientific, Kalamazoo, MI). 
Due to their intrinsic fluorescence, Rbead injections could be visualized without any 
histochemical processing.  Accordingly, sections through the VTA were rinsed in PBS and 
mounted directly onto glass slides.  Long xylene exposures are detrimental to the fluorescence of 
the Rbeads (per the manufacturer’s instructions); therefore these slides were coverslipped 
immediately with a water-based fluorescence-compatible mounting medium (Fluoromount-G, 
Southern Biotech, Birmingham, AL). 
 111 
4.2.4 Dual Immunohistochemistry of Brainstem Sections 
In order to identify AVN-projecting, VTA-projecting, and cholinergic neuronal 
populations in the tegmentum, sections through the PPT/LDT of successful cases were processed 
to reveal CTxß and VAChT immunofluorescence, and examined for each of these markers, as 
well as for the presence of intrinsically fluorescent Rbeads.  A one in six series of sections was 
used for quantification of these neuronal populations.  During all immunohistochemical steps, 
sections were protected from light exposure to minimize fading of the Rbeads.  Briefly, sections 
were rinsed several times in PBS, and treated for 3 hours with a blocking solution containing 5% 
nonfat dry milk, 0.3% Triton X-100, 0.1% L-lysine acetate and 0.1% glycine.  Sections were 
then incubated in primary antibodies diluted in the same blocking solution for 48 hours at 4˚C:  
goat anti- CTxß (1:10,000) and rabbit anti-VAChT (1:5000, gift from Dr. Yongjian Liu, 
University of Pittsburgh).  Sections were rinsed extensively in PBS, and incubated overnight at 
4˚C in fluorescent-tagged secondary antibodies, diluted in blocking solution:  Alexa 568 donkey 
anti-goat IgG and Alexa 647 chicken anti-rabbit IgG (1:500 each, Invitrogen Corp., Carlsbad, 
CA).  All sections were rinsed extensively in PBS, mounted on glass slides, and coverslipped 
with Fluoromount-G.  Slides were protected from light exposure while drying and prior to 
microscopic examination. 
4.2.5 Identification of Labeled Neurons 
Sections were examined on an Olympus BX51 microscope (Olympus, Center Valley, 
PA) equipped with a xenon/argon illumination source, a CCD camera (Hamamatsu, Sewickley, 
PA), and image acquisition software (SimplePCi, Hamamatsu).  Sections were first 
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photographed at 4x magnification under illumination for Alexa 647/VAChT.  This allowed the 
visualization of the cholinergic cell populations in the brainstem and appropriate selection of 
regions for further examination at high magnification using triple immunofluorescence.  Fields 
adjacent to the PPT/LDT that contained no VAChT-labeled cells were excluded. 
Three channel fluorescence images were then acquired at 20x magnification, using the 
following filter sets (Chroma Technology Corp., Bellows Falls, VT):  1) Red channel:  Alexa 
568 (CTxß labeled, AVN-projecting neurons), excitation (ex): 555/28 nm and  emission (em): 
617/73 nm; 2) Green channel:  Rbeads (VTA-projecting neurons), ex: 490/20 nm and em: 528/38 
nm; 3) Blue channel:  Alexa 647 (VAChT-immunoreactive neurons, VAChT-ir), ex: 635/20 nm 
and em: 685/40 nm.  Exposure and gain settings were adjusted in the blue channel to maximize 
signal without saturation; subsequently, the other channels were adjusted to yield equivalent 
minimum fluorescence values (e.g. equivalent background fluorescence).  Three channel RGB 
images were saved as TIF files.  Finally, for each XY location on a section, images were 
collected from all focal planes that contained unique instances of labeled cells. 
All TIF files were examined in Adobe Photoshop (Adobe, San Jose, CA).  For each 
image, the total number of labeled neurons in each channel was recorded.  In addition to using 
specific fluorescence channels to identify labeled neurons, the texture of cellular staining was 
helpful in identifying true labeling and excluding the possibility of cross-channel excitation.  
Furthermore, neurons labeled in more than one channel were classified as belonging to one of the 
following groups:  1) collateralized, cholinergic (CTxβ+ Rbead+ VAChT +); 2) collateralized, 
non-cholinergic (CTxβ+ Rbead+ VAChT -); 3) cholinergic, AVN-projecting only (CTxβ+ Rbead- 
VAChT +); or 4) cholinergic, VTA-projecting only (CTxβ- Rbead+ VAChT +).  Tallies of these 
cell populations were made using Microsoft Excel (Microsoft, Redmond, WA).  For locations 
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with multiple focal planes, great care was taken to avoid counting any labeled neuron more than 
once.   
Tables were prepared using Microsoft Excel.  Figures were prepared using Photoshop to 
adjust brightness and contrast and to add figure labels. 
4.3 RESULTS 
4.3.1 Injection Sites 
Seven cases resulted in acceptable injections for both the AVN and VTA targets.  An 
additional case (Case 35) was examined to contrast the afferents to the paratenial nucleus (PT) 
with those of the more lateral AVN.   
Figure 17 shows representative injections of both CTxβ (A) and Rbeads (B) from Case 
34. Immunoperoxidase for CTxβ typically filled the anterodorsal (AD) and anteroventral nuclei, 
with additional reaction product evident in the anteromedial (AM) nucleus and intralaminar 
paracentral nucleus (PC).  Much of the reaction product in the PC was contained within 
retrogradely labeled cells, and punctate processes having the appearance of axon terminals 
suggested a degree of anterograde transport from the injection site as well (Figure 17A inset). 
Anterogradely transported CTxβ was also present in the contralateral AVN.  These observations 
may be explained by inclusion of the anteromedial most portion of the reticular thalamic nucleus 
in the injection site (Gonzalo-Ruiz & Lieberman 1995; Kolmac & Mitrofanis 1998).  It is 
possible that the CTxβ itself spread to the ipsilateral AM, given that diffuse reaction product was  
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Figure 17  Representative examples of tracer injections in the AVN and VTA.   
 
Immunoperoxidase staining for CTxβ in the AVN from case 34 shows that the tracer diffused from the center of the 
injection to fill the AVN.  Additional tracer spread was evident in the adjacent AD and AM.  Peroxidase product 
was also observed in midline and intralaminar nuclei (insert; the black box in A indicates the region shown at higher 
magnification). The punctate appearance of this labeling (small arrows) suggests that it represents anterograde 
transport. Retrograde labeling of cell soma (arrowheads) was also visible in these areas.  The Rbead deposit 
involved primarily the lateral VTA near the edge of the medial lemniscus (ml) and just above the mammillary 
peduncle (mp). Abbreviations: AD, anterodorsal nucleus; AM, anteromedial nucleus; IF, interfascicular nucleus; 
RLi, rostral linear nucleus; sm, stria medullaris; SNr, substantia nigra pars reticulata; st, stria terminalis. Scale bar 
represents 500 µm in panels A and B, 50 µm in insert.  
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also apparent in the neuropil, similar to what is visible within the AVN at the core of the 
injection site.  
The relative size and placement of CTxβ and Rbead injection sites for all cases are 
illustrated in Figures 18 and 19.  For ease of display, we grouped these cases by the extent of 
CTxβ spread to thalamic structures medial to the anterior nuclei. As shown in Figure 18, Cases 
25, 27, and 34 had injections of CTxβ that were predominantly restricted to the AVN, AD, and 
AM. The remaining cases had large AVN injections (Figure 19) that typically filled both the 
AVN and AM, with additional spread of CTxβ laterally in some cases to the ventral nuclei and 
medially in other cases to midline/intralaminar nuclei: paracentral (PC), centrolateral (CL), or 
lateral division of the mediodorsal (MD).  One additional case (Case 35; Figure. 18) was 
included as a control, as the CTxβ injection was centered on the PT nucleus and spread to the 
anterior most portions of the MD and PC thalamic nuclei.  In addition to serving as a control, the 
PT injection allowed comparison as a limbic thalamic division whose projections overlap those 
of the VTA DA system (e.g. projections to the nucleus accumbens) (Beckstead et al 1979; Kelley 
& Stinus 1984; Giménez-Amaya et al 1995; Erro et al 1999; Vertes & Hoover 2008).  
4.3.2 Retrograde Transport 
Within the PPT and LDT, we observed many neurons that were singly labeled for one 
retrograde tracer or dually labeled for one tracer and for VAChT.  Figure 20 shows singly and 
dually labeled cells intermingled in the same photographic field.  Less often, we observed 
neurons retrogradely labeled from both regions, such as the example shown in Figure 21, that 
were not immunoreactive for VAChT (non- VAChT-ir). Likewise, triply labeled neurons, i.e.  
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Figure 18  CTxβ and Retrobead tracer deposits in selected cases with small thalamic injections.  
 
Illustration of the extent of CTxβ injections in the AVN (left panels) and Rbead injections in the VTA (right panels) 
for three cases in which the thalamic injections were well restricted within the anterior thalamic group (AD, AV, 
AM and LD), with minimal spread to the midline and intralaminar nuclei (PC, PT, MD, CL, CM).  The solid areas 
show the core of the injections, where CTxβ immunoreactivity was most   .  Hatched regions demarcate the extent of 
diffusion of CTxβ observed in adjacent regions.  An additional control (Case 35) is shown in which the thalamic 
injection centered on the paratenial nucleus (PT) and did not spread laterally into the AV.    
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Figure 19  Tracer deposits in the AVN and VTA from tract-tracing cases with large thalamic injections. 
 
Illustrations of CTxβ injections in the AVN (left panels) and Rbead injections in the VTA (right panels) for cases 22 
and 33 (A) and cases 36 and 37 (B).  As in Figure 4- 2, the hatched regions show diffusion spread of tracer from the 
center of the injection represented by the solid regions.  Tracer spread was more extensive in these cases, resulting in 
significant involvement of the intralaminar nuclei medial to the AVN. 
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Figure 20  PPT neurons retrogradely labeled from the AVN and VTA singly labeled for tracer or dually 
labeled for tracer and VAChT. 
 
Examination of single channel immunofluorescence identified neurons containing: (A) CTxβ retrogradely 
transported from the AVN; (B) Retrobeads transported from the VTA; and/or (C) immunoreactivity for the 
vesicular acetylcholine transporter (VAChT). (D) The three channels were merged to show colocalization of 
tracers and VAChT.  In this field from the lateral PPT, both VAChT-ir (thick arrows) and non-VAChT-ir 
neurons (arrowhead in A) are labeled from the thalamus.  A dual Retrobead- and VAChT labeled neuron lies 
nearby (thin arrows in B-D).  In addition, several neurons singly labeled for VAChT are visible (arrowheads in 
C).  Scale bar represents 50 µm in all panels. 
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Figure 21 A dual tracer-labeled cell in the LDT does not contain VAChT immunoreactivity.  
 
Triple immunofluorescence image of the LDT revealing a non-cholinergic dual-tracer labeled neuron.  CTxβ 
immunoreactivity (A) and Rbeads (B) are both present in a single neuron.  VAChT immunoreactivity is present in 
nearby cells (C), but absent from the dual-tracer labeled neuron. D Merger of the single fluorescence channels 
demonstrates colocalization of CTxβ-ir and Rbeads.  Scale bar in D represents 20 µm in all panels. 
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containing both tracers and immunoreactivity for VAChT (Figure 22) were infrequently 
detected.  The total neuronal counts obtained for each immunolabeling category are shown in 
Table 3.  In general, smaller thalamic injections produced fewer CTxβ immunopositive cells, 
whereas the number of Rbead labeled neurons was more consistent across cases, most likely due 
to the similar small size of Rbead injections.   
The spatial distribution of retrogradely labeled neurons following injections in the AVN 
and VTA, shown in Table 4, was in agreement with previous studies (Shibata 1992; Gonzalo-
Ruiz et al 1995; Oakman et al 1995; Geisler & Zahm 2005).  The percentage of each afferent 
population (CTxβ-labeled or Rbead-labeled) that was observed in each subdivision of the 
mesopontine tegmentum across hemispheres (i.e. ipsilateral PPT, etc.) is shown for each case.  
AVN injections resulted in preferential labeling of ipsilateral neurons, and in most cases the 
majority of CTxβ-labeled cells were found in the LDT.  Neurons labeled from VTA Rbead 
injections were also more likely to be found on the ipsilateral side and were slightly more 
commonly observed in the LDT.  In contrast, cells labeled with CTxβ following injections in the 
PT nucleus were more evenly distributed across hemispheres and subregions.  VAChT-ir 
neurons were also evenly distributed to the ipsilateral and contralateral sides (53% versus 47%, 
respectively, data not shown). These observations suggest that the laterality observed for 
retrograde transport from the AVN and VTA was not due to uneven or biased sampling of 
hemispheres.   
The percentage of retrogradely labeled neurons that were VAChT-ir, shown in Table 5, 
was also consistent with previous tract-tracing studies (Gonzalo-Ruiz et al 1995; Holmstrand & 
Sesack 2004).  Nearly all injections involving the AVN labeled more VAChT-ir than  
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Figure 22  Three channel immunofluorescence for CTxβ, Retrobeads, and VAChT   
 
A triply labeled neuron in the caudal lateral PPT contains labeling for CTxβ (A), Rbeads (B), and VAChT 
immunoreactivity (C).  The merged fluorescence channels shown in D demonstrate the distinct textures of the three 
markers used, eliminating the chance of false positive labeling due to cross channel bleed-through.  Scale bar equals 
20 µm in all panels. 
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Table 3 Retrograde tracer labeling and VAChT immunoreactivity in rat PPT/LDT 
neurons  
 
 
 
 
 
  
A.  Total Number of Neurons Labeled for:
Case CTxβ Rbeads VAChT
CTxβ+ 
Rbeads+ 
VAChT-
CTxβ+ 
Rbeads- 
VAChT+
CTxβ- 
Rbeads+ 
VAChT+
CTxβ+ 
Rbeads+ 
VAChT+
22 210 (111)* 161 (77) 1178 (1000) 0 94 79 5
25 46 (6) 156 (62) 1108 (977) 0 37 91 3
27 9 (1) 56 (40) 794 (770) 0 8 16 0
33 261 (61) 163 (86) 1398 (1133) 5 193 70 2
34 260 (107) 201 (155) 1239 (1055) 5 143 36 5
36 179 (75) 111 (63) 836 (688) 1 101 45 2
37 216 (86) 179 (87) 1154 (945) 4 121 83 5
CTxβ in PT
35 179 (49) 267 (166) 874 (751) 18 40 72 11
B.  Subsets of Neurons Labeled for:
CTxβ in AVN
* Numbers in parentheses denote the total number of neurons that were labeled for only a single marker
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Table 4 Distribution of retrogradely labeled neurons by tegmental subregion and 
hemisphere 
 
 
 
 
 
 
 
  
Case ipsi contra ipsi contra ipsi contra ipsi contra
22 38% 15% 38% 10% 24% 13% 39% 25%
25 13% 4% 63% 20% 19% 19% 45% 17%
27 11% 0% 78% 11% 34% 2% 55% 9%
33 42% 12% 30% 16% 41% 12% 29% 18%
34 20% 7% 48% 24% 20% 5% 58% 17%
36 28% 8% 45% 19% 27% 16% 33% 23%
37 31% 18% 31% 20% 40% 30% 20% 10%
Average all AVN cases
26% 9% 48% 17% 29% 14% 40% 17%
CTxβ in PT
35 31% 27% 27% 14% 45% 26% 24% 6%
CTxβ in AVN
Cells with CTxβ Cells with Rbeads
PPT LDT PPT LDT
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Table 5  Proportion of retrogradely labeled neurons that colocalize VAChT 
immunoreactivity 
 
  
CTxβ + VAChT Rbeads + VAChT
Case CTxβ Rbeads
CTxβ in AVN
22 47.1% 52.2%
25 87.0% 60.3%
27 88.9% 28.6%
33 74.7% 44.2%
34 56.5% 20.4%
36 57.5% 42.3%
37 58.3% 49.2%
Average all AVN cases
67.2% 42.4%
CTxβ in PT
35 28.5% 31.1%
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non-VAChT-ir cells in the PPT/LDT. Qualitatively, the smaller, more discrete AVN injections 
(e.g. Cases 25 and 27) resulted in retrograde transport by predominantly VAChT-ir afferents.  In 
contrast, injection of CTxβ into the PT resulted in substantially more labeling of non-VAChT-ir 
neurons, with VAChT-ir detected in only 28% of cells retrogradely labeled from the PT. 
The contribution of VAChT-ir neurons to the mesopontine projection to the VTA was 
variable and ranged from ~20-60% with an average of about 40% (Table 5). This indication that 
non-cholinergic neurons contribute substantially to the midbrain innervation is consistent with a 
prior preliminary estimate from our laboratory (Holmstrand and Sesack, 2004).  
Finally, we examined the extent of collateralization (i.e. colocalization of both retrograde 
tracers) to the AVN and VTA from the brainstem tegmentum. As shown in Table 6, few 
PPT/LDT neurons (<5%) with projections to either region exhibited evidence of branching to the 
other target area. This was true for both VAChT-ir and non-VAChT-ir populations of 
mesopontine tegmental cells.  Conversely, tegmental neurons retrogradely labeled from the PT 
were more likely to also contain retrograde tracer from the VTA and vice versa (~11-16%). 
Again, this greater degree of dual labeling was similar for both VAChT-ir and non-VAChT-ir 
populations, although the percentage of afferents that showed evidence of collateralized 
projections was somewhat higher for VAChT-ir neurons.  
Finally, the rates of collateralization of both VAChT-ir and non-VAChT-ir neurons 
observed within different subregions of the tegmental brainstem nuclei are shown in Figure 23.  
Although collateralization to the VTA and the AVN or PT was observed in PPT neurons, a 
greater percentage of LDT afferents to the midbrain and thalamus were labeled by both 
injections. 
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Table 6 Proportion of collateralized neurons in the rat PPT/LDT with and without 
VAChT-ir 
 
  
All Retrogradely Labeled Neurons
CTxβ + Rbeads Rbeads + CTxβ CTxβ + Rbeads Rbeads + CTxβ CTxβ + Rbeads Rbeads + CTxβ
Case CTxβ Rbeads CTxβ Rbeads CTxβ Rbeads
CTxβ in AVN
22 2.4% 3.1% 0.0% 0.0% 5.1% 6.0%
25 6.5% 1.9% 0.0% 0.0% 7.5% 3.2%
27 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
33 2.7% 4.3% 7.6% 5.5% 1.0% 2.8%
34 4.0% 5.3% 4.5% 3.1% 3.4% 12.2%
36 1.7% 2.7% 1.3% 1.6% 1.9% 4.3%
37 4.2% 5.0% 4.4% 4.4% 4.0% 5.7%
3.1% 3.2% 2.5% 2.1% 3.3% 4.9%
CTxβ in PT
35 16.2% 10.9% 14.1% 9.8% 21.6% 13.3%
Non VAChT-ir VAChT-ir
Average all AVN cases
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Figure 23  Collateralized afferents to the midbrain VTA and AVN or PT in subregions of the PPT/LDT. 
 
The percentage of all thalamic (CTxβ, A & B) and VTA (Rbeads, C & D) afferents that were also labeled from the 
other brain region is shown divided by tegmental subregion and hemisphere (relative to the injected side).  Although 
neurons in the PPT projected to both the thalamus and the VTA, the proportion of LDT afferents that showed such 
collateralization was markedly higher, especially for the paired PT/VTA case. 
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4.4  DISCUSSION 
Our results indicate that the cholinergic innervation of the AVN and the VTA arises from 
largely separate populations of PPT/LDT cholinergic neurons.  This novel report of the relative 
infrequency of collateralization in these afferent populations indicates that the brainstem 
cholinergic system maintains relatively segregated projections to functionally distinct limbic 
forebrain structures.   Furthermore, the greater frequency of collateralization observed following 
the CTxβ injection that involved the PT nucleus is consistent with a previous report of 
collateralized PPT/LDT projections to the VTA and midline and intralaminar thalamic nuclei 
(Bolton et al 1993).  Furthermore, this pattern of labeling demonstrates that the low percentage 
of dual retrograde labeling from the AVN and VTA does not result from a general segregation of 
thalamic and midbrain projections from the brainstem.  From a functional standpoint, 
collateralized cholinergic input to the VTA and the AVN versus the midline/intralaminar 
thalamic nuclei suggests that cholinergic modulation is coordinated across different components 
of an interconnected limbic circuit, while remaining distinct from that impinging on functionally 
separate circuits.  
4.4.1 Methodological Limitations 
Neuronal tract-tracing studies are limited by the specificity of the tracer used, and the 
placement and size of the injection.  The first limitation, specificity, refers to intrinsic properties 
of the tracer that determine whether it can be taken up by non-terminating axons that traverse a 
region, thereby leading to the labeling of neurons that are not true afferents of the injected brain 
region.   This uptake by fibers of passage is a well-known drawback to the use of CTxβ (Chen & 
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Aston-Jones 1995), but was not of paramount concern in this study.  The cholinergic afferents to 
the AVN are assumed to terminate in this region, as there is extensive arborization of cholinergic 
axons present here and these nuclei form the most anterior pole of the thalamus.  Since there are 
no nuclei anterior to the AVN to which axons traversing this region could be directed, we do not 
believe that our CTxβ-labeled population is unduly affected by the fiber-of-passage problem.  
CTxβ can also be transported both retrogradely and anterogradely, especially when deposits are 
made by pressure injection (Luppi et al 1990).  Fortunately, anterograde and retrograde labeling 
are easily distinguished based on the size and appearance of labeled structures (e.g. cell body 
versus axon terminal), eliminating the need to utilize strictly unidirectional tracers. 
In contrast to the AVN, the VTA is traversed by many axons originating in the 
tegmentum that ultimately target brain regions that lie anterior to the VTA.  For this reason, we 
chose to use Rbeads as the retrograde tracer for this region, as the beads demonstrate little to no 
uptake by fibers of passage (Katz et al 1984; Cornwall & Phillipson 1988a; Schofield 2001).  
Unfortunately, the specificity of uptake is gained at the expense of complete labeling of 
afferents, as the beads do not diffuse far from the injection site.  Based on the size of our 
injections, it is reasonable to conclude that we labeled only a portion of the afferents to the VTA, 
and therefore our estimates of the collateralization of AVN and VTA afferents should be 
interpreted with caution as a minimum estimate of the true rate of collateralization.  However, 
our VTA injections did not systematically exclude any particular division of the VTA, and 
displayed enough topographical variation to inspire confidence that the low rate of tracer co-
localization was not simply due to omission of a particular subregion of the VTA which 
collateralized afferents might target.   
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We did note that the contribution of VAChT-ir neurons to the mesopontine projection to 
the VTA appears to be higher in the present study (~ 20-60%) than in a previous investigation 
from our laboratory (~ 25%) (Holmstrand & Sesack 2004), perhaps due to our failure to label the 
entire population of afferents to the VTA.  It should be noted however, that the larger 
FluoroGold tracer injections in those experiments may have resulted in uptake by fibers-of-
passage ((Luppi et al 1990) and unpublished observations). Consequently, we felt that 
underestimating the total population of afferents to the VTA was preferable to spurious labeling 
from non-specific uptake.   
Finally, the higher proportion of collateralization observed following the paratenial 
thalamic injection demonstrates that the restricted VTA injections did not artificially limit 
detection of collateralized afferents to the lower proportions found in our other cases.  While our 
results should be interpreted with caution due to these technical limitations, we feel that our 
findings are still representative of the true organization of PPT/LDT cholinergic forebrain 
projections. 
A final limitation of our methodology concerns the use of antibodies to detect relevant 
proteins in the PPT/LDT neuronal population.  All immunohistochemical studies are limited by 
the specificity of the antibodies used, by the potential for cross-reaction of secondary antibodies, 
and by the ability of reagents to penetrate the relevant structures in order to bind to their target 
epitopes.  The use of Rbeads, which do not require immunohistochemical detection, helped to 
limit possible cross-reactivity and false-colocalization, and facilitated the selection of appropriate 
antibody complexes to detect the presence of VAChT and/or CTxβ.  The goat anti-CTxβ 
antibody has been characterized previously (Angelucci et al 1996; Pakan et al 2008; Xu et al 
2009).  Evidence for the specificity of this antibody includes the labeling of a single band of 
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cholera toxin subunit B by Western blot (Xu et al 2009), labeling in expected brain regions 
following injection of tracer, and the absence of immunoreactivity in uninjected controls.  The 
rabbit anti-VAChT antibody has been previously shown to specifically label cells transfected 
with VAChT, but not the vesicular monoamine transporter (Liu & Edwards 1997), and the 
pattern of immunoreactivity obtained in our experiments was consistent with the known 
distribution of cholinergic neurons and axon terminals in the rat CNS. 
 
4.4.2 Comparison of Target Connectivity: Diversity in Limbic Structures 
Although both the AVN and the VTA are considered to be components of the limbic 
system, the anatomical connections of these individual nuclei are largely exclusive of each other.  
The mesocortical dopamine projections arising from the VTA terminate preferentially in the 
prefrontal and anterior cingulate cortices (Beckstead et al 1979; Berger et al 1991), with 
innervation of more posterior limbic cortical areas such as the retrosplenial cortex reported as 
either sparse (Berger et al 1985) or nonexistent (Theirry et al 1973; Thierry et al 1973; Hökfelt et 
al 1974; Lindvall et al 1974).  In contrast, the AVN is reciprocally interconnected with the 
retrosplenial granular cortex (Domesick 1969; Shibata 1993; Shibata & Naito 2005), and with 
structures comprising the hippocampal region, but does not send significant projections to the 
anterior cingulate, prelimbic or infralimbic cortices, or to orbital areas (Vogt et al 1992).  Sparse 
projections to the anterior thalamic nuclei from the limbic prefrontal cortex have been reported, 
but these mainly target the AM (Xiao et al 2009), which also innervates the anterior cingulate 
(Shibata & Naito 2005).  Similarly, one of the major subcortical targets of VTA dopamine 
projections is the nucleus accumbens, but this region is not innervated by the AVN.  AVN 
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neurons receive input from the hippocampus and mammillary body, both of which receive only 
minor, if any, dopamine projections from the VTA in the rat (Oades & Halliday 1987).  In 
contrast, the midline/intralaminar nuclei of the thalamus are connected with cortical and 
subcortical structures that receive VTA dopamine inputs (Beckstead 1976; Berendse & 
Groenewegen 1990; 1991; Erro et al 2002; Smith et al 2009), some of which send reciprocal 
excitatory or inhibitory projections to the VTA. Additionally, the mediodorsal thalamic nucleus 
(MD) receives direct dopamine innervation in both rats and primates (Beckstead et al 1979; 
Simon et al 1979; Sanchez-Gonzalez et al 2005), and other midline/intralaminar thalamic nuclei 
appear to be targets of dopamine input in primates as well (Sanchez-Gonzalez et al 2005). 
Conversely, the AVN does not appear to be directly influenced by dopaminergic modulation.  
The paratenial nucleus used as a control thalamic region in our study sends a dense projection to 
the nucleus accumbens (Erro et al 1999), and is reciprocally connected with prefrontal cortical 
regions (Krettek & Price 1977; Vertes & Hoover 2008), indicating that it participates in limbic 
circuitry that is subject to substantial dopaminergic modulation by VTA neurons. 
The segregation of anatomical connections of the VTA and the AVN indicate that there 
are likely to be separate circuits operating within the broader limbic system (Vertes 2006). At 
least two of these might include: 1) a prefrontal-accumbens-ventral pallidal-intralaminar 
thalamic circuit that is heavily influenced by dopaminergic projections from the midbrain VTA 
and SNc; and 2) a circuit involving the AVN, the retrosplenial cortex, hippocampal structures, 
the mammillary body and other hypothalamic nuclei, that is not a significant target of 
mesocorticolimbic DA projections.  Interestingly, our results indicate that these separate circuits 
receive specifically targeted cholinergic and non-cholinergic innervation from largely separate 
neurons in the PPT/LDT.  The finding that > 20% of the cholinergic afferents to the PT showed 
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evidence of sending a collateral projection to the VTA, combined with prior studies 
demonstrating collateralization of brainstem inputs to the VTA and mediodorsal, parafascicular, 
and midline thalamic nuclei (Bolton et al 1993), implies that components of the same circuit 
receive coordinated cholinergic modulation and non-cholinergic input from the brainstem. 
The restriction of projections to and from the AVN to distinct cortical and subcortical 
regions with poor dopamine innervation may be a species-specific phenomenon.  In both cats 
and primates, AVN neurons have an expanded projection field that includes the anterior 
cingulate cortex (Niimi et al 1978; Barbas et al 1991), and possibly the ventral striatum as well 
(Giménez-Amaya et al 1995).  Furthermore, dopamine innervation of thalamic nuclei is 
markedly expanded in primates beyond the restricted projections to the mediodorsal nucleus 
observed in rodents (Melchitzky et al 2006; Garcia-Cabezas et al 2009).  Given the specific 
organization of collateralized PPT/LDT projections to functionally related thalamic and 
subcortical nuclei, these relationships must be examined in higher mammals as well as in rodent, 
to determine whether the expansion of overlapping limbic projections is accompanied by 
increased collateralization of brainstem cholinergic and non-cholinergic afferents.  
4.4.3 Sub-Populations of Brainstem Cholinergic Neurons:  Functional Implications 
Our previous investigation of the cholinergic axons innervating the AVN and the VTA 
indicated that afferents to the AVN display greater total immunoreactivity for CHT compared to 
VTA axon terminals, and that the density of transporters associated with the plasma membrane is 
greater in the AVN as well (Holmstrand et al 2010).  We recognized that these differences in 
CHT membrane density might reflect different properties of distinct subsets of cholinergic cells.  
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Alternatively, if the two regions were innervated through collateralization of a common afferent 
population, the unique environment of an innervated region might result in the different axonal 
properties we observed. The results reported here support the former perspective by indicating 
that the AVN and VTA receive input from largely segregated cholinergic cell groups. Given that 
CHT is delivered to the plasma membrane through the fusion of synaptic vesicles during 
neuronal activity (Ferguson et al 2003), our findings of predominantly discrete PPT/LDT 
innervation of the AVN and VTA suggest that differences in firing rates between the separate 
populations of neurons could underlie the differences in levels of membrane-associated CHT 
immunoreactivity (Holmstrand et al 2010).  Variations in the basal activity of PPT and LDT 
neurons have been reported (Steriade et al 1990a; Pascoe & Kapp 1993; Datta & Siwek 2002); 
however, direct electrophysiological evidence of differences between the AVN and VTA afferent 
populations has yet to be reported.   
In addition to possible differences in baseline firing rate of these cholinergic sub-
populations, the patterns of activity across sleep-wake states of both cholinergic and non-
cholinergic afferents to the AVN and VTA might differ, given that some PPT/LDT neurons 
show variation in the association of their activity with wakefulness, slow-wave sleep, and REM 
sleep (Steriade et al 1990a; Datta & Siwek 2002).  While the characterization of these activity 
patterns is more complete for the PPT than for the LDT, both regions appear to contain at least 
three population of cells:  1) neurons that display increased activity during wake and/or REM 
sleep; 2) neurons that display a progressive increase in activity from wakefulness to slow-wave-
sleep to REM, with significantly greater activity during REM sleep than during the other stages; 
and 3) neurons whose firing rates do not correlate with sleep-wake states. 
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The possibility that afferents to the AVN versus the VTA might arise from different 
physiologically-identified populations of PPT/LDT neurons is intriguing in light of the lack of 
sleep-wake associated variation in VTA dopamine cell firing (Trulson & Preussler 1984; Lee et 
al 2001).  Perhaps the state-independent neurons comprise most of the VTA afferent population.  
However, it should be noted that despite the absence of changes in firing rate, sleep-wake state 
correlated changes in dopamine release in forebrain areas suggest that the pattern of VTA DA 
cell firing can vary across behavioral states (Monti & Monti 2007).  These questions will require 
the careful identification of the projection targets of individual neurons during 
electrophysiological investigation of PPT/LDT function.  Finally, the specific inputs to these 
sub-populations might reveal further important clues to the organization and function of 
brainstem modulatory influence over specific limbic circuitry.   
Cholinergic neurons in the brainstem have been noted to co-localize immunoreactivity 
for substance P (Vincent et al 1983; Sutin & Jacobowitz 1990) and other peptide co-transmitters 
(Crawley et al 1985).  Cholinergic axon terminals in the AVN and VTA also contain dense-cored 
vesicles, a marker of neuropeptide co-transmission, although the more frequent observation of 
these structures in the VTA suggests that peptide co-transmission may play a larger role in 
shaping VTA activity (Holmstrand et al 2010).  Further work is needed to determine whether 
cholinergic neurons that utilize peptide co-transmitters preferentially project to the VTA and the 
midline/intralaminar thalamic groups.  Additional experiments will also be required to elucidate 
the identity of the relevant peptides and to determine whether the separate projections from the 
PPT/LDT might be identified on this basis.  More generally, any biological marker that could 
delineate these projections would be useful for future investigations of PPT/LDT function. 
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A clearer understanding of the organization and function of the PPT and LDT may also 
aid our understanding of human health and disease.  Many studies have noted PPT/LDT 
pathology in tissue from patients with neurodegenerative diseases and over the course of normal 
aging (Zhang et al 2005).  There is cell loss in the PPT in the brains of both Parkinson’s disease 
patients and patients with progressive supranuclear palsy (Halliday et al 1990; Jellinger 1991; 
Emre 2003), although whether this loss is causative rather than symptomatic is still debated 
(Xuereb et al 1990).  In addition, changes in cell number and cell size have been reported in 
schizophrenic brains (Karson et al 1991), and the sleep disruptions that are characteristic of a 
wide range of mental disorders indicate that the role of PPT/LDT in maintaining normal limbic 
functions may be underappreciated.  Further study of the specific connections and phenotypes of 
these brainstem nuclei may reveal important pathophysiological details and present new targets 
for therapeutic intervention.  
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5.0  GENERAL DISCUSSION 
These studies represent the first quantitative evaluations of the expression and 
localization of CHT in the ascending cholinergic projections of the brainstem PPT and LDT.  We 
found subtle but statistically significant differences in the population characteristics of CHT 
immunoreactive axon terminals in two different limbic targets of the PPT/LDT cholinergic 
system.  Furthermore, boutons in these regions showed morphological differences indicating that 
the ascending cholinergic innervation of the AVN and the VTA arise from separate sub-groups 
of PPT/LDT cholinergic neurons, a hypothesis that we confirmed by dual retrograde tract-tracing 
from these regions.  The combined findings suggest that the differences we found with respect to 
CHT immunoreactivity and localization across these two brain regions result from this specific 
and segregated pattern of innervation. These findings support our original hypothesis that levels 
of CHT expression, and therefore high-affinity choline uptake, can vary among innervation 
targets of the ascending projections from the cholinergic brainstem.  While the initial aim of 
these studies was to detect such differences, taken in total, our results strongly indicate that the 
mechanisms regulating high-affinity choline uptake are remarkably robust across different 
groups of cholinergic terminals arising from the PPT/LDT. 
The major findings are discussed below in relation to general principles regarding 
regulation of CHT expression and subcellular trafficking, and about the brainstem tegmental 
cholinergic system specifically.  Briefly, we will discuss the greater total expression of CHT and 
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how this is predicted to impact the functional levels of high-affinity choline uptake.  The likely 
mechanisms underlying the difference in total CHT content of these axons will be explored.  
Finally, the implications of the segregation of ACh projections to these regions are treated.  
Throughout these treatments, the methodological limitations of these studies, and how these 
limitations constrain the conclusions that can be drawn from of our results are carefully 
considered.   
 
5.1 CHOLINERGIC TERMINALS IN THE AVN HAVE MORE CHT THAN 
SIMILAR BOUTONS IN THE VTA 
Our most significant finding was that total levels of CHT immunoreactivity were higher 
in the AVN terminals than in the VTA.  This was independently determined in two experiments, 
using electron microscopy to examine immunogold-silver staining for CHT at the ultrastructural 
level (Chapter 2), and confirmed in the immunofluorescence study of VAChT and CHT (Chapter 
3).    The size of this difference in total immunolabeling for CHT was also large enough to have 
clear biological relevance. 
The differential fluorescence imaging settings applied to AVN versus VTA tissue 
sections might cast doubt on the validity of this regional difference, but quantification of 
immunogold-silver labeling for CHT demonstrated that the mean density of CHT 
immunoreactivity within AVN axon terminals was nearly twice as high as that seen for the VTA 
population.  By immunofluorescence, the relative difference in labeling intensity was smaller, 
with the mean CHT FI of AVN CHT-ir profiles approximately 45% higher than the mean CHT 
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FI of VTA profiles.  This discrepancy is most likely due to differences in the methods of 
sampling used between the two studies.  Furthermore, intrinsic differences in the labeling 
methods complicate direct comparison of the effect size between the studies.  Suffice it to say, 
that the relationship between AVN CHT levels and VTA CHT levels was shown to be 
qualitatively similar across two independent immunohistochemical methods.  The 
complementary findings of these two studies refute concerns that methodological limitations 
contributed significantly to the observed regional differences in CHT immunoreactivity.   
Furthermore, we observed colocalization of CHT and VAChT immunofluorescence 
within axon terminals imaged from the AVN more frequently than in VTA immunofluorescent 
puncta.  The simple threshold criteria used to identify CHT-ir and VAChT-ir puncta precludes 
the interpretation that singly labeled terminals contain no molecules of the sub-threshold protein, 
but the presence of these singly immuolabeled profiles does indicate that levels of protein 
expression can vary at different sites of ACh release. 
 
5.1.1 Immunoreactivity as a Measure of Protein Concentration: Methodological 
Considerations 
Although a subset of labeled terminals in the AVN and VTA were examined in serial 
ultra-thin sections for morphological characterization, gold particle density was quantified from a 
single section through each profile (Table 1).  In contrast, fluorescence intensity data was 
obtained throughout the entirety of the immuolabeled volume, and quantitative comparisons 
were carried out on the mean intensity of all component voxels.  This produced a more complete 
assessment of total CHT immunoreactivity than the immunogold-silver analysis, as CHT is 
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present throughout the three dimensional volume of axon varicosities.  Furthermore, the size 
differences between AVN and VTA cholinergic axon varicosities indicate that a single ultrathin 
section through the VTA varicosities would represent a lower proportion of the total volume of 
these profiles compared to the AVN; therefore, the number of gold particles detected would be a 
smaller percentage of the total number of particles distributed throughout the terminal.  In the 
AVN, the smaller size of CHT-ir profiles would result in a single section capturing a greater 
proportion of all gold particles contained within the labeled axon, as profiles would be divided 
into fewer ultrathin sections.  In contrast, imaging throughout the entire volume of CHT-ir 
puncta by immunofluorescence removes this sampling limitation. 
Although we did not apply systematic random sampling in these studies, it was 
nevertheless assumed that the single section examined for immunogold silver density was 
randomly selected, even for the profiles for which serial section data were available, as we chose 
to quantify immunogold labeling in the micrograph that was produced from the first visual 
identification of each labeled profile.  When serial micrographs were collected, we generally 
photographed at least 2 ultrathin sections that were more superficial than the first section, and 2 
sections that were deeper from the tissue surface than the first section as well.  Sometimes, the 
labeled profile disappeared from the photographic field in one of these directions, and expanded 
in the opposite direction, indicating that the 1st section in which the profile was encountered was 
not taken through the center of that profile (personal qualitative observations).  Thus, we did not 
necessarily obtain our measurements of total gold density from those sections with the heaviest 
labeling, but sampled pseudo-randomly from all possible sections through a given labeled 
profile.  When combined with the smaller proportion of total terminal volume that a single 
section would represent in VTA profiles versus AVN profiles (due to the regional size 
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differences in CHT-ir structures), this sampling strategy may have resulted in unequal 
underestimation of the total amount of CHT immunoreactivity within VTA versus AVN 
terminals, and may have contributed to the larger difference in CHT immunoreactivity observed 
by immunogold-silver staining.   
The independent confirmation of greater immunoreactivity for CHT in AVN terminals by 
fluorescence microscopy provided assurance that the immunogold-silver results were not purely 
an artifact of this sampling strategy.  However, it is important to note that both of these methods 
effectively measure the concentration of CHT within labeled profiles, since fluorescence 
intensity will be dependent on the concentration of fluorophores within a discrete volume.  The 
larger size of VTA axon varicosities would be expected to produce less intense labeling even if 
the same total number of transporters were present in these profiles, assuming an even 
distribution of CHT throughout the axonal compartment.  Still, larger terminals are also expected 
to contain more synaptic vesicles (Lisman & Harris 1993; Pierce & Lewin 1994), and so the 
relatively lower concentration of CHT immunoreactivity in these larger terminals probably still 
represents a functional difference in the availability of transporters that can be recruited to the 
plasma membrane.  Unfortunately, we did not count synaptic vesicles in our sample of CHT-ir 
axon varicosities, so cannot independently confirm that this is true.  Although we are comparing 
concentrations of CHT and not absolute numbers of transporters, these measurements are of 
sufficient value as to inform some functional predictions based on our results. 
The different immunohistochemical procedures used for these studies may also have 
contributed to the mismatched effect size observed between methods.  Immunogold silver 
labeling has lower sensitivity than other immunohistochemical methods, such as 
immunofluorescence (Sesack et al 2006).  This characteristic stems from the relatively poor 
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penetration of antibodies into tissue treated for electron microscopy.  Good ultrastructural images 
require the morphological preservation of lipid membranes in order to accurately identify the 
spatial limits of discrete neuronal elements.  Detergent additives that increase the permeability of 
cell membranes to antibodies, thereby increasing access to intracellular protein epitopes and 
improving the sensitivity of immunohistochemical detection, physically degrade the plasma 
membrane.  The use of detergents must therefore be restricted in ultrastructural studies if 
discrimination of distinct structures is to be obtained.  However, the low levels of detergent used 
for ultrastructural preservation impede antibody penetration.  The penetration of gold-conjugated 
secondary antibodies is particularly sensitive to this experimental detail, and pre-embedding 
immunogold-silver labeling is typically only found within the first few microns of the tissue 
surface.  While we drew our sample micrographs only from regions with apparently adequate 
levels of staining (i.e. within regions of tissue where multiple labeled profiles were visible, 
typically 1-2 µm from the interface of the tissue and the embedding medium), this determination 
was subjective, and we cannot unequivocally assert that all of the terminals in our study were 
exposed to equivalent concentrations of primary or secondary antibodies.  Rather, there was 
likely to be a gradient of antibody penetration, such that terminals from deeper parts of the 
section would show less labeling than more superficial profiles, even if these contained 
equivalent amounts of antigen.  However, this methodological limitation would presumably 
affect labeling in the AVN and VTA tissue equally, so we were still able to compare the relative 
amounts of CHT immunoreactivity across labeled profiles in the AVN and VTA populations. 
In contrast, fluorescence imaging can theoretically detect the photons emitted from a 
single fluorophore (Wouterlood 2006; Hohlbein et al 2010) and, presumably, such methods 
detect more of the antibody complexes that are bound to CHT than the less sensitive 
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immunogold-silver method.  The uncertain stoichiometry of antibody binding to transporter 
prevents the interpretation that some fixed unit of fluorescence intensity above background 
represents a single transporter, but higher fluorescence intensities can reasonably be assumed to 
arise from a greater concentration of antigen within the axonal compartment.  Furthermore, the 
generous use of detergents that is possible with light microscopic staining method improves 
antibody penetration, as evidenced by the relatively stable detection of objects throughout the 
center of the dual-fluorescence image stacks examined in Chapter 3 (see Figure 14).  This 
undoubtedly improved the detection of antigens compared to the EM study, yet did not change 
the general finding that CHT immunoreactivity is higher per terminal in the AVN compared to 
the VTA. 
 
5.1.2 Implications of Increased CHT expression in AVN versus VTA Cholinergic Boutons 
The robust difference in total immunoreactivity for CHT that we observed between these 
populations of cholinergic boutons suggests that the transcription and translation of CHT mRNA 
is elevated in neurons innervating the AVN.  This indicates that cholinergic inputs to the AVN 
and VTA are likely to arise from different PPT/LDT neurons, and that the intracellular 
mechanisms which regulate the transcription and/or sub-cellular trafficking of CHT are 
differentially activated between these afferent populations. The pattern of retrograde labeling 
observed following injection of tract-tracing agents into these two brain regions confirms that the 
axonal populations used to compare CHT immunoreactivity originate from distinct cells within 
the cholinergic brainstem tegmental complex.  Furthermore, the morphological differences in the 
relative size, synaptic incidence, and frequency of dense-cored vesicle presence reported in 
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Chapter 2 all support the conclusion that the AVN and VTA are modulated by different 
cholinergic brainstem neurons.  Similar to other studies on the functional anatomical connections 
of the PPT and LDT (Woolf & Butcher 1986; Hallanger et al 1987; Gould et al 1989), we found 
that the segregation of these afferents is not complete, as a mix of cholinergic afferents from the 
PPT and LDT were labeled from either site, and a few cholinergic neurons could be retrogradely 
labeled from both innervation targets.  However, the majority of ACh input to these regions 
appears to be specifically targeted to the recipient brain structures, as evidenced by the low rate 
of collateralization reported in Chapter 4.  
 Importantly, the observed measurements of CHT immunoreactivity indicated that the 
two bouton populations have overlapping distributions of CHT levels, but that a greater 
proportion of profiles in the AVN display intense immunostaining for the transporter.  The 
similar scale of CHT immunoreactivity in AVN and VTA cholinergic boutons suggests that the 
characteristics of PPT/LDT neurons that determine the level of CHT expression are not widely 
variable, but rather differ only in subtle ways.  Although cholinergic neurons in the PPT/LDT 
show considerable variability in their anatomical connections and peptidergic co-expression, as a 
population their physiology is relatively uniform.  Most of these neurons show tonic firing rates 
that increase during behavioral states associated with an “activated” thalamocortical system (W 
and REM-sleep) (Steriade et al 1990a; Datta & Siwek 2002; Boucetta & Jones 2009).  A 
minority of these cells may be capable of firing bursts of action potentials from a highly 
depolarized state (Wilcox et al 1989), but the majority of PPT/LDT cholinergic neurons are 
thought to be fire only in the tonic mode.  Still, sensory stimulation can dramatically increase 
their tonic firing rate (Kang et al 1990; Leonard & Llinás 1990; Boucetta & Jones 2009), 
presumably leading to increased release of ACh in the regions innervated by these cells.  The 
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relatively homogenous population responses of PPT/LDT cholinergic cells might account for the 
considerable overlap in our population measurements.  Slight variability in spontaneous firing 
rates might be reflected by differential expression of CHT, thereby providing a functional 
correlation to the differences in relative expression of CHT observed in Chapters 2 and 3.   
 
5.2 TOTAL CHT EXPRESSION IS LIKELY TO BE DRIVEN BY THE 
FUNCTIONAL DEMANDS FOR HIGH-AFFINITY CHOLINE UPTAKE WITHIN 
AXON TERMINALS 
The hypothesis that overall levels of CHT expression (i.e. total number of transporters) 
reflects the relative demand for choline uptake, and thus may be an indicator of ACh turnover in 
cholinergic axons, is supported by considerable experimental evidence.  The relatively exclusive 
expression of CHT by neurons that also express VAChT and ChAT proteins (Apparsundaram et 
al 2000; Okuda et al 2000; Misawa et al 2001; Kus et al 2003; Geyer et al 2008) reflects the 
importance of this protein for proper cholinergic function.  Functional high-affinity choline 
uptake limits the synthesis of ACh (Yamamura & Snyder 1972; 1973; Mulder et al 1974; Simon 
et al 1976; Wecker & Dettbarn 1979) and the ability of cholinergic neurons to sustain high rates 
of ACh release (Guyenet et al 1973; Van der Kloot et al 2002; Ferguson et al 2004; Matthies et 
al 2006).   The coupling of CHT membrane trafficking to neuronal activity, and the stable 
estimates of the relative distribution of CHT to the plasma membrane versus cytoplasmic 
vesicular pool further suggests that nerve terminals with greater numbers of transporters 
probably have a greater capacity for high-affinity choline uptake (Ivy et al 2001; Ferguson et al 
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2003; Grailhe et al 2009).  Higher macroscopic choline uptake is generally associated with 
increased rates of ACh synthesis (Guyenet et al 1973; Köppen et al 1997) that can more rapidly 
refill the vesicular pool of ACh (Van der Kloot et al 2000).  Increased capacity of HACU, 
mediated by greater numbers of transporters contained within the axon terminal and therefore 
able to be recruited to the plasma membrane, would be expected in neurons that release ACh at 
higher rates, presumably due to higher neuronal firing. 
Experimental manipulations that decrease the synthesis of ACh, without reducing the 
frequency of release events, induce upregulations in CHT mRNA and protein expression, 
presumably through some feedback mechanism that is activated when ACh synthesis falls below 
normal levels (Brandon et al 2004; Mellott et al 2007).  Furthermore, the depression of vesicular 
ACh release resulting from activation of muscarinic autoreceptors decreases the total capacity of 
the high-affinity choline uptake system (Breer & Knipper 1990).  Although changes to the rate of 
endocytosis of CHT can be effected by multiple intracellular processes (Gates et al 2004; Ribeiro 
et al 2007b; Wang et al 2007; Misawa et al 2008), the activity-dependent mobilization of 
transporters to the plasma membrane exceeds the rate of endocytosis during periods of increased 
neuronal activity.  This temporary imbalance of the rates of exocytic and endocytic processes 
results in a net increase of high-affinity choline uptake (Mulder et al 1974; Simon & Kuhar 1975; 
Murrin & Kuhar 1976).  
Our immunohistochemical results fit well within this theoretical framework, and further 
indicate that the regulation of CHT trafficking in the mesopontine tegmental cholinergic system 
is tightly controlled, probably by the same cellular mechanisms that operate in other cholinergic 
systems.   
 
 148 
5.2.1 Strict Regulation of CHT Membrane Trafficking in Cholinergic Axons 
The pattern of ultrastructural localization we observed in Chapter 2 resembled that found 
in all cholinergic axons examined thus far.  Not only is the majority of CHT immunoreactivity 
found associated with small clear vesicles contained within axons, but the relative amount of 
membrane/total CHT immunoreactivity has been previously estimated at 5- 20% (Nakata et al 
2004), similar to what we observed in the AVN and VTA (see Appendix A, Figure 24).  These 
results resemble measurements of plasma membrane and vesicular-associated CHT levels 
measured by Western blot (Ferguson et al 2003).  Interestingly, this percentage also corresponds 
to the estimated size of the readily releasable pool of synaptic vesicles at the neuromuscular 
junction (Van der Kloot 2003), supporting the assumptions that the immunogold-silver method 
we used accurately represents the relative distribution of CHT and that our cytoplasmic pool of 
transporters corresponds to the “reserve” pool of synaptic vesicles.  The strict agreement of our 
observations with the characteristics of CHT localization in other cholinergic systems indicates 
that the cellular processes regulating membrane trafficking of CHT within cholinergic axons are 
robust and are probably strictly conserved within all cholinergic neurons. 
The stable proportional distribution of membrane to cytoplasmic CHT immunoreactivity 
levels described in all of these studies predicts that under equivalent levels of ACh release, axons 
with increased numbers of transporters should have increased choline uptake.  Using an 
immunodepletion protocol on isolated synaptic vesicles, Ferguson and colleagues demonstrated 
the existence of two distinct populations of VAChT containing synaptic vesicles, differentiated 
by the absence or presence of CHT (Ferguson et al 2003).  The presence of more CHT+ synaptic 
vesicles relative to CHT- vesicles within an axon terminal would increase the overall probability 
of fusion events resulting in the insertion of “new” transporters into the plasma membrane.  
 149 
Accordingly, we found evidence that the total gold density of an individual terminal was a 
significant predictor of that terminal’s membrane gold density (Chapter 2), providing further 
evidence that functional levels of choline uptake can be influenced by the total protein 
expression of CHT.  
 
5.2.2 CHT is a Possible Indicator of Relative Activity in Cholinergic Terminals 
Our results also suggest that the relative rate of ACh release, and the extent to which 
release can be increased within individual cholinergic terminals, may be reflected by the total 
expression of CHT.  If we make the reasonable assumption that terminals with higher 
concentration of VAChT protein probably have higher rates of vesicular ACh release (Song et al 
1997; Roghani & Carroll 2002), then the significant correlations of VAChT and CHT 
fluorescence intensities that we reported for both the AVN and VTA bouton populations suggest 
that CHT expression levels are similarly correlated with neuronal ACh release.  Further evidence 
of a strong association between absolute levels of VAChT and CHT expression was obtained by 
comparing the ratio of CHT to VAChT immunofluorescence in VAChT-ir boutons.  We found 
that this ratio was invariant across different populations of cholinergic terminals that nevertheless 
showed significant differences in the intensities of both CHT and VAChT immunofluorescence 
labeling (Chapter 3).  This result implies that the relative levels of these proteins are stable in 
cholinergic boutons even when CHT and VAChT expression are both upregulated.   The most 
parsimonious explanation for this is that the expression of these genes is upregulated by similar 
transcription factors.  Although the expression of CHT can be differentially driven in some 
circumstances (Sherman & Friedman 1990; Lecomte et al 2005),  previous studies have 
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confirmed that many of the experimental manipulations that increase VAChT or ChAT 
expression have similar qualitative effects on CHT expression (Oosawa et al 1999; Berse et al 
2005; Madziar et al 2008).   
An important caveat to this interpretation of our data is that little direct evidence of a 
linear relationship between VAChT expression levels and activity in cholinergic neurons is 
available.  Certainly the loss of functional VAChT expression abolishes synchronized vesicular 
release of ACh (de Castro et al 2009; Lima et al 2010), and overexpression of this protein does 
increase both spontaneous and evoked ACh release (Oosawa et al 1999).  However, recent 
evidence indicates that this is due to changes in the quantal size of each ACh-containing vesicle, 
and not necessarily due to an increase in the number of vesicles available for release (Van der 
Kloot et al 2000; Van der Kloot 2003).  Although it seems reasonable to assume that all synaptic 
vesicles within a cholinergic terminal would contain this protein, the membrane trafficking of 
both VAChT and CHT is probably superimposed on more general membrane recycling pathways 
(Ferguson & Blakely 2004; Ribeiro et al 2006).  Still, if VAChT is inserted into synaptic vesicles 
at some stable rate, it follows that increasing the concentration of VAChT protein in the axonal 
compartment would result in an increased proportion of synaptic vesicles that contain VAChT 
and can package ACh, and that this increase would be proportional to the increase in VAChT 
protein. A larger pool of synaptic vesicles is further assumed to indicate that a given axon 
terminal can mobilize more synaptic vesicles from the reserve to the readily releasable pool; 
therefore, the assumption that neurons with greater VAChT immunoreactivity are capable of 
firing at higher frequencies than neurons with lower expression of VAChT (i.e. fewer ACh-
containing synaptic vesicles) appears at this time to be sound.  Even if greater expression of 
VAChT is not associated with a larger number of vesicles, elevated levels of the vesicular 
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protein support faster refilling of the recycling pool of synaptic vesicles, allowing ACh neurons 
to continue signaling for longer periods of time without depleting vesicular ACh stores. 
Although our results support the interpretation that CHT expression may be a useful 
indicator of the physiologically relevant firing capabilities of a given neuron, direct investigation 
of this claim is necessary.  Finally, it should be noted that many of the regional differences found 
between CHT-ir profiles within the AVN and VTA, though statistically significant, were small.  
The biological relevance of such a small difference in, for example, the relationship between 
total CHT immunoreactivity and CHT membrane density in these varicosities, as evidenced by 
the significant effect of region on the interaction of total gold density and membrane gold density 
(Chapter 2), is not clear.  As we suggested in that chapter, it is possible that differences in 
signaling molecules in the local environment that could impact the rate of endocytosis of CHT 
within cholinergic terminals might lead to such subtle regional differences.  However, the small 
size of such differences indicate that the rate of delivery of CHT to the plasma membrane is 
balanced by the rate of endocytosis of this protein under the conditions of our experiments, 
which only revealed the resting state of PPT/LDT cholinergic projections.   
 
5.2.3 Limitations of Immunohistochemical Methods:  Reduced Activity in the PPT/LDT 
System 
One concern with the use of immunohistochemical methods for examining the 
localization of CHT in PPT/LDT axons arises from the effects of anesthesia on neuronal activity 
in this system.  In order to obtain well-fixed brain tissue for ultrastructural analysis, it is 
necessary to perfuse the brain mechanically with strong aldehydes.  This procedure requires that 
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animals be fully anesthetized prior to transcardial perfusion.  The elapsed time between 
administration of anesthesia and the fixation of the tissue (~ 15 mins) could be sufficient for 
endocytosis of CHT to significantly reduce the number of membrane transporters.  Due to the 
reduced activity of PPT/LDT neurons under barbiturate anesthesia (Pape & Eysel 1988), the rate 
of delivery of CHT to the membrane is expected to decline, and may have impacted our 
measurement of membrane CHT. However, the agreement of our findings with biochemical 
studies of CHT membrane trafficking, suggests that this experimental factor is not wholly 
responsible for the low levels of membrane associated CHT that we reported in Chapter 2.  Still, 
further experimentation to examine the effects of elevated neuronal firing on the ultrastructural 
localization of CHT within the axon terminal might reveal an altered membrane versus 
cytoplasmic distribution of transporters.  Such differences have been detected by homogenization 
and gradient fractionation of membranous components (e.g. synaptic vesicles versus plasma 
membrane) following depolarization of synaptosomes (Simon & Kuhar 1975; Breer & Knipper 
1990; Ferguson et al 2003) and in vivo following the performance of an attentionally demanding 
behavioral task (Apparsundaram et al 2005), but the pattern of subcellular immunohistochemical 
labeling following neuronal stimulation has not been examined by electron microscopy.  
Furthermore, the effects of increasing ACh release on high-affinity choline uptake have not yet 
been in examined in the projections of the brainstem tegmental cholinergic neurons.  Although 
we did not address this issue, our characterization of immunolabeling establishes that the 
baseline pattern of CHT localization in axon terminals arising from PPT/LDT neurons is similar 
to that of other cholinergic systems.  Furthermore, by comparing these populations, we were able 
to demonstrate that CHT expression is variable across individual cells of the same anatomical 
group, and to establish a relationship between total CHT content and probable high-affinity 
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choline uptake within individual boutons.  Finally, the similarity of our results to all existing 
observations of the subcellular distribution of CHT suggests that the regulation of high-affinity 
choline uptake is both robust and ubiquitous in cholinergic neurons. 
 
5.2.4 Activity-dependent Upregulation of CHT – Implications for REM sleep 
The pattern of immunogold-silver labeling for CHT reported in Chapter 2 suggests a low 
level of activity in these axons prior to fixation.  Separate from any effects of anesthesia, this 
pattern might also reflect the behavioral state of the animals prior to fixation, as perfusions were 
performed during the light phase of the circadian cycle during which rats usually sleep.  If the 
PPT/LDT were activated experimentally, greater differences in the membrane CHT levels of 
AVN and VTA cholinergic axons might be revealed.   
PPT/LDT cholinergic neurons show elevated firing rates during REM sleep periods 
(Steriade et al 1990a; Datta & Siwek 2002; Boucetta & Jones 2009); therefore, activity-
dependent upregulation of membrane CHT during REM sleep might also be examined to across 
behavioral state, and to further the understanding of the cellular environment in targets of 
PPT/LDT cholinergic projections across behavioral state.  The short duration of REM sleep 
epochs in the rat (Williams et al 1994; Datta & Siwek 2002) poses considerable technical 
challenges to studying PPT/LDT axon terminals across stages of the sleep-wake cycle; however, 
many psychotropic drugs have side effects that change sleep architecture (Wilson & 
Argyropoulos 2005; Doerr et al 2010).  Such agents could be used to increase REM 
experimentally and facilitate studies of CHT trafficking and function during different sleep-wake 
stages. 
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Interestingly, disturbances in sleep architecture are also observed in unmedicated patients 
with depression and schizophrenia (Hinton 1963; Tandon et al 1991; Göder et al 2004; 
Argyropoulos & Wilson 2005), emphasizing the need to understand the role of PPT/LDT 
cholinergic neurons in regulating behavioral state.  Although increased acetylcholine release has 
been detected in the thalamus during waking states and in REM sleep (Williams et al 1994), the 
assumption that similar increases occur in the PPT/LDT cholinergic projections to the ventral 
midbrain have not been directly tested.  Immunogold-silver localization of CHT might be used to 
indirectly measure changes in cholinergic activity due to experimental manipulations, facilitating 
the study of these less tractable pathways.  In addition, a single nucleotide polymorphism for 
CHT has been implicated in major depressive disorder (Hahn et al 2008) and is associated with 
altered corticolimbic reactivity during an behavioral task that requires inhibition of inappropriate 
responses (Neumann et al 2006), presumably due to altered function of CHT within the 
projections of the basal forebrain cholinergic neurons.  Transgenic models that incorporate this 
allele could be used to examine the effects of this polymorphism on cholinergic signaling in the 
innervation targets of the ascending projections of PPT/LDT neurons.  
5.2.5 Restricted Membrane Expression of CHT – Functional Implications  
Why should choline transport be so limited under resting conditions?  High-affinity 
choline uptake is the rate limiting step in acetylcholine synthesis and it seems counterintuitive 
that transmitter synthesis should be restricted in this manner.  However, CHT membrane content 
may be tightly regulated in order to limit secondary effects of high-affinity choline uptake on 
general cellular processes in the vicinity of cholinergic terminals.  To our knowledge, no 
detrimental action of elevated extracellular choline levels has been demonstrated, yet the 
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transport of this molecule across the blood brain barrier is carefully balanced with choline efflux 
from the brain, indicating that free choline levels in the brain are controlled by multiple 
regulatory mechanisms (Klein et al 1992). 
 In addition to its role as a precursor to ACh, choline is incorporated into membrane 
lipids as phosphatidylcholine and sphingeomyelin (Löffelholz et al 1993; Cooper et al 2003), so 
its monopolization by ACh synthesizing compartments could adversely affect non-cholinergic 
cells in the vicinity of ACh terminals.  In some brain regions, synaptic plasticity produces drastic 
changes in the morphology of spiny neurons (Robinson & Kolb 2004; Hofer & Bonhoeffer 2010; 
Russo et al 2010), indicating a need for increased production of phospholipid membranes.  
Furthermore, turnover of membrane components requires the constitutive generation of 
phospholipids to replace membranes that are degraded (Klein et al 1993b; Löffelholz et al 1993; 
Michel et al 2006). The total demand for choline for these cellular processes is high, and is met 
by low-affinity transport mechanisms with low affinity for choline, but faster kinetics than seen 
for CHT (Michel et al 2006).  Although the capacity of low-affinity uptake mechanisms is 
greater than that of CHT, the difference in affinities of CHT and other choline transporters is 
sufficiently great that high-affinity choline uptake following neuronal stimulation is estimated to 
account for up to 60% of total choline uptake in the vicinity of cholinergic terminals (Farber et al 
1996).  CHT transports extracellular choline with a Km = 1-5 µM, and so is predicted to be 
saturated by the typical concentrations of choline in the brain (10-15 µM; (Klein et al 1993a; 
Cooper et al 2003)).  Less restricted expression of membrane CHT would increase the total 
capacity of the transport system, and might decrease available extracellular choline for use by 
non-cholinergic cells in the immediate vicinity of cholinergic axons. 
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5.2.6 Alternative Explanations for the Regional Differences in CHT Expression – Role of 
the Specific Microenvironment of Innervated Regions 
High rates of ACh synthesis would only be required to rapidly refill synaptic vesicles 
during, or in the wake of, elevated ACh release.  Therefore, the tight coupling of the increase in 
CHT membrane levels to evoked release of ACh represents an elegant implementation of this 
specific choline uptake mechanism only when functionally necessary.  At resting levels of 
activity, limited membrane transporters exert little effect on extracellular choline levels.  During 
periods of high ACh release, increased high-affinity choline transport could temporarily act as a 
“sink” of extracellular choline, particularly if cholinergic terminals are dense in the 
microenvironment, and/or if many terminals were simultaneously activated.  However, the rapid 
endocytosis of CHT would reduce the impact of high-affinity choline transport once activity in 
cholinergic neurons returned to basal levels. 
The consideration of the extracellular environment with respect to choline concentrations 
raises an interesting possibility that the unique neurochemical architecture of the anterior 
thalamus might contribute to the higher CHT expression in that region.  The cholinergic 
innervation of the AVN is extremely dense relative to most other thalamic nuclei, and appears to 
consist of highly ramified axonal arborizations (Woolf & Butcher 1986; Woolf 1991).  These 
structural characteristics suggest that high-affinity choline uptake is likely to be increased in 
many cholinergic varicosities as a result of the activation of a single cholinergic afferent to the 
AVN.  Furthermore, the distinctive pattern of cholinesterase staining in the anterior thalamic 
nuclei (including the anterodorsal and anteromedial nuclei) suggests that extracellular choline 
may be relatively scarce within portions of the AVN (see Figure 16). 
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As discussed in Chapter 3, the particular elements of the local environment could 
theoretically influence both the expression and membrane trafficking of CHT.  Although the 
mechanisms that could signal the need for greater CHT expression to the cell body have yet to be 
identified, both CHT and VAChT mRNA are upregulated by exposure to nerve growth factor 
(NGF) (Berse et al 2005), indicating that retrograde signaling from axon terminals can influence 
the expression of these proteins.  This regulation appears to depend on intracellular Akt signaling 
(Madziar et al 2008).  The NGF pathway is not likely to operate in the projections that we 
studied, as the brainstem tegmental ACh neurons do not express receptors for this growth factor 
(Heckers et al 1992), nor does the AVN or the VTA display immunoreactivity for this receptor 
(Yan & Johnson Jr. 1989).  However, the existence of this regulatory mechanism serves as a 
proof-of-principle that receptor mediated events occurring at the axon terminal can influence 
transcriptional processes within the cell body.  Undoubtedly, there are other intracellular 
pathways that could link the relative demand for ACh synthesis to the expression of necessary 
cholinergic proteins in PPT/LDT cells. 
 
5.2.7 Little Evidence that CHT is Differentially Regulated in Regions with Choline 
Sensitive nAChRs 
Although we had speculated that CHT might be differentially regulated in areas with 
functionally significant expression of choline-sensitive α7 nAChRs (i.e. VTA compared to 
AVN), we found little evidence to specifically support this claim.  The finding of a significant 
interaction of brain region and total immunogold density on the density of membrane gold in the 
same terminals (Chapter 2) could be interpreted as evidence that the specific microenvironment 
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of an innervated brain region can exert modulatory influence over CHT trafficking; however, a 
more conservative explanation for this finding lies in the segregation of afferents to these brain 
regions to separate sets of cholinergic brainstem tegmental neurons.  It is possible that our 
population comparison could not adequately capture differences in the localization of CHT that 
might indicate a role for the transporter in regulating the excitability of this receptor.  Within 
both the AVN and VTA populations we saw a range of patterns to the immunogold-silver 
staining, with between 0 - 100% of gold particles being associated with the plasma membrane 
(See Appendix A, Figure 24).  If the relative membrane expression of CHT plays any regulatory 
role in restricting or facilitating α7 nAChR availability through the regulation of extracellular 
choline levels in the vicinity of these receptors, this might affect the distribution of CHT 
immunoreactivity in only a few axonal profiles at any one time, and would be further obscured 
by the reduced activity in the PPT/LDT neurons resulting from anesthesia.  Such hypothesized 
profiles would be unlikely to significantly skew the regional population statistics that we 
examined in Chapter 2.  In the absence of any additional information linking CHT function to α7 
nAChRs, we must conclude that the expression and regulation of CHT is directed solely toward 
maintaining adequate supplies of vesicular ACh.   
However, α7 nAChRs are not particularly dense in the VTA (Whiteaker et al 1999; 
Tribollet et al 2004), so the relative weakness of any effect that their presence may have on CHT 
regulation in PPT/LDT axons may have contributed to our difficulty in detecting gross 
differences in the distribution of CHT.  Comparison of cholinergic terminals in the AVN to a 
region with a heavier reliance on this mode of signaling might be more fruitful in determining if 
CHT function is altered in regions with choline-sensitive nicotinic receptors.  The thalamic 
parafascicular nucleus (PF) receives a heavy cholinergic innervation from the PPT/LDT (Levey 
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et al 1987; Cornwall et al 1990; Bolton et al 1993) and shows a high concentration of α7 
nAChRs (Whiteaker et al 1999; Tribollet et al 2004).  Examination of this region might reveal a 
difference in the membrane versus cytoplasmic distribution of CHT.  Additionally, the more 
similar density of cholinergic innervation between the AVN and the PF would eliminate the 
fluorescence imaging problems that necessitated the use of different capture settings in Chapter 
3.  Although we applied a correction to our data to facilitate the comparison of CHT and VAChT 
immunofluorescence, the ability to directly compare fluorescence intensity values across regions 
would strengthen any conclusions arising from comparison of two different brain regions.  
 
5.3 SURPRISING SPECIFICITY IN THE COLLATERALIZED LIMBIC 
PROJECTIONS OF CHOLINERGIC BRAINSTEM TEGMENTAL NEURONS 
Using dual retrograde tract-tracing from the AVN and the VTA, combined with 
immunohistochemistry for VAChT, we confirmed that the afferents to these limbic regions come 
from largely separate groups of ACh neurons in the PPT and LDT.  This finding confirmed our 
supposition that the morphological differences between the AVN and VTA populations of axon 
terminals, as well as differences in CHT immunoreactivity, are most easily explained by the 
existence of segregated projections to these brain regions.  However, the inclusion of a control 
case in which retrograde tracers were deposited in the midline/intralaminar paratenial nucleus 
revealed a sharp contrast of a highly collateralized ascending cholinergic input to the thalamus 
and the VTA.  Moreover, the collateralization observed in this case is consistent with similar 
findings from other laboratories (Woolf & Butcher 1986; Bolton et al 1993).  Importantly, 
 160 
collateralization of ACh inputs to the thalamus and VTA has previously only been investigated 
specifically for the midline and intralaminar groups which are functionally related to the VTA.  
Our novel description of a contrasting lack of collateralization between functionally dissimilar 
limbic regions indicates that the projections of the PPT/LDT are more highly organized than has 
been previously appreciated. 
 
5.3.1 Functional Organization of the Ascending Tegmental Cholinergic System 
Anterograde tract-tracing studies that examined the ascending projections from these 
tegmental brainstem nuclei emphasized the diverse subcortical targets of PPT/LDT axons (Satoh 
& Fibiger 1986; Woolf & Butcher 1986; Hallanger & Wainer 1988; Cornwall et al 1990).  The 
confirmation of these projections by retrograde tract-tracing suggested that there was some 
functional organization to the PPT versus LDT, in that retrogradely labeled neurons were more 
likely to arise from the PPT if the tracer injection was placed in regions that had clear sensory or 
motor-associated functions, such as the dorsal lateral geniculate nucleus of the thalamus, superior 
colliculus, and substantia nigra (Gould et al 1989).  Conversely, LDT neurons were more likely 
to innervate limbic structures whose function is more difficult to characterize (Woolf & Butcher 
1986).  Preferential retrograde labeling of LDT cells was also observed following tract-tracing 
from the monoamine cell groups in the locus coeruleus, ventral tegmental area, and dorsal raphé 
nuclei that innervate many limbic forebrain structures as well (Woolf & Butcher 1989).   
These anatomical observations have led to the appreciation of a functional topographic 
organization in the brainstem PPT/LDT; still, cholinergic neurons in these nuclei are still 
generally treated as homogenous and interchangeable units in the ascending cholinergic 
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brainstem system. This follows from the similar physiological phenotypes of these cells 
demonstrated in electrophysiological recordings from unanesthetized animals (Steriade et al 
1990a; Datta & Siwek 2002).  Although most PPT and LDT cholinergic neurons are believed to 
share similar biophysical characteristics (Kang et al 1990; Leonard & Llinás 1990) and firing 
patterns (Steriade et al 1990a; Grant & Highfield 1991; Steriade et al 1997), these cells do show 
some variability in sensory responsiveness (Grant & Highfield 1991; Pan & Hyland 2005).  
Furthermore, reciprocal connections between the PPT/LDT neurons and their forebrain and 
midbrain targets indicate that the functional topography that exists in the ascending PPT/LDT 
projections is paralleled by a functional organization of afferent input the brainstem tegmental 
nuclei (Satoh & Fibiger 1986; Woolf & Butcher 1986; Cornwall et al 1990; Woolf 1991).  The 
functional organization of PPT/LDT cholinergic neurons into separate sub-groups is further 
supported by studies on the discriminable behavioral effects of lesions or pharmacological 
manipulations of specific regions of the PPT (Winn 1998; Ainge et al 2004; Kayalioglu & 
Balkan 2004; Alderson et al 2008).  Although less is known about the intrinsic behavioral 
relevance of the LDT, it has a clearly demonstrated role in the process of addiction (Laviolette et 
al 2000; Forster et al 2002; Schmidt et al 2009), and its preferential innervation of limbic regions 
suggests a general role for this brainstem nucleus in higher cognitive functions. 
However, the idea that PPT and LDT cholinergic neurons form sub-groups of 
functionally related modulatory cells has been contradicted by the extensive collateralization of 
their axons.  Following several studies that examined colocalization of two or more retrograde 
tracers, transported from different brain regions, many concluded that the projections of these 
neurons were diffusely spread throughout thalamic and subcortical regions (Wainer & Mesulam 
1990; Bolton et al 1993).  This property of divergent projections to widespread structures from 
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through the bifurcation of a single axon has been compared to similarly diffuse projections 
arising from the monoaminergic NE and 5-HT cells in the brainstem (Mesulam et al 1983; 
Mesulam 1995a; Mesulam 1995b).  Furthermore, collateralization of axons is a characteristic 
property of many neurons found in the reticular formation, an anatomical structure that includes 
both the PPT and LDT, but encompasses large portions of the brainstem in which neurons are 
organized without clear nuclear boundaries (reviewed in Jones, 1995).   
The contrasting results of our retrograde tract-tracing from the AVN and the anterior 
medial/intralaminar thalamus help to resolve these conflicting views of the anatomical specificity 
of PPT/LDT cholinergic neurons.  In light of this finding, it was fortuitous that we initially chose 
to examine CHT immunoreactivity in the AVN rather than a thalamic nucleus with a clearer 
functional relationship to limbic dopamine projections.  All previous studies that suggested 
heavy collateralization of the ascending PPT or LDT projections have examined related targets 
of brainstem tegmental ACh (e.g. visual thalamus and superior colliculus (Billet et al 1999), 
midline/intralaminar thalamic and VTA (Bolton et al 1993)).  
As previously discussed (see General Introduction and Discussion, Chapter 4), there is 
significant topographical organization to limbic forebrain regions that supports the existence of 
separate functional circuitry within the umbrella concept of the limbic system (Domesick 1969; 
Krettek & Price 1977; Berendse & Groenewegen 1991; Bentivoglio et al 1993; Giménez-Amaya 
et al 1995; Gabbott et al 2005; Morgane et al 2005).  As delineated by the thalamic components 
of these functional systems, it is clear that at least two such circuits exist and are relatively 
isolated from each other.  The AVN has prominent connections with cortical regions that 
subserve spatial learning and memory, and may play a role in conditioned aversion learning as 
well (Gabriel et al 1980; Sparenborg & Gabriel 1992; Michel et al 2006).  These functions 
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appear more closely related to the association of behaviorally relevant events with a specific 
location in space, rather than a specific action on the part of the animal (Gibb et al 2006).  In 
contrast, the midline/intralaminar nuclei in the thalamus innervate distinctly different parts of the 
cerebral cortex and striatum that have well-defined roles in guiding appetitively motivated 
behavior, particularly in selecting an appropriate action based on environmental cues 
(Groenewegen & Witter 2004).  This characterization of the functions of these systems is, of 
course, a great simplification. However, the specific behavioral deficits observed following 
lateral anterior thalamic lesions versus medial/intralaminar thalamic lesions supports this view of 
the distinctive roles mediated by these circuits (Morgane et al 2005; Mitchell & Dalrymple-
Alford 2006).  Our results indicate that the anatomical segregation of this circuitry extends to the 
specific ascending cholinergic modulation of these regions. 
 
5.3.2 Significance of Functionally Targeted Collateralized Projections of the PPT/LDT 
Cholinergic System 
The functional significance of collateral ACh projections from the PPT/LDT has not, to 
our knowledge, been determined.  The general function of ascending cholinergic modulation 
from the brainstem tegmental ACh system is to promote the excitability of innervated principal 
neurons (Paré et al 1990; Wainer & Mesulam 1990; Steriade et al 1997); hence coordinated input 
would presumably increase activity at several different sites within a specific limbic circuit.  
However, more specific predictions of the integrated effects of coordinated modulatory ACh 
input to multiple components of the same forebrain circuitry are currently elusive.   
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Furthermore, the co-transmission of ACh and neuropeptides invites the supposition that 
collateralization of cholinergic axons to distinct brain regions may represent distinct 
neurochemical projection systems, and that peptidergic co-expression might be used as a way to 
identify PPT/LDT ACh neurons which project to specific forebrain and midbrain targets, but 
further work delineating peptide phenotype and anatomical connections of brainstem cholinergic 
neurons is needed. 
Finally, future investigations might reveal collateral projections of cholinergic afferents 
to the AVN that target other, functionally related subcortical regions.  Interestingly, anterograde 
labeling from the LDT indicates a substantial projection to the lateral septum (Satoh & Fibiger 
1986), a region that is functionally related to the AVN through its similar anatomical 
connections.  If cholinergic neurons in the PPT and LDT possess a general property of 
collateralized projections to functionally related targets, then dual tract-tracing from the AVN 
and the septum would be expected to result in labeling from both regions in the same neurons.  
Conversely, if AVN- projecting tegmental cholinergic neurons do not innervate other related 
structures, then the heavy collateralization of PPT and LDT projections to medial thalamic nuclei 
and the midbrain VTA described here and elsewhere (Woolf & Butcher 1986; Bolton et al 1993) 
may be relatively specific to this limbic circuitry.  Interestingly, collateralization of other inputs 
to midline/intralaminar thalamic nuclei has been demonstrated (Cornwall & Phillipson 1988b; 
Cornwall & Phillipson 1989), and thalamic neurons in these regions also have branched 
projections (Otake & Nakamura 1998) suggesting that medial limbic circuitry might be 
characterized by extensive co-ordination of inputs.  Further experimentation is needed to fully 
understand the anatomical characteristics of these systems, and to appreciate the functional 
consequences of these collateralized projections. 
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APPENDIX A 
ULTRASTRUCTURAL LOCALIZATION OF CHT IMMUNOGOLD-SILVER 
LABELING IN AVN & VTA:  RATIO OF MEMBRANE TO CYTOPLASMIC GOLD 
PARTICLES IN CHT IMMUNOREACTIVE AXON VARICOSITIES 
The following figures were not included in the published manuscript presented in Chapter 
2, but were generated from the same dataset used for that publication (Table 1, Data Set #3).  
However, this analysis included an additional 20 terminals (3 from AVN and 17 from VTA) that 
were later discarded due to low total gold labeling relative to background.  The estimation and 
regional comparison of the proportional membrane gold immunolabeling were presented at the 
2008 Society for Neuroscience Annual Meeting in poster form (Holmstrand et al 2008), and are 
shown here with minimal changes.  
 
A.1.1 Materials and Methods 
Details of the immunohistochemical procedures and classification of gold particles can be 
found in the Methods section in Chapter 2.  The proportional membrane gold labeling was 
calculated by dividing the total number of membrane gold particles by total number of gold 
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particles for each profile.  Mean proportions for each region were calculated by averaging this 
proportion over all profiles within each region.  The regional means were compared using a 
mixed model ANCOVA with fixed effects of region and profile area.  Statistical significance 
was assessed at the p = 0.05 level. 
A.1.2 Results 
The mean proportion of CHT immunogold particles associated with the plasma 
membrane of all CHT-ir profiles in the VTA (0.19) was apparently lower than the mean 
proportion observed over all CHT-ir AVN profiles (0.25, Figure 24A).  The lower mean of the 
VTA population probably resulted from the fact that more VTA profiles showed membrane/total 
gold ratios in the low range of this value (Figure 24B).  In both regions, we saw profiles with a 
membrane/total gold ratio ranging from 0 (i.e. no membrane-associated CHT), to 1 (i.e. all CHT 
immunogold particles were < 20 nm from the plasma membrane).  However, when we examined 
the effect of brain region on this proportion while accounting for variability due to repeated 
sampling from the same tissue sections and animals, the difference in this mean proportion of 
membrane/total gold was not statistically significant. 
A.1.3 Conclusion 
Consistent with previous estimates of the subcellular distribution of CHT in other 
cholinergic neurons, the proportion of membrane/total gold labeling was stable across different 
regional populations of CHT immunoreactive axon profiles arising from the PPT/LDT 
cholinergic neurons.  The distribution of CHT to membrane versus cytoplasmic cellular  
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Figure 24  Proportional membrane gold labeling of CHT-ir axon varicosities in the AVN and VTA 
 
A  Mean values obtained for the proportion of CHT immunogold particles observed within 20 nm of the plasma 
membrane (# membrane gold particles / # total gold particles).  Although the mean for the AVN terminals was 
apparently higher than that observed in the VTA population, we observed some variability in this relationship across 
animals.  A mixed model ANCOVA was therefore used to analyze the fixed effects of region and profile area on this 
proportion.  The analysis revealed that the effect of region was not significant (F(1, 1064)  = 1.89; p = 0.1699).  B  
Cumulative frequency of values observed for the ratio of membrane gold particles / total gold particles in AVN and 
VTA populations of CHT-ir axon varicosities.  Although the regional distributions of this ratio were similarly 
shaped, more VTA varicosities appeared to have low ratios of membrane/total gold labeling for CHT, resulting in 
the lower (though not statistically significant) apparent mean shown in A. 
 
  
 168 
compartments probably reflects the balance of exocytic and endocytic processes.  Therefore, the 
present findings indicate that the equilibrium of these two processes is the same across 
cholinergic axons innervating the AVN versus the VTA.  The stability of this ratio may represent 
well-conserved cellular processes that control the recycling of CHT under resting conditions.  
However, the redistribution of CHT to the membrane (e.g. due to prolonged excitation of the 
parent neurons) may yet reveal regional differences in the functional regulation of high-affinity 
choline uptake.   
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APPENDIX B 
DUAL IMMUNOFLUORESCENCE FOR CHT AND VAChT:  SUPPLEMENTARY 
TECHNICAL DATA AND ADDITIONAL STATISTICAL ANALYSIS 
In the dual immunofluorescence investigation of CHT and VAChT described in Chapter 
3 , the higher density of cholinergic terminals in the AVN compared to the VTA resulted in 
binding of more fluorescent-conjugated secondary antibodies.  This concentration of 
fluorophores resulted in detection of dramatically higher overall fluorescence levels, since each 
fluorophore theoretically emits a similar number of photons that reach the detector.  The non-
equivalence of the 488- and 568-fluorescence intensities from the AVN and VTA stacks required 
the use of different capture settings to avoid unnecessarily low signal to noise ratios in the VTA 
images, or saturation of the detection system in images captured from the AVN.  We used the 
live-imaging fluorescence intensity histogram to adjust these settings, and aimed to equalize the 
range of intensity values seen in AVN and VTA image stacks.  For the 488 channel, both 
exposure and gain settings were increased for VTA imaging (exposure = 2500 ms; gain = 50) 
relative to the settings used for AVN imaging (exposure = 1700 ms; gain = 0).  For the 568 
channel, only exposure was varied (AVN: exposure = 1500 ms; VTA: exposure = 2300 ms).  
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In order to compare the quantitative fluorescence intensity data between regions, a 
correction was applied to the AVN dataset for each channel, based on the fluorescence intensities 
obtained from imaging  
B.1.1 Effects of Varying Exposure Time and Gain on Fluorescence Intensity of Standard 
Fluorescent Beads 
Fluorescent polystyrene calibration beads (InSpeck 0.3% Intensity beads: Green – ex: 
505 nm and em: 515 nm; Orange – ex: 540 nm and em: 560 nm; Invitrogen, Carlsbad, CA) were 
mounted on glass slides, air dried, and coverslipped with Fluoromount-G (Southern Biotech, 
Birmingham, AL).  The beads were then imaged on the same spinning disk confocal system that 
was used for the dual-immunofluorescence study detailed in Chapter 3.   
A range of exposures (1000 – 2500 ms) and gain settings (0 – 50) were used to collect Z-
stack images through the entirety of the green beads.  Orange beads were imaged in a similar 
manner, but only the exposure time was varied (1000 – 2300 ms).  
Image stacks were corrected photobleaching and deconvolved as in Chapter 3.  The mode 
FI value of the deconvolved image stack was subtracted from the single channel image.  The 
same threshold segmentation approach that was used to identify immunofluorescent puncta in 
brain tissue was applied to the bead image stacks (threshold value = 2x mode, threshold applied 
to background subtracted image).  The mean FI of each object identified by this threshold 
masking was exported to Microsoft Excel. 
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a. Calculation of Exposure and Gain Corrections 
Mean 488 nm FI of the calibration beads was plotted against exposure and gain, as shown 
in Figure 25 A&B.  Mean FI was regressed against exposure time and gain using PASW (v18, 
SPSS, Chicago, IL).  The regression was linear and did not include an intercept term.  The 
regression coefficients for exposure and gain (Figure 25C) were used to increase the mean 488-
CHT FI of AVN objects to compensate for the higher exposure time (+800 ms) and higher gain 
(+50) used to image VTA objects. 
Similarly, mean 568 nm fluorescence intensities of the orange calibration beads were 
plotted (Figure 26A) and regressed linearly against exposure times of the calibration data.  The 
resulting linear equation (Figure 26B) was used to transform the mean 568-VAChT FI of AVN 
objects to compensate for the higher exposure time (+800 ms) used to image the VTA. 
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Figure 25  Mean 488 Fluorescence Intensity Calibration Values  
 
Mean fluorescence intensity of green calibration beads plotted against the corresponding (A) exposure time 
or (B) gain.  Effect of the second variable is shown by series.  Lines are shown to for illustrative purposes 
only.  C  Calibration fluorescence intensity data was regressed simultaneously against exposure and gain. 
The resulting equation and coefficient of determination (R2) are shown. 
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Figure 26  Mean 568 nm Fluorescence Intensity Calibration Values 
 
A  Mean fluorescence intensity of orange calibration beads plotted against exposure time.  B  The resulting 
linear equation used to transform AVN 568-VAChT FI data and coefficient of variation of the regression 
line. 
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B.1.2 Revised Statistical Analysis of Dual Immunofluorescence for VAChT and CHT in 
the AVN and VTA 
After consulting with Dr. Alan Sampson, Ph.D., and Josephine Asafu-Adjei in the 
Department of Statistics at the University of Pittsburgh, some changes were made to the 
statistical analyses applied to these data.  The amended procedures and resulting conclusions are 
detailed below. 
a. Statistical Analysis 
Methods of data collection and image analysis remained unchanged from the procedures 
detailed in Chapter 3.  To compare colocalization frequencies observed between the AVN and 
VTA populations, the percentage of AVN and VTA immunofluorescent puncta that met 
colocalization criteria were first calculated for each tissue section, these section-specific 
percentages were then averaged for each animal.  The animal specific averages were then 
transformed by applying the arcsin(sqrt(x)) function.  The difference between the 
arcsin(sqrt(%colocalized)) for the AVN minus the VTA estimates within each rat was calculated, 
and the distribution of the differences was examined across all rats.  These differences were 
assumed to be normally distributed, as determined by Kolmogorov-Smirnov testing (for VAChT-
ir objects, p = 0.200; for CHT-ir objects, p = 0.160).  The significance of regional differences in 
the rate of colocalization observed in VAChT-ir puncta and CHT-ir puncta was determined 
using a one-sample t-test and significance level of p < 0.05.  
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The linear mixed models used to test for regional differences in the fluorescence 
intensities of VAChT or CHT immunoreactivity outlined in Chapter 3 were deemed appropriate 
for this study and remain unchanged from their presentation within that chapter. 
For comparison of the relative amounts of VAChT and CHT immunoreactivity within 
each puncta were amended under advisement from Dr. Sampson.  Rather than use the ratio of the 
log mean FIs, the test statistic was changed to the difference of these log values (i.e. [log(mean 
2nd marker)] – [log(mean 1st marker)].  The structure of the linear mixed model was not 
changed, and the random effects of animal and tissue section within animal were retained.  
Furthermore, although a different permutation of the data was used for the dependent variable, 
the revised analysis did not change the conclusions presented in Chapter 3. 
 
b. Results 
i. Regional comparison of the frequency of colocalization observed for VAChT-ir 
 and CHT-ir immunofluorescent puncta 
We recalculated the percentage of immunofluorescent objects that showed colocalization 
of the second immunofluorescent marker for each animal, resulting in slightly different estimates 
of this measure for each animal (Table 7).  These estimates were different from those initially 
reported in Chapter 3 because we first estimated the percentages in each tissue sections, then 
averaged the section-specific estimates for each animal.   
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Table 7 Percentages of VAChT-ir and CHT-ir objects that colocalize immunoreactivity 
for both proteins 
 
 
 
 
 
  
A.  VAChT-ir Objects
Animal AVN VTA
1 62% 66%
2 70% 56%
3 77% 67%
4 71% 48%
5 86% 61%
B.  CHT-ir Objects
Animal AVN VTA
1 77% 73%
2 71% 43%
3 75% 45%
4 82% 57%
5 75% 59%
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For formal statistical testing, the revised mean colocalization estimates for each animal 
were transformed by computing the arcsine of the square root of each estimate.  For each animal, 
these transformed values were compared across region by subtracting the value obtained for the 
VTA population from that obtained for the AVN population.  The resulting differences were 
tested against the null hypothesis that the true difference between the populations was equal to 
zero, using a Student’s one sample t-test.  For the VAChT-ir objects, the null hypothesis was not 
rejected.  The estimated difference of the arcsin(sqrt) values was 0.1486 + 0.1272 (mean + SD), 
which corresponds to a difference of less than 0.0007% in the rate of colocalization (t(4) = 2.613,  
p = 0.059).  This result stood in contrast to the significant difference in colocalization observed 
between the AVN and VTA populations when the odds ratio was used to construct confidence 
intervals, as presented in Chapter 3.  However, the estimate of the odds ratio did not take into 
account relatedness of data from the same sections and hence may have underestimated the true 
variability in the dataset.  Given this limitation, and under advisement of the consulting 
statisticians, we believe that the analysis presented here more accurately captures the true 
relationship between colocalization of VAChT-ir objects in the AVN and VTA.  Therefore, we 
conclude that VAChT-ir puncta are just as likely to display colocalization in the AVN as in the 
VTA.   
For CHT-ir objects, the same analysis was performed.  In this case, one sample t-test on 
the difference in arcsine(sqrt(%colocalized) between the AVN and VTA revealed a significant 
difference in the percentage of CHT-ir puncta between regions (t(4) = 4.586,  p = 0.010).  The 
estimated difference (AVN-VTA) was 0.2225 + 0.1085 (mean + SD), which corresponds to a 
difference in percentages of 0.015%.  Although statistically significant, the small size of this 
estimated difference emphasizes that CHT-ir objects in both regions were still similar in their 
 178 
tendency to colocalize VAChT immunoreactivity.  The significant difference that we report here 
most likely arises from a sub-population of CHT-ir puncta that are more prominent in the VTA. 
 
ii. Quantitative regional comparison of VAChT and CHT fluorescence intensity 
As noted in the methods of this appendix, the comparisons of fluorescence intensities 
observed in VAChT- or CHT-ir objects across regions was not modified from that originally 
presented in Chapter 3.  However, an additional analysis of the fluorescence intensities of the 
secondary marker in all puncta was performed that was not initially described in that chapter.  
The distribution of mean object fluorescence intensity of the second marker is shown in Figure 
28.  Mixed model analysis was used to compare the mean CHT FI of all VAChT-ir objects, 
while accounting for variability due to repeated sampling from the each tissue section and rat.  
This analysis revealed that AVN objects had higher mean CHT FI than VTA VAChT-ir objects 
(F(1, 47.33) = 7.468, p = 0.009; estimated difference (AVN-VTA) = 424).  Similarly, the mean 
VAChT FI of CHT-ir objects in the AVN was also higher than that observed in VTA puncta (F(1, 
44.35) = 42.52, p < 0.001; estimated  difference (AVN-VTA) = 1019).   
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Figure 27 Frequency distributions of mean object fluorescence intensities – primary 
 immunofluorescent marker 
 
Mean CHT FI of CHT-ir objects (top panel) and mean VAChT FI of VAChT-ir objects (bottom 
panel) sampled from the AVN and VTA.  Values obtained from the VTA sample had a broader 
distribution of values, with the lower end of the VTA distribution displaying lower fluorescence 
intensities than the corresponding distribution of AVN datapoints. However, the VTA distribution 
extended to similarly high values as that of the AVN. 
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Figure 28 Frequency distributions of mean object fluorescence intensities – secondary 
 immunofluorescent marker 
 
Mean CHT FI of VAChT-ir objects (top panel) and mean VAChT FI of CHT-ir objects (bottom 
panel) sampled from the AVN and VTA.  The VTA population displayed a greater range of 
values, both on the lower end of the range, which was lower for the VTA sample than for the 
AVN, and at the upper end of the range, where a higher percentage of VTA objects were 
represented. 
 181 
iii. Comparison of relative levels of CHT and VAChT fluorescence intensities within 
colocalized puncta 
Within colocalized boutons, the change in statistical analysis from using the ratio of the 
log mean FIs to using the difference of the log mean FI did not result in any change to our 
conclusions.  For the difference of log mean CHT FI – log mean VAChT FI of colocalized  
VAChT-ir puncta, there was no significant effect of region ( F(1, 45.09) = 0.275, p = 0.603).  
Similarly, in colocalized CHT-ir puncta, the difference of log mean VAChT FI – log mean CHT 
FI was not significantly different across regions (F(1, 44.94) = 2.420, p = 0.127).  By either method 
used to examine the relationship between VAChT FI and CHT FI in individual puncta, there 
does not appear to be any regional differences in the relative expression of these two proteins. 
 
c. Conclusions 
Only one substantive change to the conclusions presented in Chapter 3 has resulted from 
the alternative statistical analysis of these data.  Concerning the colocalization of significant 
CHT-immunoreactivity (i.e. above-threshold fluorescence for CHT) in objects identified on the 
basis of VAChT-immunoreactivity, the more precise analysis presented in this appendix 
indicates that there is no difference in the frequency of colocalization between the brain regions 
examined.  However, colocalization of VAChT- immunoreactivity in CHT-ir objects was 
significantly less common in the VTA population of boutons than in the AVN.  The preservation 
of this difference, even when the section related variability was accounted for, further supports 
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the notion that the singly labeled CHT-ir objects in our sample are real examples of axonal 
compartments that contain appreciable levels of CHT, but little or no VAChT.   
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